Highlights
Updated Nov 12, 2026, 11:15 AM ET- Nvidia faces severe governance and national-security overhang: CEO Jensen Huang admitted to an affair with alleged Chinese spy Alice Huang and a second alleged affair with a VP; DOJ and congressional probes focus on Megaspeed export violations and Chinese universities bypassing chip bans. The board hired Wachtell Lipton and crisis firm Heller, is weighing his removal, and has no clear succession plan (60 direct reports, family on payroll). Market reaction has been sharp: stock is down 9–11% over several days, off 34% from its high, with over $300B in market cap lost; multiple law firms are preparing securities-fraud class actions. Prediction market Kalshi puts only ~30% odds he remains CEO; the board may keep him as chair.
- Nvidia’s troubles are spilling over into the broader AI complex but haven’t derailed it: CoreWeave’s strong Q3 (revenue $3.66B, +168% YoY; $132.5B backlog funded via contract-backed loans; 35% cumulative price hikes; still a $709M net loss) drove its stock up 20% and lifted peers including Nebius and Nvidia. Bernstein flags capacity risk but management says regulation won’t alter plans.
- OpenAI and Anthropic show explosive but uneven economics: OpenAI Q3 revenue reached $10B (+50% QoQ) with adjusted margin still deeply negative (-109%). Anthropic reported $17B Q3 revenue and an $81B ARR vs OpenAI’s $50B, and is planning a massive IPO: filings target 825M shares at $70–$78, implying $57.8B–$64.4B IPO valuation plus $26B of concurrent private sales to AMD, Broadcom, Google, Nvidia and others, for total proceeds up to ~$94B; founders will sell shares for ~$236M–$264M each while retaining 51.1% voting control via Class F stock. A separate report mentions a tech IPO next week with valuation cut from $2T to under $1.5T amid Nasdaq weakness and the Nvidia scandal.
- AI infrastructure and data-center buildout is materially impacting capex and macro data: AI-related investment is ~1.7% of U.S. GDP and has driven business fixed investment to 17% of GDP, but >70% of spend is on imported equipment, so the direct GDP boost is offset by a wider trade deficit. The buildout has created a strong wealth effect via higher profits and equity valuations, though political resistance to data centers in the US and Europe is an emerging constraint.
- AI hardware competition is intensifying: Google launched TPU 8tx and TPU 8i Max (co-developed with AMD) to reduce reliance on external chipmakers, with higher security, on-the-fly training and doubled memory/power. UK startup Fractile raised $720M at >$7B valuation, targeting shipment of domestic AI chips next year to secure the UK’s hardware base.
- Software and AI platforms continue to roll out new agents and tools: Databricks introduced Genie, an enterprise AI agent for firms with 150+ employees that executes multi-step tasks via custom ontologies and Unity Gateway. Anthropic launched Claude Meetings, Whiteboards, Sheets and Claude Data for collaborative work and data connectivity. OpenAI rolled out a Business Hub for verified profiles and specialized agents, repositioning ChatGPT more as a discovery platform than direct commerce. Startups like Plurai (raised $13M) and Helix (raised $6M) focus on improving AI agent reliability via synthetic data/digital twins and on-device voice identity, respectively.
- Consumer/creator-facing AI features are expanding: Spotify upgraded its AI DJ for 94M+ Premium users with more voices and lower commentary. Reddit launched AI-powered Reviews for 10k products ahead of the holidays. X rolled out a video clipping tool with creator rewards. Otter.ai added multilingual transcription in 31 languages with new work and coaching features. Adobe MAX updates added Firefly Builder beta, ChatGPT-based MCP integration, and new Photoshop/Premiere capabilities.
- Google and Adobe deepened their strategic partnership: Acrobat will be embedded into Google Workspace (Drive, Gmail), while Google’s Gemini models will power AI in Acrobat, Photoshop and other Adobe apps; Google’s imaging/video models will feed Adobe Firefly, Premiere and Express, tightening integration across productivity and creative workflows.
- Cloud and dev tooling: AWS launched AWS Emulator, a Rust-based local tool that lets developers run AWS APIs on their own machines for free, compatible with existing CLI/SDK scripts. Kora Systems announced a Linux OS (launching 2027) with integrated AI and autonomous agents, targeting 50M users with a subscription model for its Cortex AI engine. N-able temporarily disabled N-Central to patch a zero-day root-access bug, saying no exploitation occurred. Wyndham disclosed a Salesforce data exposure via hardcoded Android credentials, later revoked with no evidence of unauthorized access.
- Meta and Google continue to push consumer AI/infra: Meta replaced its infrastructure head with ex-Amazon VP Dave Brown as it ramps AI infra spend; it also launched the Muse AI agent on Apple Watch and Wear OS (10M US downloads in 40 days) for voice/text/video tasks and avatars. Google’s Pixel Tag item tracker debuts at $29.99 with UWB and Find Hub integration.
- Security and governance risks in AI are rising: Irene Solaiman highlighted hacking risks on open AI platforms after attacks on OpenCode, OpenAI and Fireworks, prompting tighter security at Hugging Face and GitHub. A separate report notes AI-sector espionage beyond Nvidia, including multiple unpublicized cases involving executives and state actors.
- Venture and capital markets for tech: In US VC, firms on their 4th+ fund captured 88.2% of dollars in 2026 YTD; first-time funds raised just 4.5% and only 81 closed, worst in a decade, despite evidence that $1M–$10M funds often outperform larger ones. The global AI boom has created broad equity exposure across pension funds and insurers, making any correction in AI-linked names a macro risk.
- Other notable tech launches: X’s new video clipping tool with monetization; Amazon’s Ring Robotics (indoor Drone Cam and Rover Cam for businesses); Aura’s $349 10" E Ink photo frame; Matter’s Sundrop on-device baby-photo recap app; Apple TV’s sign-language overlay feature; Adobe–Google integration for AI editing; and MIT’s use of Anthropic Fable 5.2 in proving a major quantum-computing conjecture, underscoring AI’s role in research productivity.
- Economic commentary on AI investing: Analysts emphasize that while Nvidia and TSMC are near-term winners, AI’s long-run profitability is uncertain due to potential commoditization, heavy infrastructure needs, regulatory/tax risks, and the possibility of rapid shifts in competitive leadership.
News Briefs
- NVDAJensen Huang resigned as Nvidia CEO after admitting to an affair with an alleged Chinese spy. Collete Kress serves as interim CEO. Shares fell 11% as market cap dropped over $300B. Harvey C. Jones appointed first-ever board chair. Nvidia thanked Huang for contributions. TechCrunch · 2h ago
- DISCosm partners w/ Disney for Star Wars dome films in March, coinciding w/ the franchise's 50th anniversary. The experience features 87ft 12k screens, immersive backgrounds & a themed menu. This marks Cosm's sixth Hollywood collab, following Warner Bros. & Universal. CNBC · 2h ago
- 005930.KSNine Korean deep tech startups pitched at DETO 2026 for 200 Startup Battlefield spots. Voinosis won with an AI brain health tool. Others include Awesome Lab, Crosshub, DeepFusion AI, EFLOW, Otiton Medical, Riibotics, Ternell & Testbank. All target U.S. market entry. TechCrunch · 2h ago
- VOW3Scout Motors has 212k reservations for its Terra pickup & Traveler SUV, nearing completion of a $2B SC plant. Full production starts next year with deliveries in 2028. CEO Keogh expects orders to double, with 87% for EREV models & 75% for SUVs. CNBC · 4h ago
- NVDAKalshi gives Jensen Huang 30% chance to stay CEO amid admitted affair. Nvidia lacks succession plan. Potential candidates include Lisa Su, Eric Schmidt, Lip-Bu Tan, Bret Taylor, Ian Buck, Andrew Bell, Colette Kress, or wife Lori Huang. Board may keep him as chairman. TechCrunch · 13h ago
- NVDAJensen Huang admitted cheating on his wife with Alice Huang, a spy suspect. Nvidia board plans to oust him amid national security concerns & Megaspeed chip smuggling probe. Shares slid over 5%. Trump supports Huang. TechCrunch · 16h ago
- NVDANvidia's board meets Wednesday to decide CEO Jensen Huang's fate after he admitted an affair with a Chinese spy. Stock dropped 8% in after-hours trading and is down 11% in five days. Huang has 60 direct reports with no clear successor. TechCrunch · 16h ago
- NVDANvidia CEO Jensen Huang faces investigation for an affair with a woman accused of being a Chinese spy & a second alleged affair with VP Kimberly Powell. The board is looking into ousting Huang, while House Republicans plan to subpoena him regarding spy allegations. TechCrunch · 17h ago
- GILDUS accuses CANARX of illegal drug imports 2017-2026. Treasurer John Thomas Howard arrested Sunday; president Bob Howard at large. Company sources meds from Canada, UK, Australia, NZ. Gilead sues over HIV meds; FDA seized shipments in 2023. CNBC · 18h ago
- METAMeta's Santosh Janardhan steps down as head of infrastructure, replaced by ex-Amazon VP Dave Brown. Janardhan transitions to an advisory role on Meta Compute before leaving next year. The move comes as Meta boosts infrastructure investment to compete in the AI race. TechCrunch · 20h ago
- Firms with 4th+ funds captured 88.2% of US VC dollars in 2026 Q1-Q3 while first-time funds got 4.5%. Just 81 first-time funds closed, making 2026 the worst year in a decade. Yet small funds between $1M-$10M consistently outperform larger ones. TechCrunch · 20h ago
- MSFTCoreWeave Q3 revenue hit $3.66B, up 168% YoY, but net loss was $709M. To fund $132.5B backlog, it uses contract-backed loans, avoiding unsecured debt at yields over 15%. Prices rose 35% total, with short-term contracts exceeding $40M per megawatt annually. TechCrunch · 20h ago
- FTSEFractile raised $720M Series C led by Thrive, Founders Fund, Lightspeed & Redpoint, with backing from Britain's Sovereign AI Fund. Valued over $7B, the UK startup aims to ship AI chips next year to secure domestic hardware for its future economy. TechCrunch · 20h ago
- NVDAHouse Republicans plan to subpoena Nvidia CEO Jensen Huang over alleged China spy ties. Reps Mast, Moolenaar & Crawford seek a closed-door briefing. Moolenaar demands a response by end of day or face subpoena. Nvidia did not immediately comment. TechCrunch · 20h ago
- AALAmerican Airlines reintroduces fresh first class bites on NY-Chicago flights this month, including prosciutto & melon or Thai noodle salad. This marks the return of fresh food since 2019 as the carrier seeks to compete with Delta & United through premium upgrades. CNBC · 22h ago
- NVDAAI sector faces espionage beyond Nvidia scandal. Heron CEO Nate Singer cites execs crossing lines with state actors via jet incidents & 3+ cases. Semis are frequent trade secret theft targets. Sexual elements rarely public. Singer claims many condone activities. TechCrunch · 1d ago
- METAOpenAI Q3 revenue hit $10B, a 50% jump from Q2. Adjusted margin improved to -109%. Anthropic reported $17B Q3 revenue with an $81B annual run rate vs OpenAI's $50B. Both face competition from Meta, Amazon, Microsoft, Google, & open-source labs. TechCrunch · 1d ago
- TCKRHelix, a 2025 startup by Oberg, Dorofiyenko & Hall, raised $6M for on-device voice identity tech. Backed by Chicago Ventures & Siri's Kittlaus, it pilots CAPTCHA replacement & distress detection. CEO Oberg notes it cannot detect lies or AI agents reliably. TechCrunch · 1d ago
- JBLUJetBlue denies bankruptcy & restructuring plans as shares surged 40%. CEO Geraghty confirmed no layoffs. New BlueFirst seats launch next month. Targets operating profit next year & $1 EPS by 2028. Debt stands at $8.4B. Deutsche Bank upgraded stock citing conservative growth. CNBC · 1d ago
- Databricks unveiled Genie, an AI agent for firms with 150+ employees. It executes multi-step tasks via custom ontologies & Unity Gateway for cost control. CEO Ali Ghodsi demonstrated real-time advice & analysis of unvarnished feedback without external tools. TechCrunch · 1d ago
- NVDAAI agents lack reliability for complex unsupervised work. Startup Plurai uses synthetic data & digital twins to fix edge cases. Founders Ilan Kadar & Elad Levi secured $13M seed funding from Team8 to post-train small open-weight models for lower costs. TechCrunch · 1d ago
- NVDANvidia shares fell 9.5% in two days after CEO Huang admitted to an affair & suspected spying for China. The board hired Wachtell Lipton to investigate violations. A class action alleges securities fraud while experts criticize lack of succession planning & family employment. TechCrunch · 1d ago
- GOOGLX launched a new video clipping tool. Users can edit & post directly. "Clip from" links to sources. Creators earn via Original Content Rewards. This follows 2022 long-form updates, March paywalled threads, & July's $1M live-streaming studio grant. TechCrunch · 1d ago
- FOSLFossil Group hit Q3 profitability with $25.3M op income & $11.7M net. Sales up 0.4% to $271.2M, fueled by 15.1% Asia growth. Raised FY guidance to $980-$985M, expects positive free cash flow by year-end, & plans smaller retail base for 2027. CNBC · 1d ago
- EXPEOpenAI quietly acq-hired Odessia, a 1-year-old AI travel agent founded by Francis Davidson. Odessia raised $6M from Sequoia before shutting down after helping users plan millions in travel. This follows OpenAI's July 2025 mention of travel as a key AI assistant use case. TechCrunch · 1d ago
- NY opened AI registration for firms >$500M revenue by Jan 1, 2027 under RAISE Act. Firms must publish safety frameworks & report incidents within 72 hours. Violations face fines up to $3M. Gov Hochul launched $55M AI safety center. CA & IL have similar laws. TechCrunch · 1d ago
- ROGSahir Raoof raised $27.5M for Proximal Ventures targeting AI drug development at pre-seed & seed stages with $500K-$1.5M checks. Backed six startups incl. ChronicleBio. LPs include SignalFire, Kleiner Perkins & former FDA official Amy Abernethy. TechCrunch · 1d ago
- DOWX-energy gained US approval for four Xe-100 reactors at a Dow Texas plant, marking the first advanced nuclear permit for an industrial site. Amazon invested $500M and pledged 5GW capacity. Critics question safety. Shares trade below IPO price despite 2030s start. TechCrunch · 1d ago
- GOOGLAnthropic plans IPO valuing firm at $1.4T with shares priced $70-$78. Seven co-founders leave OpenAI in 2021 to prioritize AI safety. Each founder sells 3.4M shares for $236M-$264M. Founders retain 51.1% voting power via Class F stock. Reed Hastings buys $300M shares. TechCrunch · 1d ago
- Oura acquires Counsel Health for $625M after IPO delay. Counsel's CEO & 70 staff join to expand care. Deal closes by end of 2027. Oura hit $1.75B FY2026 revenue, up 92% YoY. TechCrunch · 1d ago
- MIT's David Turturean used Anthropic Fable 5.2 to prove the 18-year-old Aaronson-Ambainis conjecture, confirmed by Scott Aaronson via Lean. The result shows quantum computers cannot speed-solve specific problems. PSI uses AI scaffolding to turn theory into tech. TechCrunch · 1d ago
- GOOGLOpenAI launched a beta Business Hub for creating verified profiles & specialized agents. It offers limited insights like views & clicks. Businesses must verify via formal processes. This shifts ChatGPT from a direct e-commerce hub to a consumer discovery engine. TechCrunch · 1d ago
- GOOGLGoogle Pixel Tag launches Tuesday at $29.99. It uses Bluetooth & ultra-wideband for item tracking via Find Hub app. Features an 80dB speaker, stainless steel build, IP67 rating, & replaceable CR2032 battery. Pairs with Android 9+. Sold in silver & pale green. TechCrunch · 1d ago
- MSFTAnthropic launched Claude Meetings, Whiteboards & Sheets in beta for Team & Enterprise plans. AI joins calls as visible participants. Whiteboards enable visual collaboration. Sheets allows AI edits. Claude Data is now GA to connect to data warehouses. TechCrunch · 1d ago
- NVDAJensen Huang admitted cheating on his wife & linked it to national security. U.S. officials believe Alice Huang is a Chinese spy who ran Megaspeed, which bought billions in Nvidia chips. Trump called Huang a fine person & said he should stay. Nvidia shares slid over 5%. TechCrunch · 1d ago
- GOOGLMatter's Sundrop turns baby photos into weekly recaps locally on-device using Apple Vision & Core ML, avoiding cloud uploads or generative AI. Features include sibling comparisons & iCloud sync. Priced at $39.99/year with a week-long free trial. TechCrunch · 1d ago
- AAPLApple TV launches integrated sign language interpretation for titles like Being Heumann & F1. Real interpreters appear in bottom right corner with no AI used. Feature arrives Friday on iOS 27.2 via Settings. More titles including Greyhound follow later. TechCrunch · 2d ago
- GOOGLGoogle unveiled TPU 8tx & TPU 8i Max to cut reliance on external chipmakers. TPU 8tx, made with AMD, adds security & on-the-fly training. TPU 8i Max doubles memory & power. This launch follows Nvidia CEO Jensen Huang admitting to an affair with an alleged Chinese spy. TechCrunch · 2d ago
- N-able disabled N-Central to patch zero-day Able2Shell bugs allowing root access. Researcher Ben Bales disclosed flaws after alleging prior unpatched failures. Customers must self-host deployments. N-able states no successful exploitation occurred. TechCrunch · 2d ago
- METAMeta launched Muse AI agent on Apple Watch & Wear OS for voice & text tasks. U.S. users video chat with avatars. Spaces feature enables topic chats. Muse hit 10M U.S. downloads in 40 days. TechCrunch · 2d ago
- METAMeta's Muse AI agent is now on Apple Watch, following a recent iPad launch. Users can connect accounts to manage tasks & personalize avatars. Muse supports voice, text, & video chats without seeing users. It recently hit 10M U.S. downloads in 40 days. TechCrunch · 2d ago
- RIVNRivian delivered record 19,248 Q3 2026 vehicles, a 46% increase. CEO Scaringe cites 2027 as an inflection year driven by the $45k R2 SUV. The company has $13B liquidity, including a $4.5B DOE loan. Analysts rate stock overweight with a $17.70 target. CNBC · 2d ago
- WhatsApp CEO Kunal Shah aims to simplify the app for 3B users. Plans include easier voice notes, AI summaries, & new finance features like bill payments via partners. End-to-end encryption & privacy remain core. TechCrunch · 2d ago
- Reddit launches AI-powered Reviews for 10k products on iOS, Android & web. Features include anti-abuse tools, visual feedback & topic filtering ahead of the holiday season. TechCrunch · 2d ago
- ADBEAdobe MAX updates include Firefly Builder beta, MCP integration with ChatGPT, & third-party models. New Photoshop relighting, Premiere color grading, & Topaz Labs image tools arrive. TechCrunch · 2d ago
- AMDAnthropic files for IPO offering 825M shares at $70-$78, targeting $57.75B-$64.35B. Private sales to AMD, Broadcom, Google, Nvidia & others add $26B. Total proceeds estimated $84.6B-$93.7B. Nasdaq listing expected Nov 19 under ANT. TechCrunch · 2d ago
- Aura launched a $349 10-inch Ink photo frame using E Ink Spectra 6 with custom hues. It features a dithering algorithm for smooth gradients, connects to the Aura app, & lasts three months per charge. Includes hanging hardware, stand & USB-C cable. TechCrunch · 2d ago
- SPOTSpotify upgrades AI DJ for 94M+ Premium users with 7 English & 2 Spanish voices plus reduced commentary. New options include Casey, Tess, Lane, Nico, & Fabi alongside original X. Rolling Nov 10 in 95 markets. TechCrunch · 2d ago
- MSFTKora Systems unveils Linux OS integrating AI & autonomous agents, launching 2027 free for Intel, AMD, & Snapdragon chips. Built by 50 engineers using AI tools, it targets 50M users. Revenue via subscriptions for Cortex AI engine & agentic services. TechCrunch · 2d ago
- AMZNAmazon's Ring launched Ring Robotics with two devices. Ring Drone Cam ($270, Jan 27) is a flying indoor camera. Ring Rover Cam ($1,000, Dec 16) patrols business routes. Both use AI Pilot for navigation. TechCrunch · 2d ago
Research Briefs
- Global economic momentum has softened as the world faces cheaper energy and dearer money. Brent crude prices fell from over $135 to around $91 per barrel due to growing hopes of a Middle East settlement, while US Treasury yields rose back toward 5 percent following stronger-than-expected core inflation. China's export growth is increasingly driven by technology sectors like semiconductors, whereas US corporate profits recovery relies heavily on finance and information industries. Forecasters have raised interest rate projections for 2027 more than inflation expectations, indicating that central banks may maintain restrictive policies for longer. Haver Analytics · 11h ago
- NVDAArtificial intelligence is described as a transformative technology with vast potential, yet its investment landscape is complicated by significant uncertainties regarding its evolution, profitability, and competitive dynamics. Key challenges include the difficulty in predicting which companies will succeed, the risk of commoditization reducing vendor profits, and the substantial infrastructure requirements involving data centers and compute power. While current leaders like Nvidia and TSMC are profiting from chip demand, the long-term outlook involves questions about AI's ethical alignment, regulatory taxation, and the potential for rapid shifts in market dominance. Oaktree Capital · 1d ago
- The buildout of AI data centers has contributed to strong business fixed investment, which now accounts for 17% of GDP, with AI investment representing roughly 1.7% of GDP. However, over 70% of the capital spending on these centers is imported, meaning the direct impact on GDP is largely offset by a widening U.S. trade deficit. Despite the muted direct GDP impact, the AI buildout has fueled a positive wealth effect and boosted consumption by raising profit and stock market expectations. While the pace of new projects may slow, numerous facilities are currently under construction or in planning stages across states including Texas, Virginia, Pennsylvania, Ohio, and Indiana. Haver Analytics · 1d ago
- German inflation metrics show mixed signals, with headline inflation falling in October while core inflation remains elevated. The HICP annual rate has eased to 2.6% over three months, and the domestic CPI excluding energy is at 1.6%. However, diffusion statistics indicate a broadening of price increases over the last three months, with 63.6% of categories showing acceleration. Oil prices, specifically Brent, have surged significantly, introducing uncertainty into future inflation forecasts. Economists suggest central banks should focus on communicating their goals and scenarios rather than making specific forward guidance on volatile variables like oil prices. Haver Analytics · 1d ago
- GSNet sovereign bond issuance is projected to remain elevated in 2027 across the G4 nations. In the United States, Euro Area, and United Kingdom, net supply to the public is expected to be stable or lower compared to 2026. Japan stands as the only major sovereign bond market where economists anticipate a modest increase in net supply to the public for the coming year. Goldman Sachs Insights · 1d ago
- Japan's Economy Watcher Index slipped in October to a 46.1 diffusion reading from 47.0 in September, indicating a deterioration in the current economic assessment. The future economy watchers index also declined to 46.5 from 47.4, with only three of nine components showing improvement. Despite month-to-month declines, the index shows point-to-point improvement over three and six months, though the year-over-year change remains negative. Haver Analytics · 2d ago
- The NFIB Small Business Optimism Index slipped to 97.8 in October, remaining slightly below its 53-year average of 98.0. The Uncertainty Index fell to 84, the lowest level since December 2025, while expectations for the economy improved for the 24th consecutive month. Labor quality, taxes, and inflation were identified as the top three concerns facing small businesses, with hiring plans rising to 18% and average selling prices increasing to 33%. Haver Analytics · 2d ago
- Japan's Economy Watcher Index slipped in October to a diffusion reading of 46.1, down from 47.0 in September. While the index shows point-to-point improvement over three and six months, the 12-month change remains negative for the headline and most components. The future economy watchers index also declined to 46.5 in October, with year-over-year assessments lower despite modest gains over the last three and six months. Haver Analytics · 2d ago
- Southeast Asia is transitioning from assembling AI hardware to hosting data centers, with Malaysia, Thailand, and Singapore leading the expansion. Malaysia's Johor region has seen significant GDP growth driven by data center investments, though power and water constraints have led to new tariffs and approval caps. Thailand's digital industries captured nearly half of approved foreign direct investment in 2025, prompting a pause on new applications due to resource scarcity in the Eastern Economic Corridor. Singapore experienced a sevenfold rise in operating surplus for data processing but imposed a moratorium from 2019 to 2022 due to resource limits, redirecting some investment to neighboring Johor. Economic gains from these facilities often remain limited for local residents due to foreign ownership, high capital intensity, and low staffing requirements. Haver Analytics · 2d ago
- BACLower-income wage growth reached 4.7% year-over-year in October 2026, surpassing the 3.4% growth rate for higher-income households. This trend, which began earlier in 2026, is attributed to tax withholding impacts from the One Big Beautiful Bill Act and a broadening labor market characterized by increased job-to-job changes and raises. Middle-income households saw wage growth of 3.8% during the same period. The data is derived from aggregated consumer deposit account information provided by Bank of America. BofA Institute — Daily Insights · 2d ago
- The global AI investment boom has created widespread demand for semiconductor exporters, equipment manufacturers, and energy suppliers, with the United States at the center of this cycle. Asian producers supply chips while European and Japanese manufacturers provide sophisticated equipment, creating a tightly linked international supply chain. Political resistance to data center construction in the US and Europe poses a potential constraint that could delay physical investment and slow the expansion of the sector. The financial exposure is global, as pension funds and insurers share risks through equity portfolios, making a market correction a potential macroeconomic issue. Haver Analytics · 2d ago
- The global media rights market grew 41% since 2020, reaching approximately $57.8 billion in 2025 and projected to hit $67 billion in 2026, driven largely by live sports and streaming services. Institutional investment in sports has surged, with private equity transactions rising from 50 in 2018 to 192 in 2025, while the WNBA Valkyries achieved a valuation of $850 million, the highest in the league. A landmark settlement allowing college athletes to monetize their name, image, and likeness has transformed college football into a highly competitive commercial sport, prompting schools to seek new financing models. Investors are increasingly exploring international expansion, women's sports, and emerging leagues like Unrivaled to capture growth equity returns. Goldman Sachs Insights · 2d ago
- U.S. consumer prices rose more than anticipated in October, with the headline Consumer Price Index increasing 0.4% month-over-month and the core index rising 0.3%. Shelter and food prices were the primary drivers of the increase, contributing significantly to the headline rate. The year-over-year headline inflation rate climbed to 4.1%, the highest level since May, while the core rate reached 2.8%. Financial markets reacted strongly to the data, pricing in a near-certain 25 basis point interest rate hike by the Federal Open Market Committee in December. Haver Analytics · 2d ago
- Japan's leading economic index fell sharply in September to 116.4, down from a peak of 118 in August, though it remains marginally higher than readings from May and June. Consumer confidence has shown a mild year-over-year increase of 1.1% since April, despite a negative trend over the preceding 24 months. The Economy Watchers index indicates modest contraction in current conditions and expected future contraction, with both metrics below their historic medians. Despite these cooling indicators, the Bank of Japan is expected to proceed with a rate hike to address inflation, supported by fiscal stimulus. Haver Analytics · 3d ago
- BACThe U.S. equity market is expected to continue a bull market in 2027 following a typical midterm election pattern, with economic growth peaking in 2026 before moderating. China's integration into the World Trade Organization has led to a global convergence where Western nations increasingly adopt state-led industrial policies similar to China's model. Significant capital investment is projected for the Artificial Intelligence sector, with data center developers expected to spend over $1.4 trillion in 2027, raising concerns about financing costs and credit spreads. Market conditions suggest a shift toward higher-quality, less leveraged segments as financial conditions tighten and earnings momentum slows. Bank of America — Private Bank Market Update · 3d ago
- U.S. wholesale inventories increased by 0.7% in September, marking the eighth consecutive month-over-month gain and a 7.6% year-over-year rise, the fastest pace since March 2023. Wholesale sales surged 2.8% month-over-month, driven by strong demand in durable and nondurable goods sectors, while the inventory-to-sales ratio fell to 1.21, its lowest level since May. Durable goods inventories grew 0.6% led by electrical and electronic goods, whereas nondurable goods inventories climbed 0.9% primarily due to a rebound in petroleum products. Haver Analytics · 3d ago
- BACConsumer confidence has declined, leading to a record-high level of consumers trading down to lower spending tiers since 2021. This shift is characterized by households becoming increasingly value-conscious, often substituting premium purchases with standard or value options in categories like apparel, dining, grocery, and travel. The trend suggests that while total spending may remain stable, the composition of spending is moving toward more affordable options as households delay discretionary purchases. Data indicates that this behavior is observed across various income levels, with specific attention paid to how spending patterns are categorized based on merchant tiers. BofA Institute — Daily Insights · 3d ago
- SInvestors are advised to maintain long-term goals during market volatility, as missing the best trading days can result in near-flat cumulative returns. A bear market is defined as a decline of 20% or more from a recent peak, with the S&P 500 experiencing 14 such periods since 1932. Historical data indicates that bull markets have lasted an average of 4.9 years compared to 1.5 years for bear markets, with average returns of 177.6% versus losses of 35.1%. Strategies to navigate these periods include dollar-cost averaging, staying invested to avoid missing rebounds, maintaining asset diversification, and managing emotional reactions to market fluctuations. Stifel Insights · 5d ago
- ARMU.S. equities declined as selling in artificial intelligence-linked stocks outweighed gains elsewhere, with the S&P 500 falling 4.4%, the Dow Jones Industrial Average dropping 3.4%, and the Nasdaq losing 5.5%. Concerns that tighter restrictions on data center construction could slow the AI investment cycle, driven by Democratic victories in midterm elections, served as the dominant catalyst for the market move. While earnings reports from Arm Holdings and Qualcomm added pressure, economic data indicated continued labor market resilience with initial jobless claims falling to 189,000. Non-U.S. markets were mixed, with Germany's DAX falling 0.4% and Japan's Nikkei declining 1.8%, while the 10-year Treasury yield fell to 4.84% and Brent crude rose 4.1%. Stifel Insights · 5d ago
- Quantum computing is projected to become a major technological advancement by 2035, potentially generating $2 trillion in value across finance, materials, life sciences, and mobility. The boundaries between humans and machines are expected to blur through advances in bionics, including artificial limbs and brain chips, while vertical farming aims to ensure food security in growing cities. The U.S. power infrastructure is anticipated to rely more on small modular nuclear reactors to support a digitalized economy, and the space economy is predicted to triple to $1.8 trillion by 2035. Stifel Insights · 5d ago
- SFGlobal GDP is projected to increase by 14% by 2030 due to artificial intelligence, driven by automation and product enhancements. The U.S. faces a fiscal transition with rising debt costs, where household, corporate, and federal debt have increased significantly since the Great Financial Crisis. Inflation and Federal Reserve policy remain central to economic forecasts, with the Fed maintaining a data-dependent approach to interest rates while monitoring labor market strength. Geopolitical tensions, including the Israel-Hamas war and global election cycles, present risks of deglobalization and market volatility. Stifel Insights · 5d ago
- The Stifel NextGen Investor Handbook provides guidance for young adults entering the workforce, covering essential topics such as budgeting, saving, and investing. It outlines strategies for job hunting, including resume preparation and networking, while explaining financial principles like the 50/30/20 rule and the power of compounding. The guide details various investment vehicles including IRAs, 401(k)s, 529 plans, ETFs, and mutual funds, alongside advice on credit management, home buying, and tax planning. It further addresses life events such as marriage, starting a family, estate planning, and helping aging parents, concluding with sections on family mission statements and philanthropy. Stifel Insights · 5d ago
- AAPLU.S. companies are reporting strong third-quarter earnings with net profit margins near 13.1%, the highest since 2009. Major firms have announced approximately $1.5 trillion in multiyear investments for nearshoring and reshoring across technology, pharmaceuticals, and industrials. The artificial intelligence boom is driving a construction surge, with the U.S. hosting over 5,400 data centers, while government incentives like the CHIPS and Science Act accelerate corporate decisions to onshore production. This structural reindustrialization is transforming the workforce by creating higher-skilled, higher-wage manufacturing roles through automation. Stifel Insights · 5d ago
- IBMTechnological innovation is breaking down boundaries between physical, digital, and biological worlds, creating opportunities in data processing, artificial intelligence, and quantum computing. Global population dynamics are shifting, with the senior population expected to reach 1.6 billion by 2050 and the global middle class projected to grow by over 1 billion people by 2030. Companies and governments are prioritizing the development of critical resources, including food, water, energy, and new materials, while reshoring production to reduce foreign dependence. Geopolitical tensions are driving increased investment in defense modernization, space exploration, and the digital economy, with the global space economy potentially reaching $1.8 trillion by 2035. Stifel Insights · 5d ago
- U.S. GDP growth is forecast to range between 1.75% and 2.5% in 2026, with inflation expected to run between 2.25% and 2.75%. The Federal Reserve is anticipated to implement one or two quarter-point rate cuts during the year, while the 10-year Treasury yield is projected to remain between 4.0% and 4.5%. Artificial intelligence is viewed as a dual force driving productivity and capital investment while presenting macro risks if adoption slows. The S&P 500 is forecast to deliver a total return of approximately 10%, driven primarily by earnings growth rather than valuation expansion. Stifel Insights · 5d ago
- SIFThe global economic landscape is shifting from globalization toward increased localization, protectionism, and geopolitical uncertainty. Key risks identified over the next three to five years include intensifying U.S.-China competition, the potential for cyberattacks, and the emergence of competing geopolitical blocs. Specific military conflicts in the South China Sea, the Middle East, and Taiwan are assessed as likely or unlikely, with significant implications for global trade, energy markets, and supply chains. Investment strategies are advised to focus on cybersecurity, defense, energy efficiency, and sectors with strong pricing power to navigate these structural shifts. Stifel Insights · 5d ago
- The U.S. economy expanded at a 2.0% annualized pace in the first quarter of 2026, driven by resilient consumer spending and investment in artificial intelligence. Inflation reached 3.8% year-over-year due to oil supply shocks and geopolitical fragmentation, leading futures markets to price out Federal Reserve rate cuts for the year. U.S. equity markets have rebounded to record highs with S&P 500 earnings tracking toward 28% growth, while the 10-year Treasury yield is expected to remain between 4.0% and 4.5%. Geopolitical tensions involving the U.S., Israel, and Iran have caused temporary spikes in oil prices, though historical data suggests equity markets typically recover as uncertainty fades. Stifel Insights · 5d ago
- GOOGLThe U.S. and Iran are engaged in a conflict with four potential scenarios: a managed off-ramp, shadow war, severe tail, or regime change. The Federal Reserve held rates at 3.50%-3.75% in July 2026, with markets pricing in potential rate hikes through 2027 due to inflation concerns and geopolitical risks. Economic forecasts project 2026 GDP growth at 2.2%, while the Congressional Budget Office estimates a $1.8 trillion deficit pushing total debt over $40 trillion. Major market indices have shown rotation away from previous trends, with the S&P 500 trading at a premium to its 10-year average P/E ratio. Stifel Insights · 5d ago
- The S&P 500 advanced 15.2% in the second quarter of 2026 as markets stabilized following an unsettled start to the year. Under new Federal Reserve Chair Kevin Warsh, the central bank held rates steady at 3.5% to 3.75% while emphasizing price stability and shifting away from forward guidance. Geopolitical tensions eased after the United States and Iran reached a memorandum of understanding to wind down conflict and reopen the Strait of Hormuz. Inflation remained firm with the core PCE price index rising to 3.4% in May, leading to an upward revision of the full-year inflation forecast. Stifel Insights · 5d ago
- SPOTA survey of 150 Stifel summer interns reveals that 56% consider remote work unimportant, though most prefer working from home at least once a week. While 61% are comfortable with robots as restaurant waiters, 91% would not feel comfortable with an AI bot as a primary care doctor. Interns expect significant labor market transformation, with 31.9% predicting 15-20% of current jobs will be replaced by AI by the end of the decade, and 43% believe NVIDIA will be the largest of the Magnificent Seven companies in ten years. Stifel Insights · 5d ago
- GSGoldman Sachs analysts discuss market reactions following the US midterm elections, noting a significant rotation away from high-multiple AI data center stocks which have declined 36% from their year-highs. The discussion highlights a shift toward healthcare as a new defensive sector driven by AI applications in diagnostics and tools, while traditional staples are deemed overvalued due to low earnings yields. Analysts recommend investing in the S&P 500 excluding AI companies to access high-quality balance sheets with lower valuations, while monitoring inflation, employment, and the December 9th FOMC decision for future market direction. Goldman Sachs Insights · 6d ago
- GSNonfarm payrolls rose by 165,000 in October, exceeding forecasts and indicating a solid labor market trend above 100,000 jobs per month. The unemployment rate remained stable between 4.1% and 4.2%, consistent with full employment and subdued wage growth. Goldman Sachs Chief Economist Jan Hatzius projects GDP growth of 2% to 2.5% for the coming year despite tightening financial conditions and geopolitical risks. Additionally, AI adoption is currently reducing employment growth in the technology sector by 10,000 to 15,000 jobs monthly, with broader impacts expected by 2027. Goldman Sachs Insights · 6d ago
- GSFollowing the US midterm elections, the AI data center trade has seen significant corrections with valuations dropping to levels comparable to June lows. Goldman Sachs analysts suggest that traditional defensive sectors like staples are overvalued and recommend shifting focus to quality compounders outside the AI sector. Healthcare is identified as the next leg of the AI trade, offering a defensive play with accelerating growth drivers. Market participants are advised to monitor employment, inflation, and the Federal Open Market Committee decision scheduled for December 9th. Goldman Sachs Insights · 6d ago
- Nonfarm payrolls rose by 165,000 in October, significantly exceeding the expected increase of 65,000. The headline unemployment rate decreased to 4.1%, while the broad unemployment rate (U-6) increased to 7.9%. Average hourly earnings grew by 0.4% in October, resulting in a year-over-year change of 3.1%. Haver Analytics · 6d ago
- GSDavid Schwimmer, CEO of the London Stock Exchange Group (LSEG), discusses market conditions characterized by a shift from rational to irrational complacency due to geopolitical tensions and inflation concerns. Capital flows are experiencing crosscurrents as investors seek to diversify away from US concentration despite recent energy crises favoring US independence. LSEG is leveraging its extensive data assets as a critical component of the AI ecosystem alongside compute and models, while also driving cultural integration following the Refinitiv acquisition. Future market infrastructure is expected to evolve toward digitization and geography-independent capital raising facilitated by AI simplification. Goldman Sachs Insights · 6d ago
- German industrial production increased by 0.7% in September following a 1% rise in August, with consumer goods and capital goods sectors posting strong gains. Capital goods output demonstrated acceleration with an annualized pace of 8% over three months, while intermediate goods output showed contractions across sequential horizons. Survey indicators for the German economy have progressed toward strength over the last three months, though their historic percentile standings remain below the median. In contrast, France, Spain, and Portugal reported output increases in September, but their sequential trends were less positive than Germany's. Haver Analytics · 6d ago
- BACApproximately one-third of family offices are currently invested in sports teams, franchises, or related opportunities, with another 31% expressing interest. Direct ownership of sports teams is more prevalent among offices led by Gen Z or Millennial principals at 27%, compared to 20% for Gen X and 16% for Baby Boomers. A survey of 355 family office decision makers in the U.S. indicates that 79% of offices with a potential next-generation successor believe alternative investments will comprise a larger portion of their portfolios. The study was conducted online in January and February 2026 by Escalent for Bank of America Private Bank. BofA Institute — Daily Insights · 6d ago
- ARMU.S. equities declined as selling in artificial intelligence-linked stocks outweighed gains elsewhere, with the S&P 500 falling 4.4%, the Dow Jones Industrial Average dropping 3.4%, and the Nasdaq losing 5.5%. The primary catalyst was concern that tighter restrictions on data center construction could slow the AI investment cycle following Democratic victories in midterm elections. While earnings from Arm Holdings and Qualcomm provided mixed signals, economic data showed resilience with initial jobless claims falling to 189,000 and third-quarter productivity growing at a 3.6% annual rate. Stifel, Nicolaus & Company maintains a constructive outlook for the U.S. economy, forecasting real GDP growth between 1.75% and 2.5% for the year without predicting a recession. Stifel Insights · 1w ago
- GSEmerging market sovereign and corporate bonds have demonstrated increased stability and resilience despite global shocks such as the Iran war and rising oil prices. The asset class has matured from a monolithic risk trade into a diverse market with over 80 countries offering varied opportunities, supported by stronger fiscal policies and deeper local-currency markets. Corporate bond issuance has grown significantly, featuring globally competitive companies with improved transparency and standardized reporting under International Financial Reporting Standards. Investors are now focusing on credit selection and fundamentals rather than broad market trends, as the constraint of the US dollar on debt servicing has lessened. Goldman Sachs Insights · 1w ago
- BACPayroll growth moderated but remained resilient at 1.2% year-over-year in October 2026, according to Bank of America deposit account data. The number of households receiving unemployment payments fell approximately 5% year-over-year during the same period. Small and mid-sized firms showed strong growth in payments to hiring firms in September, indicating continued hiring plans. These findings suggest a labor market that is directionally consistent with resilience despite a peak in payroll growth over the summer months. BofA Institute — Daily Insights · 1w ago
- Initial unemployment claims in the United States fell by 6,000 to 189,000 for the week ending October 31, 2026. Continuing claims increased by 23,000 to 1.718 million for the week ending October 24, while the insured unemployment rate remained steady at 1.1%. State-level data showed the highest insured unemployment rates in Massachusetts, Washington, and New Jersey, with the lowest rates found in South Dakota, Louisiana, and Florida. These figures represent historically low levels of claims, matching the volume seen in mid-July. Haver Analytics · 1w ago
- German orders have shown a consistent trend toward stronger ground over the long term, though growth rates over the last year and shorter horizons are generally weakening. Domestic orders improved significantly over 12 months but fell sharply in the most recent three-month period, while foreign orders showed modest improvement over three months after degrading over six months. EU industrial confidence metrics for the Big-Four economies—Germany, France, Italy, and Spain—indicate a general progression toward improvement in sequential ratings, despite mixed performance over the last 12 months. Haver Analytics · 1w ago
- GSAI presents an opportunity for music labels and rights holders by enabling streaming providers and tech companies to personalize recommendations and curate content. This technology can transform passive listeners into active creators. Monetization is expected to return to rights holders, disproportionately benefiting higher-end artists whose image, likeness, melodies, or lyrics are used to create AI music. Goldman Sachs Insights · 1w ago
- GSAaru is a startup that uses advanced AI simulations to predict human behavior and population composition for business decision-making. The company fuses large language models with statistical and mathematical models to forecast consumer actions such as product purchases, marketing clicks, and transportation choices. Aaru claims to reduce product innovation cycles from months to weeks by simulating outcomes without processing personally identifiable information. The firm operates globally across over 130 countries and maintains SOC 2 compliance while not training its core models on client data. Goldman Sachs Insights · 1w ago
- The US midterm elections have resulted in Democratic control of both houses of Congress, creating a period of divided government during President Trump's term. This political shift, driven by concerns over living costs and the war with Iran, introduces mixed economic implications including potential limits on tax cuts and complications in budget negotiations. Global markets are facing diverging signals, with US loan demand weakening while lending to non-bank institutions expands, and sovereign bond markets reacting to stretched public finances in countries like France and Japan. Haver Analytics · 1w ago
- U.S. nonfarm business productivity surged 3.6% on a quarterly seasonally adjusted annualized rate in the third quarter of 2026, exceeding the 2.7% forecast and following an upwardly revised 2.1% gain in the second quarter. Output per hour increased significantly while compensation growth slowed to 2.9%, resulting in a 0.7% quarterly decline in unit labor costs. Manufacturing productivity growth decelerated to 0.3% in the same period, causing unit labor costs in that sector to jump 2.7%. Benchmark revisions extending back to 2021 showed modest but generally positive adjustments, raising the annual productivity growth rate from 1.50% to 1.62%. Haver Analytics · 1w ago
- GSGoldman Sachs President John Waldron describes the current economic environment as characterized by resilient nominal growth exceeding 6% in the US, despite higher inflation and interest rates. The firm anticipates a record year for mergers and acquisitions, driven by a strategic bias toward scale and significant capital raising for artificial intelligence infrastructure. Goldman Sachs is deploying a four-pronged AI strategy focused on employee literacy, software development efficiency, process automation, and client-facing tools. Additionally, the firm is expanding its asset management capabilities through targeted acquisitions of Industry Ventures, Innovator, NEO Investments, and LCN Capital Partners to fill specific market gaps. Goldman Sachs Insights · 1w ago
- Democrats secured majorities in both the House and Senate following the midterm elections, creating a divided government that is expected to result in legislative gridlock over the next two years. Despite the shift in power, the administration will likely continue pursuing its agenda through executive actions and regulatory agencies, while Democrats may leverage must-pass bills to negotiate limited policy concessions. The outgoing Republican Senate majority is expected to prioritize confirming federal judges and cabinet members before losing control in 2027, potentially crowding out other legislative items during the lame duck session. Key areas of potential compromise include drug price regulation, credit card interest rate caps, and clean energy tax credits, though trade and tariff policies remain contentious. Stifel Insights · 1w ago
- The U.S. ISM Services PMI declined to 54.5 in October, marking a three-month low while still indicating expansion for the 28th consecutive month. Business activity fell to 53.8, the lowest level since September 2025, while new orders dropped to 55.9, the lowest since June. The employment index rose to 51.4, the highest since February, and the prices index decreased to 73.0, remaining above 70 for the seventh time in eight months. Haver Analytics · 1w ago
- BACConsumers maintained steady spending on gas and groceries in 2026, with all income cohorts increasing gas spending as a share of income while grocery spending shares decreased. Lower-income households continue to allocate the largest portion of their income to these essentials, though the trend of rising gas costs and falling grocery shares is consistent across all income groups. Data indicates that while spending on everyday essentials is higher than a year ago, it remains lower than levels seen four years prior, suggesting households are adapting to persistent inflation. BofA Institute — Daily Insights · 1w ago
Interviews
More →- Delta Sees No Pushback on Higher Fares, CEO SaysDelta Air Lines CEO Ed Bastian characterizes the current AI adoption phase as an early investment period focused on efficiency rather than immediate revenue growth, noting that significant returns will likely require new business models. The airline maintains strong holiday travel demand despite fare increases, while simultaneously advancing its long-term in-flight Wi-Fi strategy through an Amazon Kuiper partnership and monitoring AI agent interactions on a case-by-case basis. Although Delta has offset current fuel costs, Bastian warns that geopolitical tensions could drive jet fuel prices higher within the next year, posing financial risks to smaller carriers. Bloomberg Television · 35m ago
- Jensen Huang Resigns as Nvidia CEOFollowing a recent crisis, NVIDIA's board has appointed CFO Colette Kress as interim CEO while engaging an external firm to recruit a permanent successor, a move that triggered an 11% market correction. Although Stanford-born architect Ian Buck is the leading internal candidate, experts warn that replacing Jensen Huang's unique combination of technical leadership and supplier relationship management presents a significant hurdle for maintaining the company's aggressive six-month product cadence. Bloomberg Television · 1h ago
- Stocks Fall on Nvidia Worries; Nvidia Board Considers Huang's FutureNVIDIA's board convened to evaluate CEO Jensen Huang's future following allegations of extramarital affairs and a suspected security breach, prompting a succession review and causing the company's market capitalization to lose nearly $300 billion amid fears of tightened U.S.-China chip restrictions. This governance crisis triggered a broader market correction where Asian tech indices fell and U.S. rivals like AMD and Broadcom gained share, while geopolitical tensions threatened to disrupt the upcoming Trump-Xi summit. Concurrently, global economic developments included a UK GDP surge, a historic Democratic Senate victory in Mississippi, and UN Secretary-General Antonio Guterres warning of an AI-driven "perfect storm" requiring multilateral safety oversight at the upcoming COP 31 conference. Bloomberg Television · 2h ago
- UN Secretary-General Warns of ‘Perfect Storm’ of Global RisksThe UN Secretary General warns of a global "perfect storm" characterized by geopolitical paralysis, the Russia-Ukraine and U.S.-Iran conflicts, accelerating climate change, and uncontrolled artificial intelligence expansion. He calls for urgent reform of the UN Security Council and Bretton Woods institutions to better represent emerging economies and advocates for taxing windfall oil profits to fund a "Loss and Damage" mechanism that currently pales in comparison to industry gains. Furthermore, he urges the establishment of multilateral AI oversight to mitigate existential risks while noting that market forces in the U.S. continue to drive renewable energy adoption despite federal policy shifts. Bloomberg Television · 4h ago
- Nvidia CEO Crisis Deepens as Board Weighs Jensen Huang FutureAmid a $671 billion market collapse and revelations of CEO Jensen Huang's affairs with a woman linked to Chinese intelligence, NVIDIA's board is actively seeking a successor while facing congressional investigations into national security breaches. The crisis has exposed critical governance gaps and intensified geopolitical tensions, prompting calls for stricter U.S. export controls and broader corporate reforms led by experts like McKinsey's Bob Sternfels. Concurrently, global leaders are addressing related regional instabilities, including EU defense spending increases in Ireland and diplomatic efforts to unify a European response to hybrid warfare and the ongoing conflict in Ukraine. Bloomberg Television · 4h ago
- How Ukraine blinded Russia’s drones: Operation Vivaldi explained | The EconomistUkraine has executed Operation Vivaldi by shifting front-line tactics toward intelligence-led interdiction of Russian drone networks while deploying Starlink-guided and "5.1" drones to conduct mid-to-long-range strikes against Russia's military-industrial complex and Crimean supply chains. These asymmetric operations have decimated Russian diesel export capacity to 140,000 barrels daily and forced insurance premiums in Novorossiysk to 20%, yet they face a retaliatory volume of five times more Russian deep strikes alongside a surge in jet-propelled Geran drone production. While successfully straining Russian logistics, this strategy has sparked geopolitical friction by inadvertently inflating global fuel prices and providing Moscow with a narrative to blame Ukraine for economic instability among neutral partners. The Economist · 5h ago
- Why Alexis Ohanian Bet on Women's Sports Before Everyone Else | The DealIn March 2019, Alexis Ohanian launched Angel City FC to capitalize on the undervaluation of elite women's athletes, projecting that the sector will eventually outpace the market capitalization of Reddit within a decade. His portfolio, which includes the Golden State Valkyries and various new leagues, leverages high-engagement player brands to secure rapid revenue growth and billion-dollar valuations despite a lack of traditional legacy media deals. Ohanian positions these ventures as a strategic counter to synthetic AI content, arguing that the human element of live sports will drive future profitability as technology-driven operational efficiencies replace obsolete industry infrastructure. Bloomberg Originals · 7h ago
- Nvidia Board Considers Replacing CEO Jensen HuangAmid allegations of multiple affairs and unreported chip shipments to China, Nvidia's board is actively seeking a replacement for CEO Jensen Huang, a move that has triggered a 30% stock decline and global market losses. The crisis has drawn scrutiny from U.S. regulators and President-elect Trump, while competitors like AMD and Broadcom gained value as investors reassessed supply chains in the AI sector. Simultaneously, geopolitical tensions are escalating as the scandal threatens to overshadow upcoming trade talks with China and complicates negotiations between Ukraine and Russia. Bloomberg Television · 7h ago
- Nvidia Board Weighs Huang’s Future as Congress Prepares SubpoenaNVIDIA's board is considering leadership changes amid CEO Jensen Huang's personal scandals, triggering a sharp sell-off that dragged down the broader tech sector and Asian markets while benefiting competitors like AMD and Broadcom. In the capital markets, AI firm Anthropic targets a $1.4 trillion valuation for an upcoming IPO, whereas the UAE government highlights economic resilience and is opening infrastructure sectors to private capital to diversify funding sources. Simultaneously, institutional investors are pivoting toward asset-based private credit and self-sufficiency themes to mitigate geopolitical risks and address global market concentration. Bloomberg Television · 7h ago
- Ruchir Sharma on AI Bubble Risks, Opportunities in IndiaThe speaker warns that an AI bubble collapse would trigger a global recession if rising interest rates pierce the U.S. market, which currently absorbs 70% of global equity flows and drives consumer spending through wealth effects. While retail investors sustain the bubble with reflexive buying and access to technology, the speaker identifies undervalued quality stocks in Europe, Japan, and the U.S. as superior long-term holdings alongside the Swiss Franc as a defensive currency. The analysis concludes that divergent regional performances, particularly China's structural failures and India's limited near-term tech adoption, underscore the necessity of hedging against a concentrated U.S. exposure. Bloomberg Television · 8h ago
- Top Neurologist: The Weekend Habit That Could Raise Your Dementia Risk!Dr. David Perlmutter redefines Alzheimer's disease as a preventable metabolic synaptopathy driven by lifestyle factors and neuroinflammation, shifting focus away from ineffective amyloid-targeting drugs toward modulating microglial function through diet, exercise, and social connection. Research highlights that physical activity can reduce APOE4-related risk by 67% while dietary changes, such as avoiding ultra-processed foods and managing glucose spikes, help restore supportive M2 microglia states. The presentation underscores that immediate intervention via lifestyle modification offers a viable strategy for stabilizing or reversing early cognitive decline, effectively countering the biological mismatch between modern environments and human genetics. The Diary Of A CEO · 8h ago
- Nvidia Board Meets As Jensen Huang Fallout WidensAmid allegations of an extramarital affair with a Chinese national linked to espionage, NVIDIA's board is actively considering the removal of CEO Jensen Huang and appointing CFO Colette Kress as an interim leader. These governance and national security concerns triggered an 8% stock decline and caused major firms like Bernstein and Baird to slash price targets, while U.S. lawmakers investigate potential export control violations. Consequently, analysts warn that the scandal could permanently sever NVIDIA's access to the Chinese market and disrupt its sovereign AI partnerships, prompting competitors to watch for succession opportunities. Bloomberg Television · 9h ago
- The Rise and Reckoning of Jensen Huang | The Circuit with Emily ChangFollowing an investigation into CEO Jensen Huang's extramarital affair with a foreign executive suspected of espionage, NVIDIA faces its most significant corporate crisis while board members confirm no immediate evidence of national security breaches. Amidst this internal turmoil and external scrutiny regarding AI safety and export controls, Huang reaffirms the company's commitment to a decade-long infrastructure expansion and voluntary industry regulation despite mounting investor skepticism about the AI sector's economic sustainability. The scandal also highlights critical succession risks, as the company's global dominance remains inextricably linked to Huang's personal judgment and leadership during a period of intensifying geopolitical tension over semiconductor sovereignty. Bloomberg Originals · 11h ago
- Nvidia Weighs Ousting Jensen Huang as Infidelity Scandal DeepensFollowing the revelation that CEO Jensen Huang engaged in an extramarital affair with a Megaspeed executive suspected of espionage and admitted to a second relationship with a subordinate, the Nvidia board has convened to consider ousting Huang and engaging a search firm for a replacement. This governance crisis has triggered a severe market correction with shares plummeting over 30 percent, prompting analysts to downgrade the stock while competitors like AMD and Broadcom capture shifting investor interest. Beyond the immediate leadership vacuum, the situation forces a reevaluation of Nvidia's aggressive capital allocation strategies and exposes the fragility of an AI ecosystem heavily reliant on the founder's personal network amid tightening geopolitical export restrictions. Bloomberg Television · 12h ago
- Chief Future Officer: Eimear Bonner, Chevron | Patience Sustains ProgressChevron is projecting its strongest 2026 performance ever through the integration of Hess's Guyana assets, sustained Permian Basin cash flows, and a new $7 billion Venezuelan joint venture that aims to triple regional output. The company simultaneously accelerated structural savings by $3 billion and launched Project Kilby with Microsoft to deploy excess gas for AI data centers while utilizing the "George" technology to optimize production reliability. Leadership transitions will see CFO Emer Bonner advance to President of Oil Products and Gas in 2027, overseeing a strategy focused on deleveraging the balance sheet and extending the dividend streak to 39 years. Bloomberg Television · 13h ago
- AI Trade Roars Back, Anthropic IPO Outlook, Nordstrom Co-CEO on Going PrivatePost-election market volatility subsided as semiconductor and "neocloud" stocks rallied amid hotter-than-expected inflation data that reignited Federal Reserve rate hike expectations. While major tech names declined, investor sentiment remains divided on the sustainability of current AI valuations, with scrutiny focused on Anthropic's rumored trillion-dollar IPO and potential commoditization risks. Concurrent corporate developments include Woodside Energy's progress on LNG infrastructure, Nordstrom's strategic pivot under private ownership, and Michael Burry's renewed confidence in Lululemon despite recent share price declines. Bloomberg Television · 15h ago
- Rep. DelBene: Nvidia, Huang Should Face InvestigationFollowing historic election results that secured 28 new Democratic House seats, the party has elected Hakeem Jeffries as the first Black Speaker of the House and formed a 260-member caucus to prioritize economic relief and health care protection. While Republicans selected Jim Jordan as Minority Leader, Democratic leadership faces internal organizational challenges highlighted by high absence rates during the failed impeachment vote against Secretary Pete Hegseth. Despite the White House Counsel warning against aggressive investigations, incoming Oversight Chair Robert Garcia and the Judiciary Committee are committed to conducting constitutional oversight and launching bipartisan probes into national security implications at the Department of Defense and NVIDIA. Bloomberg Television · 16h ago
- Stocks Slide as AI Trade Roars Back | Closing BellBroad market indices advanced with the Nasdaq Composite rising 1.6% and the Philadelphia Semiconductor Index surging 5.6%, driven by renewed momentum in the artificial intelligence sector. CoreWeave led technology gains with a 25% jump following a massive backlog report, while Bloom Energy climbed 13% on expectations for fuel cell demand in data centers. In contrast, the housing sector declined as rising yield expectations pressured homebuilder stocks, and Microsoft fell 2.3% despite the broader rally. Bloomberg Television · 18h ago
- Observing Distortions in the AI Market: Sixth Street's Alan WaxmanSixth Street is bypassing direct AI infrastructure financing due to concerns over rapid credit expansion, insurance capital saturation, and a $200 billion chip inventory glut that create significant market distortions. Instead of speculative hardware investments, the firm is targeting approximately $4 trillion in expiring private assets and resilient application-layer technology companies while anticipating future regulatory shifts. Although the firm views sports valuations as generally resilient, it acknowledges they remain tethered to broader tech wealth effects and could face pressure only if a severe AI dislocation occurs. Bloomberg Television · 18h ago
- Massive Demand for Anthropic IPO, Megadeals After MidtermsAnthropic is advancing toward a potentially trillion-dollar IPO amid intense institutional demand, though critics warn the valuation may be excessively optimistic given the limited allocation available to retail investors. Simultaneously, Marvell's $115 billion acquisition of Lumentum faces mounting skepticism due to a 30% drop in its share price and a high probability of deal failure driven by regulatory and timing concerns. While executives rush to finalize major transactions before anticipated midterms reshape the regulatory landscape, broader market dislocation risks emerge from power constraints, insurance capital saturation, and significant inventory gluts in the AI hardware sector. Bloomberg Television · 20h ago
- Inside Theranos with ex-Employee Tyler ShultzFormer Theranos employee Tyler Schultz exposed a massive healthcare fraud at the startup after discovering its devices failed to perform blood tests on internal technology, relying instead on third-party equipment and falsifying data. Despite intense legal harassment, a temporary restraining order orchestrated by founder Elizabeth Holmes and Sunny Balwani, and pressure from his grandfather George Shultz, Schultz provided critical evidence to the Wall Street Journal that triggered regulatory investigations and forced Holmes's eventual ban from the industry. The investigation ultimately validated the fraudulent operations, resulting in the company's collapse and highlighting the systemic failures of corporate cultures built on secrecy and fear. Y Combinator · 20h ago
- Investor Selby on Why Anthropic's IPO Puzzles HimA critical analysis of Anthropic's potential $1 trillion IPO warns of severe valuation risks, citing fragile financials reliant on non-recurring revenue and a strategic urgency driven by investor exit needs rather than capital requirements. Broader market headwinds, including geopolitical instability, regulatory capture attempts, and intense competition from cost-efficient Chinese models, are expected to trigger a "death of a million cuts" correction that devalues AI infrastructure narratives. Consequently, the speaker advises investors to favor liquid public equities over private AI ventures, arguing that commoditized utility models cannot sustain current ultra-high valuations amidst rising interest rates and political scrutiny. Bloomberg Television · 21h ago
- Nvidia Scandal Raises China StakesMultiple parallel investigations involving the FBI, congressional committees, and NVIDIA's internal board are probing the implications of Jensen Huang's alleged conduct, potentially reclassifying the situation from a personal scandal to a national security crisis. These proceedings, expected to last until spring, aim to clarify whether the matter will trigger tighter U.S. export controls on chip sales to China while simultaneously examining broader vetting practices across the tech sector. Although the fallout is unlikely to dismantle the existing U.S.-China trade truce, the findings will inform coordinated enforcement actions and reinforce the government's long-term strategy to prevent sensitive AI technology from reaching adversarial hands. Bloomberg Television · 22h ago
- Nvidia Is Playing Out Like a Greek Tragedy, Says Seaport's GoldbergFollowing Baird's downgrade of NVIDIA to Neutral amid leadership uncertainty, Jay Goldberg of Seaport warned that the company's bull case relies inextricably on CEO Jensen Huang remaining in power, likening the potential succession crisis to a "Greek tragedy." While NVIDIA prepares to report strong numbers, the firm faces mounting political headwinds, including public calls for Huang to step down and murky legal allegations that are diverting resources and creating operational distractions. This instability has opened a window for competitors like AMD and Broadcom to capture market share, even as the market awaits clarity on whether the alleged preferential treatment for MegSpeed will lead to concrete regulatory violations. Bloomberg Television · 1d ago
- I Was the Algorithm Before Algorithms Then I Had to Start Over · Scott PulciniFormer high-volume trader Scott Polsini recounts his evolution from exploiting manual queue positioning in the 2000s to adapting rules-based algorithms after regulatory changes and algorithmic competition eliminated his previous edge. The event details his encounters with specific market manipulation schemes by rival "locals," his subsequent transition to utilizing CME MBO data and HERO flow indicators, and his strict adherence to firm-level loss limits to mitigate emotional leakage. Polsini concludes by advising modern traders to prioritize process execution over gut instinct, treat trading as a probabilistic activity similar to athletics, and diversify income streams to preserve the objectivity necessary for survival in a complex, opaque market environment. Chat With Traders · 1d ago
- Mike Volpi on Why AI Infrastructure Will Outlast the Hype CycleThis analysis outlines a critical transition in the AI infrastructure market where constrained silicon supply and extended asset lifespans drive demand far beyond historical internet benchmarks. While NVIDIA and emerging neo-clouds pursue aggressive acquisition strategies to consolidate the industry, a significant economic correction is expected as smaller operators with fragile balance sheets face obsolescence. The event further details a shift toward rack-level system optimization and deterministic networking architectures, positioning the current hardware scarcity and deep systems integration as a defining, high-stakes period for global capital allocation. a16z · 1d ago
- Chile Is in Recession, But Will Rebound, Says Finance Minister QuirozFacing a technical recession driven by a copper supply shock, the Chilean administration has successfully enacted structural reforms including a 40-year low corporate tax rate and a record $6 billion investment approval surge to target a 3.3% GDP recovery. The government has tightened its fiscal deficit to 1.8% of GDP while restructuring state miner Codelco to attract private capital and diversify export markets away from China through strategic foreign screening and U.S. partnerships. Despite low approval ratings, the administration prioritizes long-term debt stability and pension regulatory caps to secure a projected 4% annual growth trajectory by 2028. Bloomberg Television · 1d ago
- Nvidia Is Core Part AI-Basket of Stocks, Emanuel SaysEvercore ISI frames the current market environment as a strategic opportunity to build an "AI class of 2027" portfolio while dismissing bubble fears following CoreWeave's strong earnings and the resilience of the sector against potential key-person risks. The firm projects GDP growth exceeding 2% and anticipates a modest December interest rate hike of 25 basis points before the Federal Reserve pauses, citing stabilizing oil prices alongside persistent services-sector inflation. Investors are advised to view the upcoming Anthropic IPO as the next critical litmus test for the AI trade, which continues to face volatility tied to fixed-income market gyrations despite the firm's belief that the thematic trend has significant further upside. Bloomberg Television · 1d ago
- Airbnb Is Building Its Own AI Travel Agent, Co-Founder SaysAirbnb reported its fastest revenue growth in three years, driven by a 19% quarterly increase and a strategic expansion into hotels and AI-powered tools. The platform highlighted a geographic shift where 90% of nights now occur outside major capital cities, alongside a defense against housing affordability regulations using data from markets like Barcelona. By leveraging artificial intelligence to handle 40% of customer service interactions and integrating advanced feature shipping, the company reinforces its infrastructure value while navigating a changing European regulatory landscape. Bloomberg Television · 1d ago
- Kai-Fu Lee Questions Soaring AI ValuationsKai-Fu Lee asserts that the AI revolution demands a fundamental business reinvention where organizations become "AI native" through top-down structural overhauls led by CEOs rather than superficial integrations. He advises leaders to prioritize "Boss AI" for data-driven decision-making, hire specialized Chief AI Officers, and mitigate security risks by deploying on-premise open-source models or utilizing trusted hyperscalers. Lee further notes that while proprietary data creates the only sustainable competitive moat, future value will concentrate in the application layer, encouraging European and global firms to leverage open-source technologies for niche markets instead of attempting to build foundational models from scratch. Bloomberg Television · 1d ago
Earnings Releases
By sector →- INKTNov 12, 9:49 AMMiNK Therapeutics reported its first pre-commercial product revenue in the third quarter of 2026 from agenT-797 supplied via an international named-patient access program. The company's randomized Phase 2 trial for acute respiratory distress syndrome (ARDS) is advancing with U.S. dosing expected before year-end, targeting a population with approximately 40% 28-day mortality. Additionally, agenT-797 was selected for the ARPA-H BoSS program to develop room-temperature deployable cell therapies, while preclinical data presented at SITC 2026 demonstrated the therapy's ability to clear senescent cells and enhance tumor killing in colorectal cancer models. Financially, the company achieved a 23% year-over-year improvement in net loss per share and reduced general and administrative expenses by 44%.Healthcare
- IPWRNov 12, 9:25 AMIdeal Power Inc. reported a net loss of $3.6 million for the third quarter of 2026, an increase from $2.9 million in the same period the previous year, while operating expenses rose to $3.9 million due to higher personnel costs and patent impairment charges. The company's cash and cash equivalents grew significantly to $38.3 million as of September 30, 2026, following a substantial financing activity that generated over $40 million in proceeds. During the quarter, the company advanced its B-TRAN® commercial strategy by demonstrating a solid-state circuit breaker prototype with Power Integrations, initiating shipments of new reference design kits, and expanding its sales funnel to approximately $450 million. Additionally, Ideal Power continued to develop its electric vehicle contactor opportunity with Stellantis and progressed toward JEDEC qualification for its semiconductor foundry production.Technology
- DGIINov 12, 9:23 AMDigi International reported record fourth-quarter fiscal 2026 revenue of $143 million, representing a 25% increase year-over-year, while full-year revenue reached $535 million, a 24% rise. The company achieved an annualized recurring revenue (ARR) of $197 million at the end of the quarter, up 30% from the prior year, driven by organic growth and acquisitions of Particle and Jolt Software. Net income for the quarter was $15 million, and adjusted net income reached $30 million, with adjusted EBITDA increasing to $42 million. Looking ahead to fiscal 2027, Digi projects revenue growth of 10-15% and anticipates ARR growth of at least 15%, targeting $200 million in both ARR and Adjusted EBITDA.Technology
- BRUNNov 12, 9:20 AMBoost Run Inc. reported third-quarter 2026 revenue of $39.9 million, representing a 496% year-over-year increase. The company currently holds $2.7 billion in total contracted value, with all funds either live, in deployment, or scheduled for 2027. Operating cash flow for the quarter reached $65.6 million, supported by approximately $600 million in non-dilutive project-based financing secured year-to-date. CEO Andrew Karos expects 26% of the contracted value to be live by the end of November, with full deployment targeted for 2027.Technology
- NEONNov 12, 9:18 AMNeonode reported a loss of $1.1 million, or $0.07 per share, from continuing operations for the three months ended September 30, 2026, compared to a net income of $13.9 million in the same period of the prior year. Total revenues for the quarter reached $0.5 million, representing a 24.4% increase year-over-year, driven by a 279.2% rise in non-recurring engineering revenue and a 9.4% increase in license fees. Operating expenses decreased by 13.2% to $1.8 million, primarily due to lower payroll and professional fees, while cash used by operations totaled $1.6 million. For the nine-month period, the company recorded a loss of $5.1 million with revenues of $1.6 million, as the prior year's results included a $15.5 million one-time gain from a patent assignment that was not repeated in 2026.Technology
- SGANov 12, 9:05 AMSaga Communications, Inc. reported a net loss of $7.1 million for the third quarter of 2026, driven primarily by a $9.2 million non-cash impairment charge on FCC license values. Net revenue for the quarter decreased 5.4% to $26.7 million, while station operating expense fell 1.7% to $24.2 million. The company declared a quarterly cash dividend of $0.25 per share, payable on December 11, 2026, to shareholders of record on November 23, 2026. For the nine-month period ended September 30, 2026, the company recorded a net loss of $8.5 million and net revenue of $75.9 million.Communication Services
- TGENNov 12, 8:59 AMTecogen Inc. reported third-quarter 2026 revenues of $7.87 million, representing a 9.6% increase from the same period in 2025, while the net loss narrowed to $1.59 million from $2.13 million. For the nine months ended September 30, 2026, total revenues declined 8.3% to $19.96 million, resulting in a net loss of $5.86 million compared to $4.25 million in the prior year period. The company's gross profit margin improved to 37.4% in the third quarter, driven by higher revenue and lower costs in the Services segment, and the backlog exceeded $8 million. At the end of the quarter, Tecogen held $5.33 million in cash and cash equivalents, with the CEO noting an expected increase to $5.7 million due to recent customer deposits.Industrials
- MPTINov 12, 8:55 AMM-tron Industries, Inc. reported third-quarter 2026 revenues of $15.7 million, representing an 11.1% increase from the same period in 2025. Net income for the quarter rose 66.4% to $3.0 million, or $0.70 per diluted share, driven by strong demand in aerospace and defense markets and an expansion of gross margin to 44.5%. For the nine months ended September 30, 2026, the company achieved revenues of $45.5 million and net income of $7.3 million, while its backlog grew to $84.9 million as of the end of the quarter.Technology
- STRRNov 12, 8:52 AMStar Equity Holdings reported a net loss of $2.2 million, or $0.60 per diluted share, for the third quarter of 2026, with total revenue increasing 12.4% to $53.9 million. The company generated $1.5 million in adjusted EBITDA and ended the quarter with $7.8 million in total cash, while repurchasing approximately $0.3 million of its common stock. Recent strategic actions include the acquisition of a machine shop in Vernal, Utah, and the purchase of Cornerstone RPO to expand its Business Services division. Additionally, the company has initiated a process to monetize two real estate assets through sale-leaseback transactions expected to yield over $9.0 million in gross proceeds.Industrials
- PODCNov 12, 8:50 AMPodcastOne reported record financial results for the first half of fiscal 2027, achieving revenue of $31.5 million and adjusted EBITDA of $2.9 million. For the second quarter of fiscal 2027, revenue increased to $15.4 million year-over-year, while adjusted EBITDA rose 27% to $1.4 million. The company delivered over 15 million downloads and streams in September, reaching 5.8 million unique listeners and securing a #6 ranking on Podtrac. Despite these operational gains, the company reported a net loss of $2.0 million for the six-month period ended September 30, 2026.Communication Services
- CURINov 12, 8:49 AMCuriosityStream reported third-quarter 2026 revenue of $20.7 million, representing a 13% increase from the prior year, while adjusted EBITDA rose 67% to $5.0 million. The company achieved net income of $4.8 million, a significant improvement from the $3.7 million net loss recorded in the same period last year, driven by a $0.9 million non-cash gain on a venture remeasurement. Management raised its full-year 2026 guidance to a revenue range of $79–$82 million and an adjusted EBITDA range of $20–$22 million. Additionally, the Board declared a fourth-quarter cash dividend of $0.085 per share, and the company acquired the remaining 68% interest in its German documentary channel business, Spiegel Venture.Communication Services
- LVONov 12, 8:45 AMLiveOne reported H1 Fiscal 2027 revenue of $37.3 million and an Adjusted EBITDA of $3.6 million, with its Audio Division contributing $36.3 million in revenue. The company revised its full Fiscal 2027 guidance to $70–$75 million in revenue and over $10 million in Adjusted EBITDA, while issuing first-time Fiscal 2028 guidance of $100 million or more. LiveOne has reduced its senior debt balance to $9 million after extinguishing $25 million in debt and liabilities since February 2026. Additionally, the company announced a five-year partnership with Groove Technology Solutions for Slacker Radio and highlighted accelerating AI initiatives across its subsidiaries.Communication Services
- DFDVNov 12, 8:41 AMDeFi Development Corp. reported strong third-quarter 2026 results, with net asset value per share increasing over 300% and SOL per share growing more than 20% between August 12 and September 30, 2026. The company's total SOL and SOL equivalents rose to 2,549,137 by the end of the quarter, while SOL-denominated borrowings declined by approximately 13%. Additionally, the firm launched CHAD, a perpetual capital vehicle that reached its $10 par value within 48 days of trading, and increased its annual dividend rate to 14% effective November 2.Financial Services
- HSDTNov 12, 8:41 AMSolana Company reported third-quarter 2026 revenue of $3.4 million, driven primarily by $3.3 million in staking revenue, marking a significant increase from the prior-year period. The company achieved a net income of $105.2 million, or $1.17 per diluted share, contrasting with a net loss of $352.8 million in the same quarter of the previous year. During the quarter, Solana Company expanded its treasury holdings to approximately 2.4 million SOL with a fair value of $288.2 million and executed a $15 million registered direct offering to purchase an additional 125,000 SOL. Operational highlights included the launch of the Pacific Backbone infrastructure, which now holds 1.3 million SOL in delegated stake, and the company's participation in Solana's first on-chain governance vote.Financial Services
- CTA-PANov 12, 8:34 AMCorteva reported third-quarter 2026 net sales of $1.59 billion, a 9% decline from the prior year, driven by pricing pressures in North America and Latin America. The company updated its full-year 2026 guidance, projecting Adjusted Pro Forma Operating EBITDA between $1.1 billion and $1.125 billion and Adjusted Pro Forma Operating EPS between $0.76 and $0.80. Latin America experienced a significant 31% organic sales decline due to farmer liquidity constraints and elevated channel inventory, while North America and EMEA posted organic growth of 7% and 14% respectively. Pro Forma GAAP income from continuing operations for the quarter was a loss of $54 million, whereas Adjusted Pro Forma Operating EBITDA for the nine-month period totaled $943 million.Basic Materials
- AENTNov 12, 8:32 AMAlliance Entertainment Holding Corporation reported first-quarter fiscal 2027 net revenues of $278.8 million, representing a 10% increase from the prior-year period. GAAP net income rose 56% to $7.6 million, driven by a 13% increase in gross profit and a 49% reduction in interest expense following a refinancing. Revenue growth was led by a 20% surge in physical movie sales, a 14% rise in vinyl revenue, and an 87% jump in collectibles revenue. The company also saw operating cash flow increase to $4.3 million and maintained compliance with its credit facility covenants while holding $48.9 million in available liquidity.Communication Services
- TULPNov 12, 8:30 AMBloomia Holdings, Inc. reported a net loss of $2.4 million for the first fiscal quarter ended September 30, 2026, representing a 17% improvement over the same period in the prior year. Revenue for the quarter totaled $5.0 million, a decrease from $5.2 million in the previous year, primarily driven by lower stem sales due to excess waste. Adjusted EBITDA improved to a loss of $1.9 million from a loss of $2.4 million in the prior year quarter, aided by higher prices and reduced general and administrative costs. The company's cash balance decreased to $0.7 million as of September 30, 2026, while revolver borrowings increased to $8.6 million.Consumer Defensive
- NSYSNov 12, 8:30 AMNortech Systems reported third-quarter 2026 net sales of $33.0 million, an 8.4% increase from the same period in 2025, resulting in net income of $637 thousand. The company achieved an adjusted EBITDA of $2.0 million for the quarter, up from $1.3 million in the prior year, while total backlog grew 20% to $92.8 million. Year-to-date through September 30, 2026, net sales reached $96.9 million with a net income of $919 thousand. Management highlighted strong performance in the Aerospace & Defense and Industrial markets, noting that China operations saw net sales growth exceeding 56%.Healthcare
- VANINov 12, 8:29 AMVivani Medical reported a net loss of $7.3 million for the third quarter ended September 30, 2026, driven by increased research and development expenses related to its Biopharm Division. The company anticipates announcing top-line results from its SLIM-1 Phase 1 trial for the NPM-139 semaglutide implant later in November 2026. Additionally, the merger between Cortigent and ClearOne remains pending final regulatory approvals required to establish Cortigent as a standalone Nasdaq-traded entity. Vivani's cash and cash equivalents totaled $15.5 million as of the end of the quarter, down from $20.8 million in the previous quarter.Healthcare
- SGPNov 12, 8:25 AMSpyGlass Pharma acquired Advanced Vision Science, Inc. for approximately $13 million to secure scalable manufacturing capacity for its lead product, the Bimatoprost Drug Pad-IOL System. The company announced four-year follow-up data from its first-in-human trial showing a 37% reduction in intraocular pressure and 86% of patients remaining off topical drops, while Phase 3 enrollment remains on track for completion in 2027. Additionally, the first implantations were completed for the Bimatoprost-Drug Ring System, a non-IOL-based delivery platform designed to provide up to seven years of treatment. For the third quarter ended September 30, 2026, the company reported a net loss of $24.3 million and held $215.8 million in cash and short-term investments.Healthcare
- ONDSNov 12, 8:24 AMOndas Inc. reported record third-quarter 2026 revenue of $167.5 million, representing a 100% sequential increase and more than a 16-fold year-over-year growth. The company secured $214 million in new orders, bringing its backlog to $835 million, and raised its full-year 2026 revenue outlook to at least $550 million. Ondas initiated a 2027 revenue target of at least $1.1 billion and expects to achieve company-wide Adjusted EBITDA profitability by the third quarter of 2027. Strategic expansions included the establishment of Ondas Sentinel and Regna AI, alongside six acquisitions that enhanced capabilities in defense, sovereign AI, and autonomous systems.Technology
- MOVENov 12, 8:21 AMCorvex, Inc. reported third-quarter 2026 financial results showing total revenue of $5.0 million, a 31% increase from the previous quarter, driven by its AI platform and services following the transfer of legacy healthcare assets. The company secured approximately 8 MW of critical IT capacity, with 1.5 MW currently live supporting $22 million in contracted annual recurring revenue, while expanding operations at Mid-Atlantic 1 and Midwest-1 facilities. Despite the revenue growth, the company recorded a net loss of $17.5 million for the quarter, or $0.60 per share, largely due to $11.3 million in stock-based compensation expenses. Corvex also raised approximately $33 million through a private placement and launched its Corvex Token Factory platform to enable serverless inference for open-weight models.Technology
- LEATNov 12, 8:20 AMLeatt Corporation reported third-quarter 2026 revenues of $20.46 million, representing a 43% increase from the same period in 2025 and marking the company's highest quarterly revenue in four years. Net income for the quarter surged 309% to $2.20 million, or $0.35 per basic share, driven by a 48% rise in gross profit and strong sales growth across body armor, helmets, and other product categories. For the nine months ended September 30, 2026, total revenues reached $56.36 million with net income increasing 74% to $4.88 million, while operating cash flows more than tripled to $4.59 million compared to the prior year.
- RUMNov 12, 8:17 AMRUM Group Inc. reported record third-quarter 2026 revenue of $96.6 million, representing a 290% year-over-year increase driven primarily by the Quake AI business which contributed $68.2 million. The company achieved its first profitable quarter on an Adjusted EBITDA basis, with utilization of its 22,000 GPU fleet reaching approximately 85%. Total liquidity stood at $142.3 million as of September 30, 2026, while the company advanced its acquisition of Northern Data AG to approximately 98% ownership. Management has set a fourth-quarter 2026 revenue outlook between $88 million and $94 million.Technology
- SESNov 12, 8:15 AMSES AI Corporation reported third-quarter revenue of $6.6 million, a 31% increase from the previous quarter, driven primarily by its energy storage business. The company achieved a GAAP net loss of $13.4 million, narrowing from $17.9 million in the second quarter, while completing the ramp-up of its Chungju, Korea facility to produce 1 million NDAA-compliant drone cells annually. Management reiterated its full-year 2026 revenue outlook of $30 million to $35 million and announced a reverse stock split to broaden institutional ownership eligibility. The firm maintains approximately $137 million in liquidity with no debt as it focuses on scaling drone manufacturing and advancing its Molecular Universe battery materials platform.Consumer Cyclical
- SPHNov 12, 8:14 AMSuburban Propane Partners, L.P. reported net income of $109.0 million for fiscal year 2026, representing a slight increase from the prior year, while Adjusted EBITDA rose 2.2% to $284.0 million. The company achieved this performance through strong propane demand in the eastern United States, the completion of capital projects for its renewable natural gas business, and the recognition of $12.4 million in production tax credits. During the fiscal year, the partnership acquired two propane businesses in California and refinanced $350.0 million of senior notes to extend maturities by nearly nine years. Consequently, the company increased its annualized distribution rate to $1.40 per Common Unit, reflecting a 7.7% increase over the previous rate.Utilities
- DXYNNov 12, 8:12 AMThe Dixie Group reported net income of $577,000 for the third quarter of 2026, marking its third consecutive profitable quarter. Net sales increased 4.6% to $65.2 million, while gross profit margin improved to 26.6% from 24.8% in the prior year period. For the nine months ended September 26, 2026, the company generated net income of $2.8 million with operating income rising to $8.7 million compared to $1.2 million in the same period of 2025. The company attributed these results to cost reductions, improved operating efficiencies, and new product introductions in both soft and hard surface flooring segments.Consumer Cyclical
- FRMMNov 12, 8:12 AMForum Markets reported third-quarter 2026 revenue of $2.0 million, driven entirely by commercial aircraft engine leases, and posted a net income of $7.9 million. The company formed a joint venture, Forum Edge AI, to deploy high-performance GPU compute capacity while simultaneously expanding its aircraft engine portfolio with two new acquisitions. Due to rising equipment and financing costs following the midterm elections, Forum revised its full-year 2026 revenue guidance down to $8 million–$9 million, though it maintains its 2027 revenue outlook of $125 million–$175 million. Additionally, the company repurchased approximately 330,000 shares for $1.9 million during the quarter and holds $19.8 million remaining in its share repurchase authorization.Healthcare
- TOVXNov 12, 8:10 AMTheriva Biologics reported third-quarter 2026 financial results showing cash and cash equivalents of $8.5 million with a projected runway into the first quarter of 2027. The company completed the sale of its SYN-004 antibiotic-degrading enzyme portfolio to Biossil Labs Inc. for a $350,000 upfront payment and up to $91 million in potential milestones and royalties. Clinical progress includes ongoing enrollment in the VIRAGE2 Phase 2a trial for VCN-01 in metastatic pancreatic ductal adenocarcinoma, with enrollment expected to conclude in the fourth quarter of 2026. Additionally, detailed analyses of the VIRAGE Phase 2b trial data were published in Nature Medicine, demonstrating improved survival outcomes for patients treated with VCN-01 combined with chemotherapy.Healthcare
- SLNNov 12, 8:10 AMSilence Therapeutics plc reported a net loss of $12.4 million for the third quarter ended September 30, 2026, driven by $9.3 million in research and development expenses and $4.9 million in general and administrative costs. The company's cash position increased to $247.7 million, which includes $201.3 million in proceeds from a public offering announced in August 2026. Recent business milestones include positive Phase 2 results for the investigational siRNA therapy divesiran in polycythemia vera and the announcement of a definitive agreement to be acquired by Merck KGaA, Darmstadt, Germany. The acquisition transaction is expected to close in the first quarter of 2027, subject to customary closing conditions.Healthcare
- EUNov 12, 8:09 AMenCore Energy reported third-quarter 2026 revenue of $16.7 million, an 88% increase year-over-year, driven by the delivery of 200,000 pounds of U3O8 at an average realized price of $83.46 per pound. The company recorded a net loss of $33.9 million for the quarter, primarily due to higher costs associated with purchased uranium included in sales, resulting in a gross loss of $0.8 million. As of September 30, 2026, the company held $5.1 million in unrestricted cash and $33.6 million in marketable securities while maintaining an inventory of 116,631 pounds of U3O8. Operational progress includes the completion of the first phase of the Upper Spring Creek facility and the Alta Mesa wellfield 3 Extension, with extraction expected to commence before the end of 2026.Energy
- AVLNNov 12, 8:08 AMAvalyn Pharma Inc. reported a net loss of $29.7 million for the third quarter of 2026, driven by increased research and development expenses of $25.5 million and general and administrative costs of $7.6 million. The company ended the quarter with $386.6 million in cash and marketable securities, projecting a runway into 2029. Recent pipeline progress includes the initiation of a Phase 1 study for the fixed-dose combination AP03 in healthy volunteers, the presentation of new AP01 data at the ERS Congress, and the publication of AP02 Phase 1 results in Respiratory Research. Additionally, Robert J. Meyer, MD, was appointed to the company's Board of Directors in September.Healthcare
- MGTXNov 12, 8:08 AMMeiraGTx reported a net loss of $51.3 million for the third quarter of 2026, driven by increased research and development expenses and a loss on its equity method investee, while cash and cash equivalents rose to $184.7 million. The company plans to submit a Marketing Authorisation Application for its lead candidate, botaretigene sparoparvovec, to the European Medicines Agency in December 2026, followed by a Biologics License Application to the FDA in early 2027. Operational milestones include the completion of enrollment for the pivotal Phase 2 AQUAx2 study for radiation-induced xerostomia, with data expected in mid-2027, and the initiation of a Phase 3 study for AAV-GAD in Parkinson's disease in the first quarter of 2027. Additionally, MeiraGTx strengthened its leadership team with new appointments to the executive and board levels and highlighted upcoming presentations on its AAV-BDNF program for genetic obesity.Healthcare
- LUCDNov 12, 8:05 AMLucid Diagnostics reported that Medicare now fully reimburses its EsoGuard esophageal DNA test nationwide, enabling the company to accelerate commercialization efforts. In the third quarter of 2026, the company recognized $1.2 million in revenue from 2,871 tests, with October setting a record volume of over 1,800 tests. The company announced a $15 million private placement to strengthen its balance sheet and reported a GAAP net loss of $6.7 million for the quarter. Additionally, Lucid highlighted the publication of a large-scale real-world study and the inclusion of its test in draft American Gastroenterological Association guidelines as alternatives to endoscopy.Healthcare
- AKTSNov 12, 8:05 AMAktis Oncology reported a net loss of $29.9 million for the third quarter ended September 30, 2026, while increasing its cash position to $492.9 million. The company initiated its third Phase 1b clinical trial, BActinium-2, to evaluate AKY-2519 in non-small cell lung cancer and other B7-H3 expressing tumors. Additionally, backfill cohorts were started in the ongoing NECTINIUM-2 and BActinium-1 trials to further assess safety and antitumor activity for AKY-1189 and AKY-2519. Aktis expects to present preliminary data for AKY-1189 in the first quarter of 2027 and for AKY-2519 later in 2027.Healthcare
- COHNNov 12, 8:03 AMCohen & Company Inc. reported third-quarter 2026 financial results with total revenues of $32.4 million and net income attributable to the company of $6.7 million, or $0.12 per fully diluted share. The company's investment banking and new issue revenue declined to $12.7 million due to $17.6 million in mark-to-market losses, while its gestation repo book reached an all-time high of $4.5 billion. The Board of Directors declared a quarterly dividend of $0.25 per share, payable on December 14, 2026, to stockholders of record as of November 30, 2026. Daniel G. Cohen was appointed Chief Executive Officer, succeeding his role as Executive Chairman.Financial Services
- KYTXNov 12, 8:01 AMKyverna Therapeutics has completed the submission of a rolling Biologics License Application to the FDA for miv-cel in stiff person syndrome, requesting priority review under its Regenerative Medicine Advanced Therapy designation. The company reports that miv-cel demonstrated durable efficacy and a well-tolerated safety profile in registrational trials, with no high-grade cytokine release syndrome or neurotoxicity observed. Financial results for the third quarter of 2026 show a net loss of $41.9 million, while the company maintains $170.6 million in cash and marketable securities to support operations into 2028. Additionally, enrollment for the Phase 3 gMG trial is on track for completion in mid-2027, and the KYV-102 program has been deprioritized to focus resources on late-stage neurologic indications.Healthcare
- GRCENov 12, 8:01 AMGrace Therapeutics reported a net loss of $2.1 million for the three months ended September 30, 2026, driven by increased research and development expenses related to its dual-source manufacturing strategy for GTx-104. The company completed a $10 million private placement in August 2026, extending its cash runway through the end of 2028 to support regulatory resubmission efforts for its New Drug Application. Following a Complete Response Letter from the FDA in April 2026, Grace Therapeutics is addressing chemistry, manufacturing, and controls issues while initiating technology transfer to a second U.S.-based contract manufacturer. As of September 30, 2026, the company held $21.3 million in cash and cash equivalents to fund operations and resolve FDA-identified items.Healthcare
- MNPRNov 12, 8:01 AMMonopar Therapeutics reported a net loss of $6.2 million for the third quarter of 2026, with cash and investments totaling $129.4 million sufficient to fund operations through March 31, 2028. The company initiated a rolling New Drug Application submission to the FDA for ALXN1840, a first-in-class treatment for Wilson disease, and appointed Jeffrey D. Kent as Executive Vice President of Medical Affairs. Financial results showed increased research and development expenses driven by contractor and personnel costs, while interest income rose due to higher cash balances from a prior capital raise.Healthcare
- BTCSNov 12, 8:01 AMBTCS Inc. reported a record third quarter 2026 gross profit of $3.5 million with an 86% gross margin, surpassing its full-year target of $6 million within the first nine months of the year. Total revenues for the quarter increased 67% to $4.1 million, driven primarily by a 133% quarter-over-quarter growth in DeFi revenues from its Imperium business line. The company expanded its Imperium liquidity pool positions from approximately $8 million to $41 million and integrated operations on the Base network. Net income for the quarter was $54.5 million, largely attributed to $58.3 million in non-cash unrealized gains on digital assets due to Ethereum price appreciation.Financial Services
- IMNNNov 12, 8:00 AMIMUNON, Inc. reported a net loss of $3.8 million for the third quarter of 2026, with operating expenses totaling $3.4 million. The company advanced its lead candidate IMNN-001 in a Phase 3 trial for advanced ovarian cancer, supported by a new Cooperative Research and Development Agreement with the National Cancer Institute. Recent corporate developments include a debt-for-equity exchange reducing debt by approximately 43% and an agreement to sell rights to ThermoDox to VoxelDox Therapeutics. As of September 30, 2026, the company held $4.0 million in cash and cash equivalents alongside $5.0 million in restricted cash.Healthcare
- ARXNov 12, 8:00 AMAccelerant Holdings reported third-quarter 2026 results showing a 27% year-over-year increase in Exchange Written Premium to $1.33 billion, with third-party direct written premium accounting for 49% of the volume. The company recorded a GAAP net loss of $9.2 million, or $0.06 per diluted share, while reporting adjusted net income of $38.2 million and adjusted EBITDA of $71.3 million. Accelerant added 26 Managing General Agents during the quarter, bringing the total member count to 340, and announced a definitive merger agreement with Thoma Bravo expected to close in the first half of 2027. Due to the pending transaction, the company will not host an earnings conference call or provide guidance for the remainder of 2026.Financial Services
- ICUNov 12, 8:00 AMSeaStar Medical Holding Corporation reported net revenue of $635,000 for the third quarter of 2026, representing a 247% increase compared to the same period in 2025, driven by the adoption of its QUELIMMUNE therapy for pediatric acute kidney injury. The company achieved nearly 75% enrollment in its NEUTRALIZE-AKI pivotal clinical trial for adult patients and received Breakthrough Device Designation from the FDA for treating hyperinflammation in adults with sepsis. During the quarter, the company reported a net loss of $4.5 million, or $1.03 per share, while maintaining cash reserves of $4.0 million as of September 30, 2026.Healthcare
- CRMDNov 12, 8:00 AMCorMedix Therapeutics reported third-quarter 2026 consolidated revenue of $54.5 million and a net loss of $14.7 million, resulting in adjusted EBITDA of $3.1 million. The company announced a definitive agreement to acquire substantially all assets of Heron Therapeutics, a transaction expected to close in the first quarter of 2027 and contribute between $125 million and $150 million in revenue for the full year 2027. DefenCath sales declined to $17.2 million due to post-TDAPA pricing pressures, while the remainder of the portfolio generated $37.3 million in revenue. CorMedix maintained its full-year 2026 revenue guidance of $325 million to $345 million but narrowed its adjusted EBITDA guidance to $130 million to $140 million, while suspending 2027 DefenCath revenue guidance pending further clarity on CMS reimbursement frameworks.Healthcare
- LTCHNov 12, 7:51 AMLatch, Inc., operating as DOOR, reported third-quarter 2026 total revenue of $14.1 million, an 18.9% decrease year-over-year driven by lower hardware shipments and professional services activity. Software revenue grew 18.1% to $6.3 million, contributing to an expanded gross margin of 55.2% despite a net loss of $20.5 million that included a $13.6 million non-cash goodwill impairment charge. The company launched its OpenDOOR developer platform and executed a restructuring plan expected to reduce annualized operating costs by $10 million to $12 million. Additionally, DOOR settled a Securities and Exchange Commission investigation with a $1.0 million civil penalty and aims to achieve positive cash flow by the second half of 2027.Technology
- SGMTNov 12, 7:48 AMSagimet Biosciences initiated its registrational U.S. AURORA Phase 3 clinical trial for denifanstat in moderate to severe acne, with topline data expected in the second half of 2027. The company completed an underwritten offering of Series A common stock and pre-funded warrants in October 2026, generating $115 million in gross proceeds. As of September 30, 2026, Sagimet reported a pro forma cash balance of approximately $356 million, which is projected to fund operations through mid-2029. Additionally, the company presented positive 52-week efficacy data from its license partner Ascletis' Phase 3 trial in China and announced plans to initiate a Phase 2 trial for its FASN inhibitor TVB-3567 before the end of 2026.Healthcare
- EROCNov 12, 7:48 AMERock, Inc. reported a third quarter 2026 net income of $8.9 million and Adjusted EBITDA of $12.6 million, marking a nearly fourfold increase in revenue quarter-over-quarter to $152.8 million. The company began construction on a 366-megawatt generation facility for Meta in El Paso and expanded its manufacturing capacity with a new Atlas facility in Houston. ERock ended the quarter with $549 million in unrestricted cash, no outstanding debt, and a backlog reaching a new record level. The company reaffirmed its full-year 2026 guidance, projecting revenue between $435 million and $465 million and Adjusted EBITDA between $3 million and $9 million.Industrials
- ENVXNov 12, 7:44 AMEnovix Corporation reported Q3 2026 revenue of $11.0 million, representing a 38% year-over-year increase driven by strong demand in the drone and defense sectors. The company achieved a record non-GAAP gross margin of 34.5% and announced a new fiscal year 2027 revenue guidance range of $65 million to $85 million. Strategic initiatives included retiring $128 million of 2030 Notes at a 36% discount, executing a restructuring to reduce annual costs by $8.5 million, and expanding battery production capacity in South Korea. Additionally, Enovix declared a warrant dividend to retire its 2028 Notes and shifted its silicon-anode development focus toward smart eyewear applications following qualification challenges in the smartphone market.Industrials
- TSHANov 12, 7:38 AMTaysha Gene Therapies reported a net loss of $39.1 million for the third quarter of 2026, driven by increased research and development expenses related to its TSHA-102 clinical trials. The company successfully completed a BLA-enabling Process Performance Qualification manufacturing campaign for TSHA-102, which met all predefined product specifications and comparability criteria. As of November 2026, TSHA-102 has been generally well tolerated across 33 patients in the REVEAL and ASPIRE trials with no severe treatment-related serious adverse events or dose-limiting toxicities observed. Taysha expects to report topline data from the six-month interim analysis of the REVEAL pivotal trial and receive FDA feedback on its BLA submission pathway in the first half of 2027.Healthcare
- FBYDNov 12, 7:35 AMFalcon's Beyond Global, Inc. reported consolidated revenue of $7.3 million for the third quarter of 2026, representing an 80% increase compared to the prior year period. The company recorded a consolidated net loss of $7.7 million and an Adjusted EBITDA loss of $7.4 million for the quarter, though both metrics showed improvement over the previous year. Key unconsolidated entities contributed significantly to the results, with Falcon's Creative Group generating $5.2 million in revenue and the joint venture Producciones de Parques generating $11.8 million. The company's contracted pipeline for attractions and creative services totaled $28.0 million as of the end of the quarter.Industrials
- CAPSNov 12, 7:35 AMCapstone Holding Corp. reported third-quarter 2026 revenue of $20.0 million, representing a 46% year-over-year increase, with income from operations reaching $0.4 million. The company's Stone Business Adjusted EBITDA for the quarter was $1.5 million, and full-year revenue guidance was revised downward to approximately $70 million due to higher interest rates impacting housing activity. Despite these macroeconomic headwinds, organic revenue grew 7.5% in the third quarter, and all three operating businesses outperformed their respective markets.Basic Materials
- SBDSNov 12, 7:35 AMSolo Brands, Inc. reported fiscal 2026 third-quarter net sales of $43.7 million, a 17.6% decrease from the prior year period, driven by lower unit volumes and retail channel softness. Despite the revenue decline, the company achieved positive operating cash flow of over $6 million and improved segment adjusted EBITDA across its Solo Stove, Chubbies, and Watersports divisions. Consolidated net loss for the quarter was $20.8 million, while adjusted net loss narrowed to $11.6 million, reflecting disciplined cost management and reduced promotional activity. For the full year 2026, the company updated its guidance to project net sales between $270 million and $290 million and adjusted EBITDA between $21 million and $25 million.Consumer Cyclical
- ALTNov 12, 7:33 AMAltimmune, Inc. reported a net loss of $31.6 million for the third quarter ended September 30, 2026, driven by increased research and development expenses related to its PERFORMA Phase 3 trial in MASH and RESTORE Phase 2 trial in ALD. The company holds $480 million in cash, cash equivalents, and investments as of the end of the quarter. Clinical progress includes the ongoing global PERFORMA Phase 3 trial in MASH with topline data anticipated in 2029, positive RECLAIM Phase 2 data in AUD presented at AASLD, and a scheduled End-of-Phase 2 meeting with the FDA for the AUD program in December 2026. Additionally, enrollment is complete for the RESTORE Phase 2 trial in ALD, with topline data expected in the second half of 2027.Healthcare
- LUNRNov 12, 7:32 AMIntuitive Machines reported record third-quarter 2026 revenue of $269 million, driven by satellite production, lunar delivery, and ground communication services. The company achieved a gross margin of $69 million (26%) and generated positive free cash flow of $33 million during the quarter. Backlog reached a record $1.9 billion, an increase of $1.7 billion from the end of 2025, fueled by new awards including NASA's CLPS 2 contract and the Accelerated Missile Defense Tranche 3 constellation. Full-year 2026 revenue is projected to fall between $920 million and $950 million, with the company expecting positive Adjusted EBITDA for the year.Industrials
- YSWYNov 12, 7:30 AMYesway, Inc. reported third-quarter 2026 net income of $24.8 million and Adjusted EBITDA of $59.6 million, reflecting growth in both fuel and inside merchandise categories. The company achieved a 1.9% year-over-year increase in same-store inside merchandise sales and a 1.1% increase in same-store fuel gallons sold, while total fuel gallons rose 4.8% to 164.7 million. Yesway opened two new stores during the quarter, including its first location in Arizona, bringing its total store count to 423 as of September 30, 2026. The company reaffirmed its full-year 2026 outlook, projecting Adjusted EBITDA between $235 million and $245 million and capital expenditures between $85 million and $95 million.Consumer Defensive
- LGNNov 12, 7:23 AMLegence Corp. reported record third-quarter 2026 revenues of $1.31 billion, representing an 85% increase from the prior year, driven by strong demand in the Installation & Maintenance segment. The company achieved a non-GAAP Adjusted EBITDA of $177.0 million, a 99% year-over-year increase, while total backlog and awarded contracts reached a record $5.90 billion. Following the acquisition of The Bowers Group, Inc., Legence raised its full-year 2026 revenue guidance to $4.87–$4.91 billion and established 2027 guidance of $5.3–$5.6 billion. Additionally, the Board authorized a $150 million stock repurchase program to reflect the company's strong financial position and capital allocation strategy.Industrials
- TWSTNov 12, 7:19 AMTwist Bioscience reported record full-year fiscal 2026 revenue of $459.4 million, representing a 22% increase over the prior year, with fourth-quarter revenue reaching $126.6 million. The company achieved a gross margin of 52.4% for the full year and posted positive adjusted EBITDA of $2.2 million in the fourth quarter. Fiscal 2027 revenue guidance is set between $550 million and $560 million, reflecting an expected 21% year-over-year growth at the midpoint. As of September 30, 2026, the company maintained a cash position of approximately $582 million while expanding its customer base to roughly 4,100 clients.Healthcare
- FLYXNov 12, 7:17 AMflyExclusive, Inc. reported consolidated revenue of $111 million for the third quarter of 2026, representing a 21% year-over-year increase. The company achieved a positive Adjusted EBITDA of $5.1 million, driven by a 95% year-over-year rise in gross profit and a 38% increase in MRO revenue. Operational efficiencies were highlighted by a 7% growth in flight hours despite a 19% reduction in the aircraft fleet, alongside a 930 basis point improvement in dispatch availability. Additionally, the company reduced long-term notes payable by $106 million since 2024 while maintaining a $92 million at-the-market facility availability.Industrials
- IPSCNov 12, 7:16 AMCentury Therapeutics reported a net loss of $23.5 million for the third quarter ended September 30, 2026, with research and development expenses decreasing to $18.1 million due to portfolio prioritization. The company maintains a cash position of $174.1 million, providing a runway into the first quarter of 2029. Nonclinical data for its CNTY-813 therapy demonstrated sustained normoglycemia in diabetic mice, supporting an anticipated IND submission in the fourth quarter of 2026. Additionally, the CD19-targeted CAR-iT cell therapy CNTY-308 remains on track to enter clinical trials in 2026 following alignment with health authorities.Healthcare
- GENBNov 12, 7:16 AMGenerate Biomedicines reported third-quarter 2026 financial results showing a net loss of $87.7 million and revenue of $4.2 million, with cash and marketable securities totaling $404.2 million as of September 30, 2026. The company advanced its lead candidate GB-0895, an AI-engineered anti-TSLP antibody, into two Phase 3 asthma studies and demonstrated sustained six-month pharmacological activity in COPD patients. Strategic partnerships were established with Zealand Pharma for a $30 million upfront payment to develop obesity therapeutics and with Anthropic to apply agentic AI to CAR T-cell research. Clinical progress included enrollment in the second cohort for GB-4362 in urothelial cancer and the first patient dosing for GB-5267 in ovarian cancer.Healthcare
- DPCNov 12, 7:15 AMDPC Holdings reported record third-quarter 2026 revenue of $308 million, representing a 39% year-over-year increase driven by strong performance in its Aerospace and Industrial Gas Turbine segments. The company achieved a net income of $32 million, a significant turnaround from a $42 million loss in the same period last year, while adjusted EBITDA rose 56% to $58 million. Strategic milestones included the acquisition of a 50% stake in Montana Precision Products, the signing of a fifth major customer partnership expected to generate over $100 million in annual incremental revenue by 2032, and the refinancing of debt facilities with a new $325 million credit line. Consequently, DPC Holdings raised its full-year 2026 revenue guidance to a range of $1.115 billion to $1.13 billion and introduced full-year 2027 guidance projecting revenue between $1.23 billion and $1.33 billion.Industrials
- ADIGNov 12, 7:15 AMADI Global Distribution reported a net loss of $655 million for the third quarter of 2026, driven primarily by a $659 million non-cash goodwill impairment charge triggered by residential market weakness. Net revenue for the quarter reached $1,306 million, representing a 9% year-over-year increase, while gross margin declined to 20.9% due to unfavorable product mix and inventory charges. The company lowered its full-year 2026 financial guidance, projecting net revenue between $4.91 billion and $4.93 billion and Adjusted Standalone EBITDA between $230 million and $240 million. Management cited continued challenges in the residential sector and weaker demand for Exclusive Brands products as key factors necessitating the revised outlook.Technology
- MWHNov 12, 7:14 AMSOLV Energy reported third-quarter 2026 revenue of $1.242 billion, representing a 65% year-over-year increase, with full-year revenue reaching $2.87 billion. The company achieved net income of $123 million for the quarter and $162 million year-to-date, driven by higher operating income and reduced interest expenses following the repayment of term debt. SOLV Energy raised its full-year 2026 financial guidance, projecting revenue between $4.03 billion and $4.12 billion and adjusted EBITDA between $525 million and $540 million. Additionally, the company completed the acquisition of ASB Energy Services in October 2026 and reported a total backlog of approximately $9.2 billion as of September 30, 2026.Utilities
- ABSINov 12, 7:11 AMAbsci Corporation reported third-quarter 2026 financial results showing $0.3 million in revenue and a net loss of $33.3 million. The company advanced its ABS-201 program for pattern hair loss, with 13-week interim proof-of-concept data anticipated in December 2026, and announced plans for a Phase 2 trial in endometriosis to begin in mid-2027. Absci appointed Gerry Muhle as Chief Commercial Officer to support the commercialization of its pipeline. As of September 30, 2026, the company held $173.7 million in cash, cash equivalents, and marketable securities, which is projected to fund operations into the second half of 2028.Healthcare
- DAIONov 12, 7:10 AMData I/O Corporation reported third-quarter 2026 net sales of $4.9 million and bookings of $5.0 million, reflecting a recovery in platform equipment demand despite softness in adapter sales. The company achieved a gross margin of 58.0% and recorded an adjusted EBITDA of negative $71,000, excluding equity compensation and one-time expenses. A transformational acquisition of V-TEK, Inc. and A&J Programming, Inc. was completed in October 2026 for $23 million, expanding the business into high-growth markets such as AI, data centers, and robotics. Financial results for the quarter included a net loss of $2.7 million driven by $1.5 million in one-time expenses related to debt, financing, and IT transitions. The company ended the quarter with $9.4 million in cash and subsequently secured $13.25 million in direct investment and a $7.5 million bank line of credit.Technology
- PTHSNov 12, 7:10 AMPelthos Therapeutics reported third-quarter 2026 net product revenue of $15.2 million for Zelsuvmi, representing an 114% increase from the same period in 2025. The company dispensed 12,384 units of Zelsuvmi to 4,942 unique prescribers while expanding formulary coverage to 127 million commercially covered lives. On October 30, 2026, Pelthos announced a definitive merger agreement with Castle Creek Biosciences to create a diversified biotechnology company focused on serious skin diseases, with the transaction expected to close by the end of the first quarter of 2027. For the quarter, the company recorded a net loss of $7.9 million and held a cash balance of $17.7 million as of September 30, 2026.Healthcare
- CWBHFNov 12, 7:09 AMCharlotte's Web Holdings reported a third-quarter 2026 operating loss of $3.7 million, narrowing from $5.3 million in the prior year despite revenue declining 18.3% to $9.4 million due to California hemp restrictions and reduced promotional discounting. The company successfully improved its gross margin to 46.9% by simplifying its product range and insourcing production, while total liabilities decreased significantly to $19.4 million following the conversion of convertible debentures into equity. Federal policy changes scheduled for December 11, 2026, may restrict full-spectrum products containing more than 0.4 milligrams of total THC, prompting the company to advocate for legislative protections and reintroduce broad-spectrum options in California. Additionally, the company is preparing for potential healthcare channel opportunities, including Medicare Advantage programs, while maintaining a cash position of $11.4 million.
- AADXNov 12, 7:07 AMApplied Aerospace & Defense reported record third-quarter 2026 revenue of $182.1 million, representing a 48.6% increase year over year, driven by strong demand across space, defense aviation, and advanced sensing markets. The company generated net income of $30.6 million and delivered Adjusted EBITDA of $39.7 million, while expanding its contract backlog to nearly $1.3 billion. Excluding the impact of 2026 acquisitions, organic revenue growth was 20.3%, with double-digit growth achieved in all three core end markets. For the full year 2026, the company updated its outlook to project total revenue between $660 million and $670 million and non-GAAP Adjusted EBITDA between $137 million and $142 million.Industrials
- YARWNov 12, 7:07 AMYarrow Bioscience reported a net loss of $9.7 million for the third quarter of 2026, with research and development expenses totaling $5.3 million and general and administrative expenses at $5.5 million. The company holds $268.9 million in cash and cash equivalents as of September 30, 2026, following a $172.5 million public offering completed in September, which extends its operational runway into 2030. Enrollment is ongoing for the Phase 2a portion of the DIRECTION-GD trial evaluating the anti-TSHR antibody YB-101 in patients with Graves' disease, with topline results expected in the second half of 2027. Additionally, data from a partner's Phase 1 trial in thyroid eye disease is anticipated in the same timeframe to inform global development plans.Healthcare
- PBLSNov 12, 7:07 AMParabilis Medicines reported third-quarter 2026 financial results showing $1.1 billion in cash and cash equivalents, sufficient to fund operations into 2030. The company presented updated Phase 1/2 data for zolucatetide in desmoid tumors at the ESMO Congress 2026, demonstrating a 72.2% objective response rate and a favorable safety profile. Parabilis reached alignment with the U.S. FDA on the design for the upcoming PEDESTAL Phase 3 registrational trial, which is scheduled to begin in the first half of 2027. Additionally, the company initiated a dose-ranging study for zolucatetide in familial adenomatous polyposis and entered a clinical collaboration with Revolution Medicines to evaluate the drug in combination therapies for metastatic colorectal cancer.Healthcare
- OCTVNov 12, 7:07 AMOctave Intelligence reported third-quarter 2026 total revenue of $415 million, representing a 6% year-over-year increase, while annualized recurring revenue (ARR) grew 7% to $1.17 billion. The company generated $95 million in operating cash flow and $65 million in free cash flow, with an adjusted operating margin of 28%. Recent strategic initiatives include the acquisition of Cerebre, the launch of Attune Facilities, and the release of a new version of its Alto geospatial solution. Additionally, the Board of Directors approved a $200 million share repurchase program to offset dilution and support capital allocation, while providing full-year 2026 revenue guidance between $1.64 billion and $1.66 billion.Technology
- EYPTNov 12, 7:05 AMEyePoint, Inc. reported a net loss of $95.6 million for the third quarter ended September 30, 2026, driven by $97.6 million in operating expenses primarily related to ongoing Phase 3 clinical trials. The company announced a strategic shift to prioritize its DURAVYU program for diabetic macular edema (DME), following Phase 3 trials for wet AMD that did not meet primary non-inferiority endpoints but showed significant reductions in treatment burden. To extend its financial runway, EyePoint implemented a workforce reduction of approximately 53%, expecting to generate $30 million in annualized savings. As of September 30, 2026, the company held $118 million in cash, cash equivalents, and short-term investments, with operations funded through the late third quarter of 2027.Healthcare
- CYNNov 12, 7:05 AMCyngn reported a net loss of $6.0 million for the third quarter of 2026, with revenue increasing to $156.5 thousand from $70 thousand in the prior year period. The company secured a follow-on order from a Fortune 100 heavy equipment manufacturer and achieved ISO 27001 certification alongside a zero-exception SOC 2 Type II examination. As of September 30, 2026, Cyngn held $34.9 million in unrestricted cash and short-term investments with no outstanding debt. The company also launched the DriveMod EasyLaunch program to facilitate lower-barrier adoption of its autonomous tugger technology.Technology
- MBGLNov 12, 7:03 AMMobility Global reported third-quarter 2026 revenue of $478 million, representing a 7.4% year-over-year increase driven by growth in both its CARFAX and B2B segments. The company achieved adjusted EBITDA of $195 million and net income of $42 million, marking its first full quarter as a standalone public entity. Management announced an $800 million share repurchase program and declared a quarterly dividend of $0.06 per share. Additionally, the company raised its full-year 2026 adjusted EBITDA guidance midpoint while maintaining its revenue outlook.Technology
- BKTINov 12, 7:03 AMBK Technologies reported third-quarter fiscal 2026 revenue of $25.3 million, representing a 3.6% increase year-over-year, driven by strong federal demand including a major order from the U.S. Forest Service. The company achieved a gross margin of 50.7% and net income of $3.7 million, while ending the quarter with $29.2 million in cash and no debt. Although a partial roof collapse at its West Melbourne headquarters in October temporarily disrupted BKR 9000 radio production, the company updated its full-year revenue outlook to approximately $85 million and reaffirmed its gross margin target of at least 50%. Additionally, the Board of Directors doubled its share repurchase authorization to $10 million and made a $3.0 million strategic investment in Tango Tango to expand its mission-critical software capabilities.Technology
- KARDNov 12, 7:02 AMKardigan, Inc. reported completing enrollment in Cohort 2 of the Phase 2b KINSHIP-DCM trial for its drug danicamtiv, with topline data expected in the second quarter of 2027. The company also finished enrollment in the Phase 2b KATALYST-AV trial for ataciguat, targeting aortic stenosis, and expects topline data for that study in the second half of 2027. Kardigan holds a cash position of $591.4 million as of September 30, 2026, which supports continued clinical advancement across its three programs, including the ongoing Phase 2 KARDINAL-ASH trial for tonlamarsen.Healthcare
- KPRXNov 12, 7:02 AMKiora Pharmaceuticals reported a net loss of $1.7 million for the third quarter of 2026, ending the period with approximately $16.3 million in cash and short-term investments. The company in-licensed exclusive development rights outside Asia for KIO-401, a late-stage oral calpain inhibitor, and has submitted a Type B pre-IND meeting request and an orphan drug designation request to the FDA for its use in treating Central Retinal Artery Occlusion. KIO-301 remains in Phase 2 development with the ABACUS-2 trial actively enrolling patients, while the company also expanded its commercial network by out-licensing rights in South Korea to Chong Kun Dang Pharmaceutical Corporation. Additionally, Kiora discontinued further research and development investment in KIO-104 and appointed Keith Lane as Executive Vice President of Clinical Development and Regulatory Affairs.Healthcare
- NIQNov 12, 7:01 AMNIQ Global Intelligence reported third-quarter 2026 revenue of $1,119.1 million, reflecting a 6.3% year-over-year increase and 5.8% organic constant currency growth. The company achieved its first positive GAAP net income since its IPO, recording $35.8 million in net income and $0.12 per share, while Adjusted EBITDA rose 17.8% to $263.6 million. NIQ reached a net leverage ratio of 2.9x, one quarter ahead of its target, and authorized a $150 million share repurchase program. Full-year 2026 guidance was raised to include 5.5% to 5.7% organic constant currency revenue growth and an Adjusted EBITDA margin of 23.6% to 23.8%.Communication Services
- LIENNov 12, 7:00 AMChicago Atlantic BDC, Inc. reported third-quarter 2026 net investment income of $8.3 million, or $0.36 per share, with total investment income reaching $15.4 million. The company's portfolio grew to a record fair value of $399.6 million across 39 portfolio companies, supported by $72.0 million in new funding to two borrowers during the quarter. Net assets increased by $8.0 million for the period, while the company maintained a 100% senior secured debt portfolio with a weighted average yield of 15.5%. Additionally, the Board declared a fourth-quarter dividend of $0.34 per share, and the company continues to pursue a merger with affiliated entity Chicago Atlantic Real Estate Finance, Inc.
- BWENNov 12, 7:00 AMBroadwind reported third-quarter 2026 total revenue of $22.3 million, representing a 48% year-over-year increase driven by strong demand in its Gearing and Industrial Solutions segments. The company recorded a GAAP loss from continuing operations of $1.0 million, or $0.04 per diluted share, while achieving a non-GAAP Adjusted EBITDA of $0.5 million. Total orders for the quarter reached $33.7 million, a 13% increase year-over-year, with power generation-related orders accounting for over 70% of the order book. At the end of the quarter, the company maintained liquidity of $39.7 million, including $5.9 million in total debt and financing leases.Industrials
- HYPDNov 12, 7:00 AMHyperion DeFi reported a record third-quarter 2026 net income of $39.6 million and adjusted EBITDA of $48.7 million, marking the third consecutive quarterly record. The company achieved breakeven core operating earnings of $0.56 million and positive adjusted net operating cash flow of $62,695, surpassing its year-end targets by one quarter. Hyperion DeFi retired all legacy debt totaling approximately $8.6 million and initiated a $20 million share repurchase program while growing its adjusted gross profit by 143% quarter-over-quarter to $2.8 million.Healthcare
- FRMINov 12, 7:00 AMFermi Inc. announced a new agreement with an investment-grade hyperscaler to advance 600 megawatts of power capacity at Project Matador, involving a $200 million prepayment and a $15 million early construction commitment. The company reported a net loss of $141.6 million for the third quarter of 2026, driven primarily by $142.2 million in general and administrative expenses, while maintaining $315.5 million in total cash and restricted cash. Additionally, Fermi terminated its data center lease with TensorWave and confirmed an ongoing partnership with the Texas Tech University System to support Project Matador development.Real Estate
- STDNNov 12, 7:00 AMStandard Nuclear reported third-quarter 2026 revenue of $6.0 million, a significant increase from $0.9 million in the prior-year period, driven by commercial TRISO fuel deliveries and development services. The company's total contract backlog more than doubled to $577.2 million, with funded backlog nearly doubling to $119.6 million, while the combined backlog and qualified pipeline reached approximately $1.4 billion. Key operational milestones included the completion and delivery of the first commercial reactor core for Radiant Industry, the substantial completion of construction at its Tennessee and Idaho production facilities, and the delivery of ultra-high-temperature fuel kernels for NASA's Nuclear Thermal Propulsion program. Despite these advancements, the company reported a net loss of $13.1 million for the quarter, primarily due to increased share-based compensation and costs associated with scaling production and public company infrastructure.Basic Materials
- AEBINov 12, 7:00 AMAebi Schmidt Group reported a 4.6% increase in third-quarter 2026 net sales to $493 million, driven by strong performance in North American Walk-In Van and Municipal sectors. Adjusted EBITDA rose 4.9% to $44.2 million, while net income significantly improved to $10.8 million despite an 80 basis point decline in gross margin due to inflationary pressures. The company updated its full-year 2026 guidance, projecting net sales between $1.95 billion and $2.00 billion and adjusted EBITDA between $170 million and $180 million. Additionally, the group announced a planned acquisition of O.J. Watson Company Inc to expand its presence in the Rocky Mountains and reported a reduction in net debt leverage to 2.66x.Industrials
- LACNov 12, 7:00 AMLithium Americas reported a net income of $96.4 million for the nine months ended September 30, 2026, driven by significant gains on financial instruments and increased interest income. The company updated its definitive capital cost estimate for the Thacker Pass Phase 1 project to $3.83 billion, reflecting increases due to labor inflation, tariff exposure, and additional contingency. Construction progress remains on track with mechanical completion targeted for late 2027, supported by a workforce of approximately 1,900 personnel and over 80% of third-party contract values committed. Financially, the company holds $1.3 billion in total cash and restricted cash as of September 30, 2026, following recent advances from the U.S. Department of Energy and the issuance of subordinated convertible debentures.Basic Materials
- AVAHNov 12, 7:00 AMAveanna Healthcare Holdings reported third-quarter 2026 revenue of $695.5 million, representing an 11.8% increase year-over-year, with net income rising to $45.5 million. Adjusted EBITDA for the quarter reached $100.1 million, a 25.0% increase compared to the prior year period. The company raised its full-year 2026 revenue guidance to greater than $2.695 billion and adjusted EBITDA guidance to greater than $374 million. For the nine-month period ended October 3, 2026, the company generated $157.5 million in net cash from operating activities and $141.2 million in free cash flow.Healthcare
- TCRXNov 12, 7:00 AMTScan Therapeutics announced a strategic reorganization to prioritize its in vivo-engineered TCR-T cell therapy program for solid tumors, advancing candidates targeting PRAME and MAGE-A4 through IND-enabling studies with a goal to dose the first patient in the fourth quarter of 2027. The company paused further enrollment in its Phase 3 ALLOHA-2 study of TSC-101 for heme malignancies due to insufficient capital and is actively seeking strategic partners for both this and its autoimmunity programs. For the third quarter of 2026, TScan reported revenue of $0.6 million and a net loss of $33.1 million, with cash and cash equivalents of $73.0 million expected to fund operations into the fourth quarter of 2027.Healthcare
- FIGRNov 12, 6:47 AMFigure Technology Solutions reported third-quarter 2026 net revenue of $287 million, representing an 84% year-over-year increase, driven by a 135% surge in Loan Marketplace volume to $5.8 billion. The acquisition of Kiavi, completed on September 1, 2026, contributed $677 million to the quarter's volume and expanded the company's presence into Residential Transition Loan and DSCR markets. Adjusted EBITDA rose 91% to $164 million, while the company maintained a cash position of $1.6 billion excluding restricted cash. Looking ahead, the company provided fourth-quarter 2026 guidance projecting Loan Marketplace volume between $6.2 billion and $6.7 billion.Financial Services
- SPBNov 12, 6:46 AMSpectrum Brands Holdings reported fiscal 2026 full-year net sales of $2.85 billion, representing a 1.5% increase, while full-year adjusted EBITDA reached $374.8 million. The company's Global Pet Care and Home and Garden segments drove growth with increases of 5.1% and 3.9% respectively, whereas Home and Personal Care sales declined by 3.0%. Fiscal 2026 fourth quarter net sales decreased 2.8% to $713.2 million, though adjusted EBITDA for the quarter rose 10.3% to $69.9 million. Looking ahead to fiscal 2027, the company forecasts flat to low single-digit growth in both net sales and adjusted EBITDA, excluding the one-time benefit of tariff refunds received in the prior year.Consumer Defensive
- TENov 12, 6:37 AMT1 Energy reported a net loss of $34.7 million for the third quarter of 2026, driven by increased inventory production and higher operating expenses. The company signed nearly 1.6 GW of new offtake contracts following a U.S. Department of Commerce Section 232 proclamation, bringing its total contracted 2027 capacity to over 3.5 GW. T1 raised $50.4 million through a private placement of convertible senior notes and received a waiver to import up to 1.725 GW of solar cells to support manufacturing while its Austin cell fab is under construction. The company has updated its full-year 2026 module production guidance to 4.0–4.2 GW and initiated preliminary 2027 guidance of 5.3 GW based on strong demand.Industrials
- NUAINov 12, 6:35 AMNew Era Energy & Digital, Inc. has contracted up to 207 MW of firm power for the Texas Critical Data Centers Phase 1 project through a 20-year agreement with Luminant, with power availability expected in the third quarter of 2027. The company completed a $64 million PIPE offering to repay borrowings and currently holds $187 million in total cash as of October 31, 2026. Phase 2 plans involve approximately 550 MW of new behind-the-meter generation with Thunderhead Energy Solutions, while the company continues advanced negotiations on lease documentation for both Phase 1 and Phase 2.Energy
- CDNLNov 12, 6:35 AMCardinal Infrastructure Group Inc. reported third-quarter 2026 revenues of $201.9 million, a 65.1% increase from the prior year, driven by organic growth and acquisitions. Despite the revenue surge, the company posted a net loss of $11.0 million and an Adjusted EBITDA margin of 4.2%, significantly below expectations due to project estimate revisions, residential pricing pressure, and rising fuel costs. In response to these performance issues, the company announced a leadership transition to strengthen project execution, postponed a proposed acquisition of Hughes Brothers, and withdrew its full-year 2026 financial guidance. Additionally, the Board authorized a $50 million share repurchase program to support capital allocation while the company focuses on operational discipline.Industrials
- EIKNNov 12, 6:35 AMEikon Therapeutics reported third-quarter 2026 financial results, ending the period with $461.7 million in cash and cash equivalents, projecting an operational runway into the first quarter of 2028. The company advanced its clinical portfolio by dosing the first patient in the registrational TeLuRide-008 trial for EIK1001 in non-small cell lung cancer and submitting an IND application for the novel androgen receptor antagonist EIK1006. Updated clinical data presented at the 2026 ESMO Congress demonstrated strong efficacy for EIK1001 in combination therapies and promising activity for its selective PARP1 inhibitors and WRN helicase inhibitor program. Additionally, the company appointed Ching-Pin Chang as Chief Scientific Officer and reported a net loss of $86.1 million for the quarter.Healthcare
- FPSNov 12, 6:33 AMForgent Power Solutions reported fiscal first quarter 2027 revenues of $479 million, representing a 69% year-over-year increase and the highest quarterly revenue in the company's history. Net income rose 252% to $55 million, while adjusted EBITDA increased 61% to $105 million, driven by strong production ramp execution and higher throughput. Based on robust customer demand and a backlog covering full-year guidance, the company raised its fiscal 2027 outlook to revenues between $2.45 billion and $2.65 billion and adjusted EBITDA between $587 million and $637 million. The company also highlighted significant growth in cash flow from operations, which improved by $130 million year-over-year to $136 million.Industrials
- ANNANov 12, 6:32 AMAleAnna, Inc. reported third-quarter 2026 net income of $6.2 million and revenue of $20.5 million, representing substantial growth compared to the second quarter of 2026. Average daily net sales gas production increased to approximately 274 thousand standard cubic meters per day, driven by robust output at the Longanesi facility and well optimization. The company achieved an Adjusted EBITDA of $12.2 million and an operating income of $9.4 million, supported by stronger realized gas prices and revenue growth that outpaced operating costs. Development progress continued on permanent facilities at Longanesi and construction at the Gradizza project, while Glen Cayley joined the Board of Directors to support the company's growth program.Energy
- WWWNov 12, 6:31 AMWolverine World Wide reported third-quarter 2026 revenue of $505.4 million, representing a 7.5% year-over-year increase, driven by strong performance in its Active Group and Work Group segments. The company achieved a gross margin of 54.6% and an operating margin of 17.7%, significantly improving upon the prior year's figures, with earnings per share rising to $0.78. These results were bolstered by $35.3 million in refunds related to IEEPA tariffs, which contributed approximately $0.31 to diluted earnings per share. Consequently, the company raised its full-year 2026 outlook, projecting revenue between $2.000 billion and $2.010 billion and adjusted diluted earnings per share between $1.95 and $1.99.Consumer Cyclical
- AIRONov 12, 6:30 AMAIRO Group Holdings reported third-quarter 2026 revenue of $17.5 million, representing a 179% increase from the prior-year period, driven by strong growth in its drone segment. The company achieved a gross margin of 57% and an adjusted EBITDA loss of $7.5 million, while maintaining a cash position of $37.8 million with minimal debt. As of November 5, 2026, AIRO's drone backlog stood at $200 million, with a total opportunity pipeline of $1.5 billion across U.S. and allied defense markets. Management expects full-year 2026 revenue growth between 15% and 25% and anticipates the majority of the current backlog will convert to revenue within the next 12 months.Industrials
- VYLRNov 12, 6:23 AMVylor, Inc. reported third-quarter 2026 pro forma net sales of $938 million, a 1% decrease from the prior year, driven by volume declines in both the Americas and Rest of World regions. Despite lower volumes caused by weather impacts and a shift to a licensing model in Brazil, the company achieved a 6% price/mix increase and reaffirmed its full-year 2026 guidance, expecting adjusted pro forma operating EBITDA of approximately $2.8 billion. The company also announced a new $3 billion share repurchase program and a quarterly dividend of $0.13 per share to reinforce its commitment to long-term value creation. Additionally, Vylor highlighted its $19 billion technology pipeline and a 2029 financial framework targeting net sales between $11.2 billion and $11.9 billion.Consumer Defensive
- KPLTNov 12, 6:17 AMKatapult Holdings reported third-quarter 2026 financial results following the August 11, 2026 merger with Aaron's and CCFI, marking its first quarter of combined operations. The company generated $753.9 million in total revenue and $110.4 million in Adjusted EBITDA, while reporting a net loss of $28.0 million driven by interest expenses and acquisition-related costs. Management identified approximately $30 million in annualized cost synergies and outlined a cautious fourth-quarter revenue outlook ranging from $975 million to $1.025 billion. The consolidated balance sheet reflects $1.95 billion in outstanding debt and $261.0 million in cash and cash equivalents as of September 30, 2026.Technology
- ENGNNov 12, 6:14 AMenGene Therapeutics is developing detalimogene voraplasmid, a non-viral gene therapy for high-risk non-muscle invasive bladder cancer (NMIBC) that activates the RIG-I pathway to induce localized immune responses. In the pivotal LEGEND study cohort, detalimogene demonstrated a 56% complete response rate at any time with a favorable safety profile, showing lower rates of treatment discontinuation compared to existing therapies. The company plans to initiate a Biologics License Application filing in the fourth quarter of 2026, with potential approval expected in 2027. Additionally, ongoing research into a surfactant bladder rinse aims to enhance drug transfection, potentially improving efficacy and reducing treatment dwell time from 60 to 30 minutes.Healthcare
- YETINov 12, 6:12 AMYETI Holdings reported third-quarter 2026 net sales of $509.4 million, a 4% increase year-over-year, while adjusted sales rose 6% to $517.9 million. Adjusted earnings per share grew 49% to $0.91, driven by an 180 basis point expansion in gross margin and a 35% increase in adjusted operating income to $90.0 million. The company updated its full-year 2026 outlook, lowering adjusted sales growth expectations to approximately 6% and adjusted EPS guidance to a range of $2.90 to $2.95 due to a cautious consumer environment. Additionally, YETI repurchased approximately 0.5 million shares for $20 million during the quarter and maintains strong liquidity with cash exceeding total debt.Consumer Cyclical
- RMTINov 12, 6:12 AMRockwell Medical reported net sales of $19.1 million for the third quarter of 2026, marking a 20% increase compared to the same period in 2025. Gross profit rose 37% to $3.1 million during the quarter, driven by higher sales volumes, while the company recorded a net loss of $2.3 million. The company announced an agreement to acquire Vantive's hemodialysis business, including manufacturing facilities in Italy, which is projected to generate annual revenue between $400 million and $450 million. Additionally, Rockwell Medical was named to the 2026 Fortune Best Workplaces in Manufacturing & Production list for the third consecutive year.Healthcare
- MRMDNov 12, 6:09 AMMariMed Inc. reported record third-quarter 2026 revenue of $44.2 million, representing a 5.5% sequential increase and an 8.5% year-over-year growth. The company achieved a non-GAAP adjusted EBITDA of $4.7 million, up 18% from the previous quarter, while maintaining a non-GAAP gross margin of 40%. Both wholesale and retail segments contributed to this growth, with wholesale revenue rising 5.2% sequentially and retail transactions increasing 2% sequentially. MariMed ended the quarter with $10.4 million in cash and cash equivalents, marking its strongest cash position in over two years.
- TTEKNov 12, 6:08 AMTetra Tech reported record fourth-quarter earnings per share of $0.51 and fiscal year 2026 adjusted earnings per share of $1.60, driven by strong performance in its global commercial and government businesses. The company achieved fourth-quarter revenue of $1.34 billion and full-year revenue of $5.08 billion, while its backlog grew 13% year-over-year to reach $4.67 billion. Significant contract wins included a $1.4 billion agreement with NASA and multiple awards totaling over $400 million from the U.S. Navy, EPA, and other federal agencies. Additionally, the Board approved an 11% increase in the quarterly dividend to $0.072 per share and repurchased $100 million of common stock during the quarter.Industrials
- EPCNov 12, 6:07 AMEdgewell Personal Care reported fourth-quarter fiscal 2026 net sales of $484.1 million, representing a 3.0% increase over the prior year, while full-year net sales reached $1,996.5 million, up 1.8%. The company posted adjusted earnings per share of $0.78 for the quarter and $1.93 for the full fiscal year, both showing significant growth compared to the previous period. Despite incurring $101.8 million in pre-tax restructuring costs for the year, the company maintained positive adjusted operating income and EBITDA. Edgewell declared a quarterly cash dividend of $0.15 per share and provided a fiscal 2027 outlook projecting adjusted EPS between $1.85 and $2.15.Consumer Defensive
- ENSNov 12, 6:06 AMEnerSys reported second-quarter fiscal 2027 net sales of $949.9 million, matching the prior year period, while achieving a gross margin of 29.9% and diluted earnings per share of $2.42. The company returned $140 million to shareholders through share repurchases and dividends, resulting in a net leverage ratio of 0.8 times EBITDA. EnerSys announced a proposed acquisition of Ultralife to expand its defense power portfolio, with the transaction expected to close in the fourth fiscal quarter of 2027. For the full year, the company expects capital expenditures of approximately $70 million and provided third-quarter net sales guidance between $935 million and $975 million.Industrials
- PXLWNov 12, 6:06 AMPixelworks, Inc. reported net income of $75.013 million for the nine months ended September 30, 2026, driven by a significant gain from discontinued operations, while net loss from continuing operations totaled $10.14 million. For the third quarter alone, the company recorded a net loss of $2.775 million with revenue of $378,000. The company announced a multi-year device certification agreement with Meta to integrate TrueCut Motion technology into Meta's VR devices. Additionally, Pixelworks repurchased $1.2 million of its common stock and ended the quarter with approximately $50 million in cash, cash equivalents, and short-term marketable securities.Technology
- EYENov 12, 6:05 AMNational Vision Holdings, Inc. reported third-quarter 2026 net revenue of $510.5 million, representing a 4.8% increase year-over-year, driven by comparable store sales growth of 3.6% and the addition of new stores. The company achieved significant margin expansion, with adjusted operating income rising to $37.1 million and adjusted diluted earnings per share more than doubling to $0.30. Management updated its full-year 2026 outlook to reflect current market conditions, projecting adjusted comparable store sales growth between 2.0% and 3.0% and adjusted diluted EPS between $0.95 and $1.03. Additionally, the company announced a new $100 million share repurchase authorization and reported a cash balance of $60.0 million as of October 3, 2026.Consumer Cyclical
- BTBTNov 12, 6:05 AMBit Digital, Inc. reported third-quarter 2026 total revenue of $27.1 million, driven by a 232% year-over-year increase in colocation services and a return to positive GAAP earnings of $28.5 million. The company's strategic focus has shifted toward Ethereum and AI infrastructure, resulting in a 19% sequential rise in colocation revenue and a 14% increase in native ETH staking revenue. As of September 30, 2026, Bit Digital held approximately 163,726 ETH valued at $439.4 million and maintained a 59.7% ownership stake in WhiteFiber Inc. with an implied value of $487 million. Concurrently, the company continued to wind down its Bitcoin mining operations, which saw revenue decline 63% year-over-year, while reducing debt through repayments totaling $60 million in the quarter.Financial Services
- XENov 12, 6:04 AMX-energy reported third-quarter 2026 revenues and grant income of $66.3 million, a 118% increase from the prior year period, driven by expanded activities under the U.S. Department of Energy's Advanced Reactor Demonstration Program. The company received a Construction Permit from the Nuclear Regulatory Commission for Dow's Long Mott project in Texas ahead of schedule and selected Fluor Corporation to advance engineering for a second Xe-100 small modular reactor project. Operational milestones included the completion of vertical construction at the TX-1 fuel fabrication facility, the acceptance of the Xe-100 reactor into the United Kingdom's Generic Design Assessment process, and the execution of the first procurement order for steam generator components. X-energy maintained a strong balance sheet with $1.8 billion in total liquidity and zero debt outstanding as of September 30, 2026.Industrials
- TISINov 12, 6:04 AMTeam, Inc. reported a net loss of $11.1 million for the third quarter of 2026, representing a slight improvement from the $11.4 million loss in the same period the previous year. Revenue for the quarter decreased by 2.0% to $220.4 million, driven by lower activity in the United States and Canada's mechanical services segment, which was partially offset by growth in international markets. Despite the revenue decline, the company achieved an Adjusted EBITDA of $15.7 million, an 8.2% increase from the prior year, supported by structural cost reductions and commercial diversification efforts. Management has updated its full-year 2026 guidance, projecting revenue between $870 million and $890 million and Adjusted EBITDA between $56 million and $59 million, citing deferred turnaround activities and Middle East conflicts as key factors influencing the outlook.Industrials
- EZPWNov 12, 6:03 AMEZCORP, Inc. reported record fourth-quarter fiscal 2026 results with net income attributable to the company rising 28% to $34.3 million and total revenues increasing 33% to $447.1 million. The company expanded its store footprint by 41 locations during the quarter, bringing the total number of stores to 1,590 across 15 countries, and completed the acquisition of the remaining interest in SMG to make it wholly owned. Core pawn revenue grew 27% to $383.4 million, driven by a 31% increase in pawn loans outstanding to $402.8 million and higher merchandise sales margins. For the full fiscal year, net income increased 51% to $165.9 million, while diluted earnings per share rose 46% to $2.07, reflecting strong operational performance across U.S., Latin American, and SMG segments.Financial Services
- AERTNov 12, 6:03 AMAeries Technology reported second-quarter fiscal 2027 revenue of $18.1 million, representing a 4.5% increase year over year, with net income rising to $1.3 million. For the first half of the fiscal year, revenue grew 23% to $40.1 million, while operating cash flow increased approximately 98% to $4.7 million. The company reaffirmed its full-year fiscal 2027 guidance, projecting revenue between $80 million and $84 million and Adjusted EBITDA between $10 million and $12 million.Industrials
- SUNSNov 10, 5:30 PMSunrise Realty Trust, Inc. reported a GAAP net income of $2.9 million, or $0.21 per share, and Distributable Earnings of $3.2 million, or $0.24 per share, for the third quarter of 2026. The company completed its merger with Southern Realty Trust on November 5, 2026, creating a larger platform with enhanced balance sheet flexibility. During the quarter, the company paid a cash dividend of $0.30 per share, totaling $4.1 million, while Distributable Earnings per share were $0.24. For the first nine months of 2026, Distributable Earnings totaled $0.89 per share compared to $0.90 per share in declared dividends.Financial Services
- AHTNov 10, 5:28 PMAshford Hospitality Trust reported a net income of $2.5 million for the third quarter of 2026, a significant turnaround from the $69.0 million loss in the prior-year period. Comparable RevPAR increased 7.3% to $140.80, driven by a 6.1% rise in Average Daily Rate and a 1.2% increase in occupancy. The company reduced its total debt to $1.9 billion through the sale of four hotels and refinancing activities, while also securing a $17 million waiver of advisory fees from Ashford Inc.Real Estate
- ASNSNov 10, 5:17 PMActelis Networks reported third-quarter 2026 revenue of $1.1 million, representing a 68% year-over-year increase driven by federal and intelligent transportation sector deliveries. The company achieved a gross margin of 40%, up from 28% in the prior-year quarter, while operating expenses decreased by 13% to $1.9 million. Net loss for the quarter narrowed by 37% to $1.2 million, or $0.04 per share, compared to $2.0 million in the same period of 2025. Additionally, the company's cash and cash equivalents rose to $4.8 million as of September 30, 2026, reflecting continued growth in North American and Asia-Pacific markets.Technology
- SNWVNov 10, 5:09 PMSanuwave Health reported third-quarter 2026 revenues of $8.6 million, representing a 24% decline from the $11.3 million recorded in the same period of 2025. The company sold 40 Ultramist systems during the quarter, a significant drop from 155 units sold in the prior year, while gross margin remained stable at 77.3%. GAAP operating results shifted to a loss of $1.1 million compared to an operating income of $0.9 million in the previous year, driven by the absence of non-recurring gains recognized in 2025. Adjusted EBITDA for the quarter was $0.7 million, down from $3.2 million in the prior year, as the company navigated market challenges related to CMS proposed reimbursement rules.Healthcare
- CPIXNov 10, 5:06 PMCumberland Pharmaceuticals reported a net income of $77.8 million for the third quarter of 2026, driven primarily by an $81.1 million gain from its strategic transaction with Apotex Health which closed on July 1, 2026. Following the transaction, the company has shifted its focus to a development-only model, retaining $80.6 million in cash and cash equivalents while integrating its commercial brands into Apotex's U.S. business. Cumberland announced plans to submit a New Drug Application to the FDA for ifetroban to treat cardiomyopathy associated with Duchenne muscular dystrophy, supported by positive Phase 2 trial data showing improved left ventricular ejection fraction. Additionally, the company released top-line results from a Phase 2a trial for ifetroban in systemic sclerosis, noting the drug was well-tolerated with no treatment-related serious adverse events.Healthcare
- LVONov 10, 5:00 PMLiveOne reported preliminary H1 Fiscal 2027 revenue of $37.3 million and record Audio Adjusted EBITDA of $7.8 million, representing a 619% year-over-year increase. The company revised its full Fiscal 2027 guidance to $70–$75 million in revenue and over $10 million in Adjusted EBITDA, while issuing first-time Fiscal 2028 guidance of $100 million or more. PodcastOne, a LiveOne subsidiary, achieved record first-half revenue of $31.5 million and Adjusted EBITDA of $3.0 million. Additionally, LiveOne has extinguished $25 million in debt and other liabilities since February 2026, reducing its senior debt balance to $9 million.Communication Services
- EMLNov 10, 5:00 PMThe Eastern Company reported third-quarter 2026 net sales of $75.0 million, representing a 36% year-over-year increase driven by higher shipments of truck mirror assemblies, returnable transport packaging, and the first full quarter of contribution from acquired Sungear and Crown Precision businesses. Operating profit more than tripled to $5.6 million, or 7.4% of net sales, while net income from continuing operations rose to $3.4 million, or $0.57 per diluted share. The company repaid $2 million of debt during the quarter, ending with $61 million in revolver availability, and saw its backlog increase 70% year-over-year to $126.1 million.Industrials
- DLPNNov 10, 4:59 PMDolphin Entertainment reported record third-quarter 2026 revenue of $16.0 million, an 8.3% increase year-over-year, driven by organic growth across its marketing and content production divisions. The company achieved net income of $0.2 million for the quarter, a significant turnaround from a $0.4 million loss in the same period last year, while adjusted EBITDA rose 42.9% to $1.6 million. Dolphin anticipates launching four new ventures in 2027, with the first expected in the first quarter, and highlighted upcoming film production and strategic lease expirations expected to enhance future free cash flow.Communication Services
- GOSSNov 10, 4:50 PMGossamer Bio submitted its first New Drug Application for seralutinib to treat pulmonary arterial hypertension to the U.S. FDA in September 2026. The company completed a 1-for-80 reverse stock split in September 2026 and reacquired worldwide rights to seralutinib from Chiesi in July 2026. A structured private placement provided $25 million in upfront capital with the potential for an additional $125 million upon FDA acceptance of the application. For the third quarter ended September 30, 2026, the company reported $51.2 million in cash, cash equivalents, and marketable securities, alongside a net loss of $48.1 million.Healthcare
- AZTANov 10, 4:46 PMAzenta reported fourth-quarter fiscal 2026 revenue of $167 million, representing a 5% year-over-year increase, while full-year revenue reached $622 million, also up 5%. The company posted a net loss from continuing operations of $157.9 million for the full year, primarily driven by a $149 million non-cash goodwill impairment charge, though adjusted diluted EPS for the period was $0.48. Looking ahead to fiscal 2027, Azenta forecasts total revenue between $648 million and $660 million, with adjusted EBITDA margins expected to expand by 200 to 250 basis points. Recent strategic moves include the acquisition of SynPlexity and a technology agreement with Elegen to enhance gene synthesis capabilities.Healthcare
- HYLNNov 10, 4:46 PMHyliion Holdings reported third-quarter 2026 revenue of $7.5 million, a significant increase from $0.8 million in the same period of 2025, driven by accelerated progress on military research and development services. The company delivered an additional KARNO Power Module to the U.S. Navy and initiated equipment movement to its first commercial customer site while raising its full-year 2026 revenue guidance to approximately $18 million. Anticipated military contract awards totaling $8 million before year-end would bring total new military awards for 2026 to roughly $50 million, with $45.5 million in remaining authorized funding under existing contracts. Hyliion ended the quarter with $121.4 million in cash and investments, maintaining a net loss of $11.1 million for the quarter as it consolidates manufacturing operations in Texas and advances additive manufacturing improvements.Consumer Cyclical
- INMNov 10, 4:45 PMMentari Therapeutics and InMed completed a merger on November 6, 2026, resulting in InMed being renamed Mentari Therapeutics, Inc., with the combined entity focusing on migraine prevention therapies. The transaction was structured as a reverse recapitalization where Mentari stockholders received approximately 99% of the combined company's common stock following a pre-closing financing that raised $490 million. Pro forma financial statements for the six months ended June 30, 2026, show a combined net loss of $37.3 million, while the year ended December 31, 2025, reflects a combined net loss of $26.9 million. The merger involved the conversion of Mentari's preferred stock and options into InMed securities and the elimination of InMed's legacy assets, which are now subject to a contingent value rights agreement.Healthcare
- TLFNov 10, 4:44 PMTandy Leather Factory reported third-quarter 2026 revenues of $18.5 million, representing a 7.3% increase from the prior year. The company generated an operating income of $0.6 million and a net income of $0.5 million, contrasting with a net loss of $1.4 million in the same period of 2025. Gross margin improved to 62.4% from 58.9% in the previous year, driven by operational enhancements and sales growth across retail and e-commerce channels. As of September 30, 2026, the company held $5.7 million in cash and cash equivalents following dividend payments and investments in new store locations and inventory.Consumer Cyclical
- KRMDNov 10, 4:43 PMKORU Medical Systems reported third-quarter 2026 net revenues of $11.6 million, an 11% increase from the prior year, driven by a 31.6% growth in domestic core sales. The company achieved its second consecutive quarter of positive net income, recording $0.2 million in profit and $1.3 million in adjusted EBITDA. Gross margin improved to 65.2% due to lower manufacturing costs and favorable customer mix, while total operating expenses rose slightly to $7.4 million. Consequently, the company revised its full-year 2026 revenue guidance upward to a range of $48.0 to $48.5 million and reiterated its expectation for positive adjusted EBITDA for the year.Healthcare
- EPMNov 10, 4:36 PMEvolution Petroleum reported a net loss of $3.0 million for the fiscal first quarter ended September 30, 2026, driven by unrealized losses on derivative contracts despite a 6% increase in oil, natural gas, and NGL revenues to $22.6 million. Average production for the quarter was 6,978 barrels of oil equivalent per day, with realized equivalent prices rising 11% to $35.13 per BOE due to higher oil and NGL prices. The company declared a $0.12 per share cash dividend for the second quarter, marking its 53rd consecutive quarterly payment, while returning $4.9 million to shareholders in the first quarter. Additionally, Evolution completed a farm-out of 636 net acres in the Williston Basin for approximately $2.5 million and continues to integrate recently acquired Permian Minerals assets which have exceeded production expectations.Energy
- IBIONov 10, 4:36 PMiBio, Inc. reported revenues of approximately $1.1 million for the first quarter of fiscal year 2027, ending September 30, 2026, representing a significant increase from the previous year. The company advanced its clinical pipeline by completing dosing in the single ascending dose portion of the Phase 1 trial for IBIO-600 and presenting new preclinical data showing that IBIO-610 combined with semaglutide resulted in 93% of weight loss coming from fat in non-human primates. Operating expenses rose to $9.4 million due to increased spending on consultants, outside services, and personnel costs associated with advancing multiple programs. As of September 30, 2026, iBio held $76.7 million in cash, cash equivalents, and investments in debt securities while reporting a net loss of $7.6 million for the quarter.Healthcare
- DTCXNov 10, 4:35 PMDatacentrex reported a positive third-quarter 2026 Adjusted EBITDA of $1.3 million, driven by $2.2 million in net gains from digital assets despite a GAAP net loss of $2.6 million. The company completed a $30 million investment in Eagle LNG, securing a 10.5% equity interest in the operating energy business. As of September 30, 2026, Datacentrex held approximately $29.3 million in combined cash and digital assets with no outstanding debt. Additionally, the firm began energizing a prepaid expansion of its mining fleet, which is projected to increase online hashrate by approximately 21% upon full deployment.Communication Services
- ANGXNov 10, 4:35 PMAngel reported third-quarter 2026 total revenue of $159.0 million, representing a 107.7% year-over-year increase, driven by Guild revenue growth of 95.3% to $115.6 million. The company's paying Guild membership expanded to 2.94 million, adding approximately 335,000 new members during the quarter while reducing its net loss to $5.2 million from $38.5 million in the prior year period. Angel generated positive operating cash flow of $10.3 million for the quarter and reiterated its full-year 2026 guidance for an Adjusted EBITDA loss of less than $25 million.
- SWAGNov 10, 4:35 PMStran & Company reported a 32.4% year-over-year increase in third-quarter 2026 gross profit to $9.4 million, driven by a gross margin expansion to 33.3%. The company achieved net income of $35,000 for the quarter, a significant turnaround from a $1.2 million net loss in the prior-year period. For the nine months ended September 30, 2026, total sales reached $92.7 million, resulting in a net income of $1.1 million compared to a net loss of approximately $1.0 million in the same period last year. Additionally, the Stran Loyalty Solutions segment saw its gross profit nearly double to $3.0 million in the third quarter, reflecting improved customer mix and cost management.Communication Services
- FTCONov 10, 4:34 PMFortitude Gold Corporation reported third-quarter 2026 net sales of $10.3 million and net income of $2.0 million, or $0.07 per share. The company produced a total of 2,139 gold ounces across its Isabella Pearl and County Line mines, resulting in a cash balance of $8.5 million as of September 30, 2026. During the quarter, Fortitude paid $0.9 million in cash dividends to shareholders and incurred $3.9 million in exploration expenses. The company continues to advance permitting for its Golden Mile property, targeting construction in 2027.
- UONENov 10, 4:31 PMUrban One, Inc. reported a net loss of approximately $119.2 million for the third quarter of 2026, driven by a $128.9 million impairment charge on goodwill and intangible assets. Net revenue for the period declined 5.0% to $88.0 million, with significant decreases in digital and cable television advertising revenue offset partially by political revenue and station acquisitions. The company recorded an adjusted EBITDA of $12.3 million, down from $14.2 million in the prior year, and revised its full-year 2026 adjusted EBITDA guidance to $40.0 million. Management cited adverse market conditions and weak demand in the cable TV scatter market as primary factors, while noting a focus on achieving at least $20.0 million in annualized cost savings.Communication Services
- MRDNNov 10, 4:30 PMMeridian Holdings reported a third-quarter 2026 revenue of $46.0 million and a net loss attributable to the company of $13.3 million, which included $11.5 million in non-cash impairment charges. These charges consisted of a $5.5 million write-off of the Brazilian gaming license following the country's prohibition of fixed-odds betting and a $5.9 million goodwill impairment related to the RKings and Classics for a Cause reporting unit. Despite the quarterly loss, the company achieved nine-month revenue growth of 10% to $146.3 million and generated $17.7 million in operating cash flow, enabling a 47% reduction in total debt to $24.1 million. The company has updated its full-year 2026 revenue outlook to a range of $195 million to $198 million, reflecting the suspension of operations in Brazil and lower expected revenue from its Australian segments.Communication Services
- NRTNov 10, 4:30 PMNorth European Oil Royalty Trust announced a fourth-quarter fiscal 2026 distribution of $0.20 per unit, payable on November 30, 2026, to shareholders of record as of November 17, 2026. This amount represents a decrease from the $0.31 per unit distributed in the fourth quarter of fiscal 2025 and the $0.26 per unit distributed in the third quarter of fiscal 2026. A maintenance shutdown of the de-sulfurization plant caused an overpayment of royalties during the quarter, creating a negative carry-over that is expected to reduce the first fiscal quarter of 2027 distribution. The cumulative 12-month distribution total reached $0.90 per unit, which is $0.09 higher than the previous 12-month period.
- INBSNov 10, 4:30 PMIntelligent Bio Solutions Inc. reported record fiscal first quarter 2027 revenue of $1.39 million, representing a 25% year-over-year increase and marking the third consecutive quarter of revenue exceeding $1 million. Cartridge sales, which constitute higher-margin recurring revenue, grew 32% year-over-year to account for 61% of total revenue, contributing to an expanded gross profit margin of 54.5%. During the quarter, the company submitted its FDA 510(k) premarket notification for its Intelligent Fingerprinting Drug Screening System and completed its associated clinical program. The company ended the period with $5.93 million in cash and cash equivalents while maintaining an installed base of 1,978 reader units across 516 active customer accounts.Healthcare
- NRGVNov 10, 4:30 PMEnergy Vault reported third-quarter 2026 revenue of $13.1 million, matching consensus estimates, while its contract backlog grew 147% year-over-year to reach $2.3 billion. The company achieved a GAAP gross margin of 71.0% and an adjusted gross margin of 81.1%, with total cash reserves increasing to $236 million. Strategic milestones included the acquisition of 2.3 GW of U.S. battery energy storage projects from Goshe Energy Storage and securing grid interconnection approval for the Stoney Creek project in Australia. Energy Vault affirmed its full-year 2026 revenue guidance of $290–310 million and provided preliminary 2027 guidance projecting revenue between $600–700 million and adjusted EBITDA between $40–50 million.Utilities
- AMPXNov 10, 4:28 PMAmprius Technologies reported third-quarter 2026 revenue of $39.1 million, representing an 83% year-over-year increase and a 15% sequential rise. The company achieved a gross profit of $10.5 million with a 27% gross margin, while reporting a net loss of $3.5 million, which improved by 10% compared to the same period in 2025. Amprius raised its full-year 2026 revenue outlook to $145 million and secured a $75 million U.S. Department of War contract to produce NDAA-compliant cells domestically by 2028. Additionally, the company introduced its new SiCore 500 battery model and expanded partnerships in the drone, aerospace, and defense sectors.Industrials
- QUIKNov 10, 4:28 PMQuickLogic Corporation reported fiscal third quarter 2026 total revenue of $5.1 million, representing a 153.2% increase compared to the same period in 2025. The company secured a six-figure eFPGA Hard IP design win for an automotive industrial SoC and expanded its IP portfolio with a new 12LP core featuring enhanced DSP capabilities. GAAP net loss for the quarter was $2.2 million, or $0.12 per share, while non-GAAP net loss was $1.3 million, or $0.07 per share. Additionally, the company appointed James Sullivan as Senior Vice President of Finance and Chief Financial Officer.Technology
- IKTNov 10, 4:28 PMInhibikase Therapeutics reported a net loss of $20.5 million for the third quarter of 2026, driven by increased research and development expenses of $15.0 million. The company's cash position stood at $193.3 million as of September 30, 2026, following a $50 million equity financing completed in July. Regulatory approvals for the Phase 3 IMPROVE-PAH study have been secured in 28 countries, with 79 of 180 planned clinical sites currently activated. Additionally, the company announced the appointment of Dr. Scott M. Wasserman to its Board of Directors and received Orphan Drug Designation for its lead candidate, IKT-001.Healthcare
- BSINNov 10, 4:25 PMBig Sky Industrial Inc. reported a net loss of $3.5 million for the third quarter of 2026, driven by $1.2 million in environmental remediation costs and lower production volumes from legacy assets. The company advanced construction of its Big Sky Carbon Hub, completing in-field gathering and injection lines while initiating fabrication of the Phase 1 processing facility. A five-year, 100% take-or-pay helium sales agreement is in place at a fixed price of $285 per Mcf, and the Department of Energy recently designated helium as a critical material. The company targets first production in spring 2027, with the Big Rose Monitoring, Reporting, and Verification plan currently in the final stage of EPA approval.Energy
- STUBNov 10, 4:24 PMStubHub Holdings reported third-quarter 2026 gross merchandise sales of $2.62 billion, representing a 7% year-over-year increase, while revenue rose 7% to $502.0 million. The company achieved an adjusted EBITDA of $124.1 million, marking an 84% increase from the prior year and an adjusted EBITDA margin of 25%. StubHub raised its full-year 2026 gross merchandise sales outlook to a range of $10.175 billion to $10.375 billion and reiterated its adjusted EBITDA guidance of $400 million to $420 million. Additionally, the company strengthened its balance sheet by extending debt maturities, reducing borrowing rates, and repaying $100 million in debt, which improved its net leverage ratio to 2.5 times trailing twelve-month adjusted EBITDA.Communication Services
- SONONov 10, 4:23 PMSonos reported a 7% year-over-year revenue increase for Fiscal 2026, reaching $1.547 billion, marking a return to growth with significant improvements in profitability. The company achieved a GAAP net income of $90 million and an Adjusted EBITDA of $184 million, representing a 39% increase from the prior year. In the fourth quarter alone, revenue grew 20% to $344 million, while the company returned $130 million to shareholders through stock repurchases during the full fiscal year.Technology
- PALINov 10, 4:22 PMPalisade Bio initiated its global Phase 2b ASCENTRA-UC clinical trial for PALI-2108 in ulcerative colitis, dosing the first patient on October 27, 2026, with topline results expected in the fourth quarter of 2027. The company also received FDA clearance for the Phase 2a ASCENTRA-CD trial in Crohn's disease, targeting enrollment initiation in the first quarter of 2027. For the three months ended September 30, 2026, the company reported research and development expenses of $10.6 million and a net loss of $14.6 million, resulting in $113.6 million in cash and cash equivalents.Healthcare
- SEERNov 10, 4:22 PMSeer, Inc. reported third-quarter 2026 revenue of $4.0 million, a 3% decrease from the same period in 2025, driven by product sales of $2.8 million and service revenue of $1.1 million. The company updated its full-year 2026 revenue guidance to a range of $13.5 million to $14.5 million, citing extended sales cycles due to pressure on academic and government funding. Seer ended the quarter with approximately $198.1 million in cash, cash equivalents, and investments while reporting a net loss of $13.7 million for the period. Scientific advancements highlighted include the identification of over 4,200 protein associations in the PRECISE study and the publication of 116 research papers utilizing the Proteograph platform.Healthcare
- SWMRNov 10, 4:22 PMSwarmer, Inc. reported third-quarter 2026 revenue of $25.6 million and a net loss of approximately $9.3 million, with operating expenses rising to $9.4 million due to increased stock-based compensation. The company announced a definitive agreement to acquire Ratel Robotics, a Ukrainian unmanned ground vehicle manufacturer, with closing expected in November 2026, alongside pending acquisitions of intellectual property from Vataga Drone and a strategic partnership with Vectus Air Defense Systems. Swarmer's management highlighted a strategic shift toward integrated end-to-end defense solutions across ground vehicles, air defense, and autonomous drone kits, supported by over 100,000 combat missions conducted in Ukraine since April 2024.Technology
- MCHXNov 10, 4:20 PMMarchex reported a return to profitability in the third quarter of 2026, generating $1.3 million in GAAP net income and $16.0 million in revenue. The company achieved an adjusted EBITDA of $2.4 million, reflecting a margin expansion to approximately 15% compared to 3% in the prior year period. Following the July 2026 acquisition of Archenia, Marchex announced the appointment of Travis Fairchild as President to lead the commercialization of its combined AI-powered platforms. Recent commercial milestones include the expansion of an AI Voice Agent deployment with an existing media customer and approval from a major automotive OEM to distribute its Engage for Service solution.Communication Services
- ATRONov 10, 4:19 PMAstronics Corporation reported record third-quarter 2026 sales of $271.7 million, representing a 28.5% increase from the prior year, driven by strong demand in its Aerospace and Test Systems segments. The company achieved record operating income of $54.0 million, resulting in an operating margin of 19.9%, while net income reached $52.2 million or $1.08 per diluted share. Aerospace sales grew 27.4% to $245.5 million, bolstered by increased orders for inflight entertainment and connectivity products, leading to a record backlog of $670.0 million for the segment. Astronics maintains its full-year 2026 revenue guidance of $1.02 billion to $1.04 billion and projects another year of double-digit growth for 2027.Industrials
- GPRONov 10, 4:19 PMGoPro, Inc. is unable to file its quarterly report on Form 10-Q and its earnings announcement on Form 8-K for the period ended September 30, 2026, due to the need for additional time to complete financial close procedures regarding specific financing arrangements. The delay stems from a material weakness in internal controls over financial reporting related to the valuation of embedded features in these financing deals, which remains unremediated. Preliminary results indicate net revenue of approximately $96 million and a gross margin of 12.7% for the quarter, a significant decline from the prior year, while the company's financial statements continue to reflect substantial doubt about its ability to operate as a going concern. The company is actively seeking waivers from lenders to avoid potential defaults that could accelerate debt repayment and jeopardize a pending merger agreement.Technology
- BBOTNov 10, 4:18 PMBridgeBio Oncology Therapeutics reported third-quarter 2026 financial results showing a net loss of $34.2 million and cash reserves of $315.3 million sufficient to fund operations into 2029. The company's lead candidate BBO-8520 demonstrated a 75% objective response rate when combined with pembrolizumab in KRASG12C inhibitor-experienced non-small cell lung cancer patients. Clinical development continues for BBO-11818 and BBO-10203 combination therapies in colorectal and pancreatic cancers, with monotherapy data updates expected in the fourth quarter of 2026. Research and development expenses decreased to $29.6 million from $35.1 million in the prior year period, while general and administrative expenses fell to $7.9 million.Healthcare
- PETSNov 10, 4:17 PMPetMed Express reported a 19.4% decline in second-quarter net sales to $35.8 million, driven by reduced prescription medication sales and increased consumer promotional usage. The company posted a net loss of $6.4 million for the quarter, representing an improvement from the $8.5 million loss in the prior year period, primarily due to lower general and administrative and advertising expenses. Adjusted EBITDA for the quarter was a loss of $3.6 million, reflecting unfavorable product mix shifts and lower manufacturer rebates that offset gains from reduced freight costs. Management indicated that the business has stabilized operations and is focusing on transforming the core direct-to-consumer pharmacy into a leaner, more profitable entity.Consumer Defensive
- AIINov 10, 4:16 PMAmerican Integrity Insurance Group reported third quarter 2026 net income of $28.4 million, representing a 115.4% increase from the same period in 2025. The company achieved record revenue growth of 83% year-over-year, driven by a 57% surge in voluntary new business policies sold, totaling 41,000 units. Gross premiums written rose 23% to $293 million, while the combined ratio improved significantly to 70.6% from 78.9% in the prior year. Book value per share increased 23.7% to $19.96, and the company maintained a disciplined underwriting approach without assuming any policies from Citizens Property Insurance Corporation.Financial Services
- SUJANov 10, 4:16 PMSuja Life reported third-quarter 2026 net sales of $76.4 million, representing a 3.3% year-over-year increase driven by volume gains and new distribution. The company posted an adjusted EBITDA of $10.5 million, a significant improvement from $1.0 million in the prior year period, while narrowing its net loss to $8.3 million. Suja Life updated its full-year 2026 outlook to project net sales between $351.0 million and $354.0 million and adjusted EBITDA between $68.0 million and $70.0 million. The company also completed a debt refinancing in August 2026 that reduced its borrowing spread and lowered its cost of capital.Consumer Defensive
- SPIRNov 10, 4:16 PMSpire Global reported third-quarter 2026 revenue of $18.0 million, representing a 42% year-over-year increase driven by growth in Space Services and Weather and Climate data sales. The company posted a net loss of $20.3 million for the quarter, while adjusted EBITDA improved to a loss of $8.6 million, reflecting a 27% year-over-year improvement. Spire secured significant new contracts, including a $33.2 million task order from NOAA and a $28 million agreement to advance hyperspectral microwave sounding technology. Looking ahead, the company forecasts full-year 2026 revenue between $75 million and $80 million and preliminary 2027 revenue between $96 million and $106 million.Industrials
- CNMNov 10, 4:16 PMCore & Main reported preliminary third-quarter fiscal 2026 net sales between $2.12 billion and $2.13 billion, with net income ranging from $128 million to $140 million and Adjusted EBITDA between $267 million and $275 million. The company maintained its full-year fiscal 2026 net sales outlook of $7.8 billion to $7.9 billion while updating its Adjusted EBITDA guidance to $950 million to $960 million. Strategic activities during the quarter included the completion of three acquisitions totaling over $250 million in annual revenue and a record $171 million in share repurchases.Industrials
- NLSTNov 10, 4:15 PMNetlist, Inc. reported third-quarter 2026 net sales of $105.1 million, representing a 149% year-over-year increase driven by $44.9 million in license fees from Samsung and $60.2 million in product sales. The company achieved a gross margin of 65.5% and reported net income of $85.4 million, or $0.22 per diluted share, compared to a net loss in the prior year period. Cash, cash equivalents, and restricted cash rose to $327.7 million at the end of the quarter, primarily due to initial and quarterly payments received from Samsung. Additionally, the company generated $245 million in operating cash flow and strengthened its balance sheet significantly during the period.Technology
- REEDNov 10, 4:15 PMReed's, Inc. reported a net loss of $3.2 million for the third quarter of 2026, an improvement from the $4.0 million loss in the same period the previous year. Net sales declined to $6.5 million from $7.0 million, primarily due to lower volumes with recurring national customers, though gross margin expanded to 25% driven by reduced promotional allowances and lower cost of goods per case. The company strengthened its balance sheet by refinancing a $9.25 million senior secured loan and subsequently closed a $10.0 million private placement of common stock. Selling, general, and administrative expenses decreased by 15% to $3.6 million as the company continued to optimize costs and restructure e-commerce operations.Consumer Defensive
- PRPONov 10, 4:15 PMPrecipio, Inc. reported third-quarter 2026 revenue of $7.3 million, representing an 8% year-over-year increase driven by growth in both product and pathology segments. The company achieved positive Adjusted EBITDA of $0.4 million and generated $0.6 million in cash flow from operations, resulting in an end-of-quarter cash balance exceeding $3.5 million. CEO Ilan Danieli stated that these financial results position the specialty cancer diagnostics firm to accelerate the commercialization of its existing product portfolio. The company plans to discuss these results in detail during a shareholder call scheduled for 5 PM ET on the day of the announcement.Healthcare
- NXTCNov 10, 4:15 PMNextCure has advanced its proposed merger with Avere Therapeutics, supported by approximately $820 million in committed financing from a syndicate of investors. The SEC declared the merger's registration statement effective on November 6, 2026, with a stockholder vote scheduled for December 9, 2026. During the third quarter of 2026, NextCure reported a net loss of $6.8 million and reduced its cash reserves to $8.7 million while executing restructuring initiatives and transferring the LNCB74 program to LigaChem. Upon completion of the merger, the combined entity will operate as Avere and trade on Nasdaq under the ticker symbol AVRX.Healthcare
- YHOONov 10, 4:15 PMAltaba Inc. reported total assets of $937,573,000 as of September 30, 2026, with investments at fair value comprising the largest portion at $467,188,000. Total liabilities for the period amounted to $31,423,000, resulting in net assets of $906,150,000. The net asset value per share was calculated at $1.74, based on 519,511,366 shares outstanding at both September 30, 2026, and December 31, 2025.Technology
- BVNov 10, 4:15 PMBrightView Holdings reported fourth-quarter fiscal 2026 net service revenue of $677.3 million, a 3.6% decrease year-over-year, while Maintenance Services revenue grew 3.2% to $495.7 million. For the full fiscal year, total net service revenue increased 1.5% to $2.7 billion, driven by a 6% rise in Maintenance Services, though Development Services revenue fell 9.4% to $714.9 million. The company announced fiscal 2027 guidance projecting total revenue between $2.535 billion and $2.720 billion, with Adjusted EBITDA expected to range from $335 million to $355 million. Additionally, BrightView repurchased 4.1 million shares during the full fiscal year and reported a Total Net Financial Debt to Adjusted EBITDA ratio of 3.1x as of September 30, 2026.Industrials
- RDNWNov 10, 4:14 PMRideNow Group, Inc. reported a 13.1% decline in third-quarter 2026 revenue to $244.3 million, driven by lower unit sales and store consolidation efforts. The company implemented a new transparent pricing strategy to align with FTC guidelines, which initially reduced retail volume but is expected to boost fourth-quarter performance. Net loss widened to $13.9 million from $4.1 million in the prior year, while Adjusted EBITDA fell to $5.3 million. Despite the revenue contraction, the company successfully refinanced its senior secured term loan to $220.0 million maturing in 2031 and completed an acquisition in Tallahassee, Florida.Consumer Cyclical
- SATLNov 10, 4:13 PMSatellogic reported record third-quarter 2026 revenue of $16.0 million, representing a 342% year-over-year increase, driven by growth in both Data & Analytics and Space Systems segments. The company achieved positive Adjusted EBITDA of $1.2 million for the second consecutive quarter, narrowing its operating loss to $2.3 million. Key operational milestones included the successful launch and commissioning of the Merlin.01 satellite and the delivery of a second NewSat Mark V satellite to Portugal's CEiiA. Additionally, Satellogic signed a new agreement after the quarter-end to sell three in-orbit satellites for approximately $37 million, bringing its total remaining performance obligations to $66.9 million.Industrials
- GENKNov 10, 4:13 PMGEN Restaurant Group signed a binding letter of intent to sell operations at 47 U.S. restaurants to Chubby Group in a transaction valued up to $100 million, allowing GEN to transition into a pure-play Korean consumer-packaged goods company. The company reported third-quarter 2026 revenue of $48.7 million, including $4.7 million in CPG revenue, while posting a net loss of $5.5 million. GEN's retail footprint has expanded to over 2,000 doors nationwide, with new placements at major retailers and venues scheduled to reach shelves in the second quarter of 2027. Management expects the transaction to eliminate outstanding debt and reduce operating lease liabilities, positioning the company for a profitable revenue run rate of $40 million annually by the end of 2027.Consumer Cyclical
- ANRONov 10, 4:12 PMAlto Neuroscience reported a net loss of $25.1 million for the third quarter ended September 30, 2026, driven by increased research and development expenses related to its ALTO-207 program. The company strengthened its balance sheet with a $100 million financing round in July 2026, bringing its cash position to $319.8 million, which is expected to fund operations through 2030. Clinical progress includes the PACE-1 trial for ALTO-207 in treatment-resistant depression, with top-line data anticipated in the second half of 2027, while Phase 2b trials for ALTO-300 and ALTO-100 are on track for data releases in 2027.Healthcare
- KLXENov 10, 4:12 PMKLX Energy Services reported Q3 2026 revenue of $186 million, representing an 11% increase from the prior year, with Adjusted EBITDA reaching approximately $25 million and a margin of 13%. The company maintains a net debt position of $183 million as of September 30, 2026, supported by $78 million in total liquidity. KLX operates across three primary geographic regions, with the Southwest accounting for 38% of revenue, followed by the Rockies at 32% and the Northeast/Mid-Con at 30%. The company's product portfolio is diversified, with completion services generating 50% of revenue, while drilling and production/intervention each contribute 25%. Looking ahead, KLX has provided Q4 2026 revenue guidance ranging between $172 million and $184 million.Energy
- REZINov 10, 4:12 PMResideo Technologies reported third-quarter 2026 total revenue of $727 million, representing a 3% year-over-year increase, while revenue excluding OEM Security grew 6%. The company achieved a gross margin of 40.4%, marking the 14th consecutive quarter of year-over-year expansion, and reported standalone adjusted diluted earnings per share of $0.52, an 8% increase from the prior year. Resideo repaid $1.1 billion of gross debt during the quarter using proceeds from a dividend received from ADI and existing cash on hand, reducing total gross debt to $2.1 billion. The company updated its full-year 2026 outlook to project revenue between $2.927 billion and $2.947 billion and standalone adjusted EBITDA between $614 million and $624 million.Industrials
- KOPNNov 10, 4:11 PMKopin Corporation reported third-quarter 2026 total revenues of $18.2 million, representing a 52% year-over-year increase and a 43% sequential rise. The company secured an additional $18.6 million U.S. Army IBAS award, bringing total funding for its color MicroLED technology to $34 million, while advancing its Neural I/o™ optical interconnect technology toward a public demonstration at CES 2027. Despite the revenue growth, the company reported a net loss of $3.4 million for the quarter, primarily driven by non-cash losses on strategic equity investments and increased operating expenses.Technology
- ATRANov 10, 4:10 PMAtara Biotherapeutics reported a net loss of $2.2 million for the third quarter of 2026, a significant improvement from the $4.3 million loss in the same period of 2025. The company's cash, cash equivalents, and short-term investments totaled $9.9 million as of September 30, 2026, which is expected to fund operations through mid-2027. Total revenues for the quarter were $1.2 million, primarily driven by commercialization activities, while research and development expenses decreased to $1.1 million. The U.S. FDA has accepted the resubmission of the Biologics License Application for tabelecleucel, with a target action date set for March 31, 2027, which could trigger a $31 million milestone payment from Pierre Fabre Laboratories upon approval.Healthcare
- LPTHNov 10, 4:10 PMLightPath Technologies reported fiscal 2027 first-quarter revenue of $20.8 million, a 38% increase from the prior year period, driven by a 76% surge in assemblies and modules sales. The company achieved a record order backlog of $132.9 million, up 20% from the previous quarter, while expanding gross margin to 41.4% due to a favorable product mix. Although the company reported a net loss of $1.7 million, it generated positive adjusted EBITDA of $1.3 million for the fifth consecutive quarter. Key operational highlights included securing over $30 million in follow-on orders for counter-unmanned aircraft systems and completing the sale of its China subsidiary.Technology
- IPMNov 10, 4:10 PMIntelligent Protection Management Corp. reported third-quarter 2026 total revenue of $11.0 million, a 75.5% increase from the prior year, driven primarily by a 271% surge in procurement revenue. The company generated $5.6 million in operating cash flow for the quarter and posted a net loss of $779,378, while achieving a positive Adjusted EBITDA of $159,201. Core managed services revenue from non-affiliated customers grew by 33%, and the company announced the acquisition of Advanced Technology Distributors Inc. for up to $2.7 million. As of September 30, 2026, the company held $12.5 million in cash and cash equivalents with no long-term debt.Technology
- BRCBNov 10, 4:09 PMBlack Rock Coffee Bar, Inc. reported third-quarter 2026 total revenue of $66.8 million, representing a 29.7% year-over-year increase, alongside a 5.8% same-store sales growth. The company achieved net income of $2.7 million and an adjusted EBITDA of $8.5 million, while opening 11 new stores to reach a total of 211 locations. Management has updated its full-year 2026 guidance to include 40 new store openings, total revenue between $255 million and $257 million, and adjusted EBITDA ranging from $34 million to $35 million.Consumer Cyclical
- VRMNov 10, 4:09 PMVroom, Inc. reported a net loss of $9.8 million for the third quarter of 2026, driven by higher mark-to-market losses associated with legacy loan vintages and rising interest rates. The company ended the quarter with $91.1 million in stockholders' equity and $64.2 million in total available liquidity, bolstered by a $20 million preferred stock issuance in its subsidiary. Management highlighted significant year-over-year improvements in adjusted net loss due to a rebuilt internal customer scoring model implemented in September 2025. Consequently, Vroom updated its full-year 2026 guidance to project indirect origination volume between $460 million and $485 million and an adjusted net loss between $30 million and $35 million.Consumer Cyclical
- NNNov 10, 4:09 PMNextNav Inc. reported a net loss of $48.6 million for the nine months ended September 30, 2026, while revenue increased to $3.7 million from $3.6 million in the prior year period. The company strengthened its balance sheet by eliminating all outstanding debt and holding approximately $290.9 million in cash, cash equivalents, and investments as of September 30, 2026. Operational milestones included achieving single-digit-meter positioning accuracy in Santa Clara County, California, and forming strategic partnerships with AiRANACULUS and Tiami Networks to advance counter-UAS detection capabilities.Technology
- SNESNov 10, 4:08 PMSenesTech, Inc. reported record third-quarter 2026 revenue of $1.097 million, representing a 59% year-over-year increase and a 42% sequential rise. Gross profit reached a record $796,000 with a gross margin of 72.6%, driven by a 52% sequential increase in e-commerce revenue and a 53% jump in subscription revenue. Despite these operational gains, the company reported a net loss of $2.0 million for the quarter, while cash and cash equivalents decreased by $1.1 million to $4.0 million.Basic Materials
- SKYHNov 10, 4:08 PMSky Harbour Group Corporation reported record third-quarter 2026 results with consolidated revenues increasing approximately 45% year-over-year and constructed assets reaching $439 million. The company updated its year-end 2026 guidance, raising revenue forecasts to $44-48 million while lowering adjusted EBITDA expectations to $0-4 million due to upcoming construction costs and delayed openings. Significant leasing progress was noted with stabilized campuses seeing 20% revenue escalations upon re-lease and new ground leases approved at Van Nuys and Dulles airports. Construction activities remain on schedule for multiple portfolio sites, with the Dallas Addison Phase 2 project expected to open in February 2027.Real Estate
- FLYNov 10, 4:08 PMFirefly Aerospace reported third-quarter 2026 revenue of $110.7 million, representing a 259% increase from the same period in the prior year, while achieving a record backlog of $1.7 billion. The company completed a cleanroom expansion to support the simultaneous assembly of up to 12 lunar landers and secured significant contracts, including a $94 million Space Force award and a $13 million subcontract for NASA's SkyFall mission. Strategic partnerships were expanded with AST SpaceMobile, Lockheed Martin, and European launch provider SSC Space, alongside the addition of commercial customers for lunar data center and payload services. Despite the revenue growth, the company reported a net loss of $94.2 million for the quarter and maintains a full-year revenue guidance range of $440 million to $450 million.Industrials
- NCMINov 10, 4:08 PMNational CineMedia, Inc. reported a third-quarter 2026 net loss of $17.2 million, or $0.18 per diluted share, following the consolidation of Captivate results effective September 18, 2026. Total revenue for the quarter decreased 3.2% to $61.4 million, while Adjusted OIBDA fell to $3.3 million from $10.2 million in the prior year period. The company raised its 2026 operational transformation savings target to over $7.5 million and provided a fourth-quarter revenue outlook of $117.0 million to $124.0 million. Additionally, CEO Tom Lesinski announced his retirement effective December 31, 2026, as part of a planned leadership transition.Communication Services
- FOSLNov 10, 4:08 PMFossil Group, Inc. reported third-quarter 2026 worldwide net sales of $271.2 million, representing a 0.4% increase on a reported basis and a 2.0% increase in constant currency compared to the prior year. The company achieved a gross margin of 59.8%, an improvement of 10.8 percentage points year-over-year, driven by reduced licensed brand royalties and improved product margins. Operating income turned positive at $25.3 million, or 9.3% of sales, contrasting with a $21.7 million operating loss in the same period last year. Consequently, Fossil Group raised its full-year 2026 financial outlook, projecting worldwide net sales between $980 million and $990 million and an adjusted operating margin between 5.5% and 6.5%.Consumer Cyclical
- LANDNov 10, 4:08 PMGladstone Land Corporation reported a net income of approximately $11.0 million for the third quarter of 2026, a significant increase from the $2.1 million reported in the prior-year quarter. The company recognized $16.8 million in participation rent revenue, driven by a grower-partner bonus for the 2025 pistachio crop and strong pricing for almonds and pistachios. During the quarter, the company sold two farms in Florida for $3.2 million, repurchased preferred stock, and executed nine new or amended lease agreements. Subsequent to the quarter, Gladstone Land acquired a 180-acre farm in Washington and entered into solar option agreements covering over 5,600 acres in California.Real Estate
- EVLVNov 10, 4:08 PMEvolv Technology reported third-quarter 2026 revenue of $47.3 million, representing a 10% year-over-year increase, while Annual Recurring Revenue (ARR) grew 20% to $140.5 million. The company posted a net loss of $15.6 million for the quarter but achieved an Adjusted EBITDA of $4.7 million, resulting in an Adjusted EBITDA margin of 10.0%. For the nine months ended September 30, 2026, total revenue reached $137.4 million, a 28% increase compared to the prior year period. Evolv Technology forecasts full-year 2026 revenue between $182 million and $185 million, with ending ARR expected to reach approximately $148 million to $150 million by year-end.Industrials
- ELMDNov 10, 4:07 PMElectromed, Inc. reported net revenues of $18.7 million for the first quarter of fiscal 2027, marking a 10.6% increase from the prior year period. Operating income rose 30.7% to $3.5 million, while net income increased to $2.8 million, or $0.32 per diluted share. The company achieved an 80.0% gross margin, driven primarily by a 17.6% growth in its direct homecare business. Electromed returned $4.3 million to shareholders through share repurchases and maintained a debt-free balance sheet with $15.9 million in cash as of September 30, 2026.Healthcare
- SLABNov 10, 4:07 PMSilicon Labs reported third-quarter 2026 revenue of $251 million, representing a 22% increase year-over-year, driven by strong growth in medical and home applications. The company achieved a GAAP diluted earnings per share of $0.26, a significant turnaround from a $0.30 loss in the prior year period, while non-GAAP diluted earnings per share reached $1.05. Medical revenue set a new quarterly record, surging 48% sequentially and over 300% year-over-year, contributing to a gross margin of 60.8% on a GAAP basis. Due to the pending acquisition by Texas Instruments, Silicon Labs has suspended its forward-looking financial guidance.Technology
- MGXNov 10, 4:07 PMMetagenomi Therapeutics has received FDA clearance for its Investigational New Drug application for MGX-001, a one-time genome editing treatment designed to provide durable Factor VIII activity for patients with hemophilia A. The company plans to initiate the global INTEGR8 Phase 1/2 clinical trial in the first half of 2027 and expects to report initial safety and efficacy data in the second half of that year. For the third quarter ended September 30, 2026, the company reported $101.7 million in cash and cash equivalents, with an anticipated operational runway extending into 2028. During this period, research and development expenses totaled $17.5 million, while general and administrative expenses reached $6.9 million, including a $1.2 million one-time litigation settlement.Healthcare
- GEVONov 10, 4:07 PMGevo, Inc. reported record third-quarter 2026 financial results with revenue reaching $83 million, net income of $23 million, and non-GAAP Adjusted EBITDA of $44 million. The company's carbon business drove significant performance, generating approximately $29.4 million in revenue from Canadian Clean Fuel Regulation credits and contributing to a total cash position of $68 million. Gevo updated its full-year 2026 non-GAAP Adjusted EBITDA outlook to exceed $90 million, supported by non-recurring credit sales and improved renewable natural gas incentives. Additionally, the company is nearing completion of a debottlenecking project at its North Dakota facility and has secured financing progress for a future expansion aimed at doubling low-carbon ethanol production.Basic Materials
- QTINov 10, 4:06 PMQT Imaging reported a 75% year-over-year revenue increase to $7.3 million in the third quarter of 2026, bringing year-to-date revenue to $21.3 million with 43 scanners sold. The company achieved a major milestone when CMS established a separate Medicare hospital outpatient payment for diagnostic QTscan examinations, effective January 1, 2027. While U.S. shipments remain on plan, full-year 2026 revenue guidance was adjusted downward to approximately $34 million due to shipment delays in the Middle East caused by ongoing armed conflict. Additionally, the company doubled its manufacturing capacity by relocating to a new 22,000-square-foot facility in Petaluma, California, and successfully completed its first routine FDA inspection with zero observations.Healthcare
- INONov 10, 4:06 PMINOVIO received accelerated FDA approval for VOCERYQ, the first FDA-approved DNA medicine, to reduce the frequency of surgery in adults with recurrent respiratory papillomatosis. The company plans to make the therapy available for order and shipment within 60 days of the October 30, 2026 approval, with a full commercial launch scheduled for the first quarter of 2027. For the third quarter ended September 30, 2026, INOVIO reported a net loss of $49.2 million, driven largely by a $26.9 million non-cash loss on warrant liabilities, while research and development expenses decreased to $10.6 million. The company recently completed a public offering that generated $80.5 million in net proceeds to support the upcoming commercial launch of VOCERYQ.Healthcare
- PRMENov 10, 4:06 PMPrime Medicine is advancing its Prime Editing platform, a gene editing technology that corrects genetic mutations without causing double-strand breaks, with a focus on liver diseases including Wilson disease and Alpha-1 Antitrypsin Deficiency. The company has initiated clinical trials for PM577a targeting the H1069Q mutation in Wilson disease and cleared an IND for PM647 to treat Alpha-1 Antitrypsin Deficiency, with initial clinical data anticipated in 2027. Additionally, Prime Medicine is progressing PM359 for Chronic Granulomatous Disease toward a Biologics License Application submission in the first half of 2027 following successful ex vivo clinical results. The company has also established strategic collaborations, including a partnership with Bristol Myers Squibb for ex vivo CAR-T products and funding from the Cystic Fibrosis Foundation to develop therapies for Cystic Fibrosis.Healthcare
- AIRGNov 10, 4:06 PMAirgain, Inc. reported third-quarter 2026 sales of $15.3 million, representing a 12% sequential increase and a 9% year-over-year growth driven by the enterprise IoT segment. The company achieved a GAAP net loss of $0.6 million, while reporting a non-GAAP net income of $0.5 million and an adjusted EBITDA of $0.6 million. Operational highlights included the introduction of an AI-powered RF Intelligence platform and securing design wins for AI data center infrastructure. Management forecasts fourth-quarter 2026 sales between $15.5 million and $17.5 million, with a midpoint non-GAAP net income per share of $0.05.Technology
- BODINov 10, 4:06 PMThe Beachbody Company, Inc. reported third-quarter 2026 net income of $3.3 million and adjusted EBITDA of $6.4 million, marking the fifth consecutive quarter of net income and the twelfth consecutive quarter of positive adjusted EBITDA. Total revenue for the quarter declined to $45.2 million from $59.9 million in the prior year period, driven by a 23.5% drop in digital revenue and a 26.1% decrease in nutrition and other revenue. The company maintained a gross margin of 70.7% while reducing total operating expenses to $30.7 million, down from $39.7 million in the same period last year. Looking ahead to the fourth quarter of 2026, the company forecasts revenue between $38 million and $42 million and adjusted EBITDA between $6 million and $9 million.Communication Services
- DRMANov 10, 4:06 PMDermata Therapeutics launched its first commercial product, Tome Foundational Treatment, on August 25, 2026, marking its transition to a revenue-generating skincare business. The company reported $74,000 in net sales and a $40,000 gross profit for the third quarter of 2026, with approximately 30% of orders generated through subscriptions. Clinical study results demonstrated improvements in skin appearance for over 71% of participants, supporting the product's positioning as studied skincare. Additionally, the company initiated a clinical trial for its second product, Tome Clearing Treatment, which is expected to launch in the first half of 2027.Healthcare
- BEEPNov 10, 4:06 PMMobile Infrastructure Corporation reported a net loss of $2.6 million for the third quarter of 2026, an improvement from the $6.4 million loss in the prior-year period. Total revenue increased 5.5% to $9.6 million, driven by a 12.8% rise in same-location revenue and a 13% year-over-year growth in contract parking volumes. The company achieved its highest utilization and Revenue Per Available Stall (RevPAS) to date, with RevPAS reaching $245.83 in the quarter. Full-year 2026 guidance remains unchanged, projecting revenue between $35 million and $38 million and Adjusted EBITDA between $15.0 million and $16.5 million.Industrials
- FLDNov 10, 4:06 PMFold Holdings, Inc. reported third-quarter 2026 revenue of $4.2 million and a net loss of $2.6 million, while total operating expenses decreased by 21% year-over-year to $10.5 million. The company expanded its Fold Credit Card to approximately 2,500 cardholders and launched new balance products, including Fold Reserve and Lead Bank accounts, which drove a 270% increase in custody and trading revenue. Fold's total verified accounts grew to over 88,500, and the firm ended the quarter with $21.7 million in cash and 247 BTC in treasury holdings.Financial Services
- QMLSNov 10, 4:06 PMQumulusAI reported third-quarter 2026 revenue of $14.8 million, representing a 376% increase from the prior year period and doubling sequentially for the second consecutive quarter. The company achieved its first positive Adjusted EBITDA of $3.7 million, driven by a 96% revenue contribution from compute power services. Cumulative signed customer contract value surpassed $500 million, reaching $528.7 million, while active capacity expanded to 8 MW with new agreements covering over 2,000 NVIDIA Blackwell B300 GPUs. Despite a net loss of $14.4 million, the period included $32.3 million in non-cash gains from changes in the fair value of convertible notes and related liabilities.Technology
- FRNMNov 10, 4:06 PMFreenome reported third-quarter 2026 total revenue of $183.5 million, a significant increase from $1.0 million in the same period of 2025, driven primarily by a $180 million milestone payment following FDA approval of its SimpleScreen CRC test. The company achieved a GAAP net income of $60.1 million for the quarter, contrasting with a net loss of $64.5 million in the prior year, while generating $38.4 million in net cash provided by operating activities. Following its public listing in July 2026, Freenome raised approximately $310 million in gross proceeds and holds $430 million in cash, cash equivalents, and marketable securities as of September 30, 2026. The company has launched SimpleScreen CRC commercially in the United States and expanded its portfolio with the introduction of SimpleScreen Lung, while providing full-year 2026 revenue guidance between $192 million and $194 million.Healthcare
- CRWVNov 10, 4:05 PMCoreWeave reported third-quarter 2026 revenue of $3.661 billion, representing a sequential increase of over $1 billion compared to the prior quarter. The company achieved an adjusted operating margin of 10% and raised its full-year 2026 revenue guidance to a range of $13.0 billion to $13.3 billion. CoreWeave expanded its active power capacity to over 1.7 gigawatts and secured a revenue backlog of approximately $132.5 billion as of September 30, 2026. Despite a GAAP net loss of $709 million for the quarter, the firm strengthened its financial position by raising $4.2 billion through convertible senior notes and establishing a new equity program.Technology
- GANXNov 10, 4:05 PMGain Therapeutics reported a net loss of $3.2 million for the third quarter of 2026, with research and development expenses decreasing to $1.4 million. The company presented long-term data from its Phase 1b trial of rexaceract in Parkinson's disease, showing no motor symptom progression after 12 months of treatment. Cash and cash equivalents stood at $11.7 million as of September 30, 2026, down from $20.8 million at the end of 2025. The company expects to initiate a Phase 2 clinical trial for rexaceract in the first quarter of 2027 and plans to advance its second candidate, GT-04686, into clinical development in the fourth quarter of 2026.Healthcare
- LMRINov 10, 4:05 PMLumexa Imaging reported third-quarter 2026 consolidated revenues of $272.0 million, representing a 5.0% increase from the prior year period, while net income turned positive at $7.2 million compared to a net loss of $3.5 million in the same quarter of 2025. The company achieved an Adjusted EBITDA of $62.6 million with a margin of 23.0%, driven by a 7.9% growth in advanced outpatient volumes and an improved procedure mix. Lumexa Imaging reiterated its full-year 2026 revenue guidance between $1.045 billion and $1.097 billion and narrowed its Adjusted EBITDA guidance range to $236 million–$240 million. Additionally, the company raised its full-year Adjusted EPS guidance to $0.86–$0.90 per share, reflecting a lower assumed effective tax rate and continued operational progress.Healthcare
- VELONov 10, 4:05 PMVelo3D reported third-quarter 2026 revenue of $20.5 million, representing a 50% year-over-year increase driven by higher sales of 3D printer systems and increased production volume in its Rapid Production Solutions segment. The company achieved a gross margin of 26.5% and recorded new bookings of $28.9 million, bringing its total backlog to $40.1 million as of September 30, 2026. Cash and cash equivalents rose to $75.7 million, supported by financing activities that also reduced total outstanding debt by approximately 76% to $7.4 million. Management reaffirmed full-year 2026 revenue guidance between $65 million and $75 million while revising gross margin expectations and reducing capital expenditure forecasts to reflect a shift of planned spending into 2027.Technology
- OIGNov 10, 4:05 PMOrion180 Insurance Group Inc. reported third-quarter 2026 net income of $11 million, representing a 32% increase from the prior year, alongside a 60% year-over-year growth in managed premiums written to $204 million. The company's managed premiums in-force expanded 72% to $678 million as of September 30, 2026, following its initial public offering completed in September. Consolidated adjusted EBITDA rose 65% to $25 million, driven by strong performance in both the Services and Underwriting segments. The firm operates across 14 states with a proprietary technology platform and a network of approximately 17,000 independent agents.Financial Services
- STXSNov 10, 4:05 PMStereotaxis reported third-quarter 2026 revenue of $8.9 million, representing a 20% increase from the prior year, driven by a 60% rise in system sales to $3 million. The company recorded a net loss of $6.5 million, with operating expenses totaling $10.4 million due to the absorption of Robocath and one-time acquisition costs. At the end of the quarter, cash and cash equivalents stood at $4.0 million, though the company announced a convertible note financing of up to $24 million to bolster liquidity. Management expects recurring revenue growth and stable operating expenses to lead to cash-flow profitability within the next year.Healthcare
- ATEXNov 10, 4:05 PMAnterix Inc. reported a net loss of $4.993 million for the second quarter of fiscal 2027, driven by operating expenses that exceeded revenue, despite recording a $6.1 million gain from exchanging narrowband for broadband licenses. The company ended the quarter with $107.5 million in cash and cash equivalents and no debt, while maintaining a $250 million share repurchase program with no activity in the quarter. Anterix announced that the iPhone 18 Pro and iPhone Duo are the first models to operate on its dedicated private LTE networks using 900 MHz spectrum, and the FCC has advanced a rulemaking to potentially include this band in Supplemental Coverage from Space rules.Communication Services
- RGTINov 10, 4:05 PMRigetti Computing reported total revenues of $1.4 million for the third quarter of 2026, bringing the nine-month total to $10.9 million, a 110% increase from the same period in 2025. The company achieved a 99.5% median two-qubit gate fidelity on its 108-qubit Cepheus-1 system and signed a definitive agreement with the U.S. Department of Commerce for up to $100 million in funding. Rigetti ended the quarter with $497.1 million in cash and investments, reporting a GAAP net loss of $3.1 million for the three-month period. The company projects full-year 2026 revenue to reach approximately $20 million, contingent on customer acceptance of its C-DAC system in the fourth quarter.Technology
- CARLNov 10, 4:05 PMCarlsmed reported third-quarter 2026 revenue of $21.6 million, marking a 65% increase compared to the same period in 2025. The company raised its full-year 2026 revenue guidance to a range of $78 million to $80 million, reflecting over 56% growth at the midpoint versus 2025. During the quarter, gross profit reached $16.7 million with a gross margin of 77.3%, while operating expenses increased to $29.4 million due to executive transition costs and legal settlements. Additionally, Carlsmed secured new inpatient CMS reimbursement for its aprevo lumbar spine fusion procedure and launched a new bilateral posterior system.Healthcare
- KURANov 10, 4:05 PMKura Oncology reported third-quarter 2026 net product revenue of $13.9 million for KOMZIFTI, representing a 53% sequential increase driven by a 30% rise in new patient starts. The company secured FDA alignment for a 40-patient monotherapy registrational study of darlifarnib in HRAS-mutant salivary gland cancer, with initiation targeted for the first half of 2027. Financially, Kura maintains a strong position with $492.1 million in cash and short-term investments, supported by a new strategic financing agreement with Oberland Capital providing up to $300 million in potential funding.Healthcare
- BGSNov 10, 4:05 PMB&G Foods reported a net loss of $32.5 million for the third quarter of 2026, driven by $40.7 million in non-cash impairment charges related to the B&M and Joan of Arc brands. Despite the net loss, the company achieved a 4.7% increase in net sales to $459.8 million, supported by base business growth of 5.0% and contributions from the recently acquired College Inn and Kitchen Basics brands. Adjusted diluted earnings per share for the quarter rose to $0.21, while adjusted EBITDA increased to $81.8 million. The company raised its full-year 2026 net sales guidance to a range of $1.760 billion to $1.800 billion and adjusted EBITDA guidance to $280.0 million to $290.0 million.Consumer Defensive
- BRVENov 10, 4:05 PMBraveheart Bio reported third-quarter 2026 financial results showing a net loss of $26.5 million and cash reserves of $503.5 million, sufficient to fund operations into 2029. The company presented 52-week clinical data for its lead candidate BHB-1893 at the AHA Scientific Sessions 2026, demonstrating improved oxygen uptake and heart function in patients with obstructive hypertrophic cardiomyopathy. Development strategies have been updated to include the enrolling LIONHEART-HCM Phase 3 trial, a planned NOBLEHEART-HCM Phase 3 trial for non-obstructive patients in the first half of 2027, and a fixed-dose TRUEHEART-HCM Phase 2b study. Additionally, partner Hengrui Pharma has completed enrollment in its Phase 3 trial in China, with topline results expected in early 2027.Healthcare
- CAPRNov 10, 4:05 PMCapricor Therapeutics reported a net loss of $42.7 million for the third quarter of 2026, with total operating expenses rising to $44.7 million due to pre-commercial activities and manufacturing scale-up. The company holds approximately $198.5 million in cash and marketable securities as of September 30, 2026, which is sufficient to fund operations for at least the next twelve months. Its Biologics License Application for Deramiocel to treat Duchenne muscular dystrophy is under FDA review with a PDUFA target date of November 22, 2026, following a major amendment that included two-year open-label extension data. Recent clinical updates show that patients switching from placebo to Deramiocel experienced a 76% slowing in upper limb decline, and the drug's cardiac results received the American Heart Association's Outstanding Research Award in Pediatric Cardiology.Healthcare
- GROVNov 10, 4:05 PMGrove Collaborative Holdings reported third-quarter 2026 net revenue of $36.8 million, representing a 15.8% year-over-year decline but a 0.7% sequential increase. The company achieved positive Adjusted EBITDA of $1.4 million for the fourth consecutive quarter, driven by a $1.2 million tariff refund and reduced operating expenses. Full-year 2026 guidance was narrowed to net revenue between $144 million and $146 million and Adjusted EBITDA between $1 million and $2 million. Key operational metrics showed a 30.6% year-over-year decrease in active customers, while net revenue per order rose 6.1% to $70.85.Consumer Defensive
- FACNov 10, 4:04 PMFactorial Energy Inc. reported its third-quarter 2026 financial results, marking the achievement of its first commercial revenue ahead of its 2027 target. The company's aerospace program cells successfully met a 450 Wh/kg energy density goal previously scheduled for year-end. Additionally, Factorial's solid-state battery technology enabled a Group I drone to set a world record for flight duration and allowed a Mercedes-Benz test vehicle to exceed 1,200 km of range on a single charge.Industrials
- TELANov 10, 4:04 PMTELA Bio reported third-quarter 2026 revenue of $19.0 million, representing an 8% decline from the prior year period, driven by lower OviTex PRS volumes despite an 18% increase in international sales. The company reduced its sequential operating loss by 21% to $7.3 million and decreased its adjusted EBITDA loss by 55% to $3.4 million, aided by a strategic cost reduction initiative targeting $17.0 million in annual expense cuts. On a GAAP basis, the net loss for the quarter was $9.3 million, or $0.16 per share, while cash and cash equivalents stood at $22.7 million as of September 30, 2026. Additionally, TELA Bio regained compliance with Nasdaq's minimum bid price requirement and received 510(k) clearance for its Liora Monofilament Scaffold.Healthcare
- ACHVNov 10, 4:04 PMAchieveRx, formerly Achieve Life Sciences, reported third-quarter 2026 financial results with cash, cash equivalents, and marketable securities totaling $201.5 million as of September 30, 2026. The company presented 52-week ORCA-OL trial data showing that 39.4% of participants new to cytisinicline achieved four-week continuous abstinence by the end of treatment. AchieveRx completed three commercial-scale stability batches for U.S. manufacturing and remains on track to resubmit its New Drug Application in the fourth quarter of 2026. The organization also rebranded as AchieveRx, The Quit Company, and expanded its leadership team with new appointments for Chief Financial Officer and Senior Vice President of Marketing and Communications.Healthcare
- AMBONov 10, 4:03 PMAmbow Education Holding Ltd. reported third-quarter 2026 net revenues of $1.7 million, a 21.4% increase year-over-year, driven by growth in both educational programs and HybriU licensing. For the first nine months of 2026, total net revenues rose 6.2% to $6.9 million, while the company increased combined selling, marketing, and research and development expenses by $0.5 million to support product launches ahead of CES 2027. Despite higher operating expenses, net cash used in operating activities decreased by 50% to $0.7 million year-to-date, and the company maintained $6.1 million in cash, restricted cash, and short-term investments as of September 30, 2026.Consumer Defensive
- GONov 10, 4:03 PMGrocery Outlet Holding Corp. reported net sales of $1.18 billion for the third quarter of fiscal 2026, marking a 0.9% increase from the prior year period. The company achieved positive comparable store sales growth of 0.5%, driven by a 2.4% rise in transaction volume, while operating income reached $24.0 million including net restructuring credits. For the 39 weeks ended October 3, 2026, net sales totaled $3.54 billion, though the period included a $158.0 million non-cash goodwill impairment charge that resulted in a reported net loss of $161.4 million. Management has revised its fiscal 2026 outlook to project comparable store sales growth between 0.2% and 0.4% and adjusted EBITDA between $225 million and $229 million.Consumer Defensive
- PRKRNov 10, 4:03 PMParkerVision, Inc. reported a net loss of $0.5 million for the nine months ended September 30, 2026, a significant improvement from the $7.4 million loss in the same period of 2025. The reduction in losses was driven by a $3.0 million decrease in operating expenses and a $3.4 million gain resulting from a decrease in the fair value of contingent payment obligations. On the legal front, an appellate court ruled in September 2026 that it lacked jurisdiction over an expedited appeal in the company's patent case against Qualcomm, remanding the case to the middle district of Florida for proceedings on transmitter patent claims only. Additionally, the company filed a Freedom of Information Act complaint against the National Archives in August 2026 to obtain documents related to its prior patent infringement litigation.Technology
- BNGONov 10, 4:03 PMBionano Genomics reported third-quarter 2026 total revenue of $8.3 million, a 12% increase from the prior year period, driven by a 24% rise in consumables revenue to $4.7 million. The company sold 9,870 flowcells during the quarter, representing an 18% year-over-year increase, while achieving a gross margin of 48%. Operating expenses decreased by 12% to $10.5 million, and the company reiterated its full-year 2026 revenue guidance range of $31 million to $33 million.Healthcare
- SNDNov 10, 4:02 PMSmart Sand, Inc. reported third-quarter 2026 revenue of $112.3 million and net income of $8.4 million, driven by a 21% year-over-year increase in sales volumes to approximately 1.78 million tons. The company generated $18.0 million in Adjusted EBITDA and $17.3 million in free cash flow, while returning approximately $14.3 million to shareholders through dividends and share repurchases during the year. Management expects full-year 2026 sales volumes to increase by 20% to 30% compared to 2025 and anticipates generating positive free cash flow for the entire year. As of September 30, 2026, the company held $21.7 million in cash and maintained $50.0 million in undrawn availability under its credit facility.Energy
- MRCYNov 10, 4:01 PMMercury Systems reported record first-quarter fiscal 2027 bookings of $370 million, representing a 48.0% year-over-year increase, which drove total backlog to nearly $2.1 billion. Revenue for the quarter reached approximately $253 million, a 12.4% rise from the prior year, while GAAP net income turned positive at $13 million compared to a loss in the previous period. The company achieved a record adjusted EBITDA of $56 million with a margin of 22.3%, and management raised its outlook for the full fiscal year 2027 based on this performance. Additionally, Dave Farnsworth's title was updated to include Chief Operating Officer alongside his role as Chief Financial Officer.Industrials
- USIONov 10, 4:01 PMUsio, Inc. reported strong third-quarter 2026 financial results, with revenue increasing 12% to $23.8 million and adjusted EBITDA rising 222% to $1.2 million. The company achieved GAAP net income of $217,000, or $0.01 per share, marking its third consecutive quarter of profitability. Total payment dollars processed grew 25% to $2.73 billion, driven by a 39% increase in ACH transactions and an 18% rise in credit card revenues. For the first nine months of 2026, operating cash flow increased 133% to $3.3 million, while the company utilized approximately $499,000 to repurchase 327,000 shares of its common stock.Technology
- AVDNov 10, 4:01 PMAmerican Vanguard reported a net loss of $17.7 million for the third quarter of 2026, driven by a 9% decline in net sales to $108 million and a gross profit margin contraction to 24%. The company's financial performance was negatively impacted by lower international sales due to El Niño and geopolitical instability, alongside rising transportation costs that offset operational savings from facility rationalization. Despite these challenges, the firm expanded its U.S. product portfolio through the acquisition of four brands from Syngenta and a distribution agreement with Sipcam Agro. Management has revised its full-year outlook, projecting adjusted EBITDA between $36 million and $40 million on sales ranging from $500 million to $530 million.Basic Materials
- CLFDNov 10, 4:00 PMClearfield, Inc. reported fiscal 2026 net sales of $151.9 million from continuing operations, with a gross margin of 32.0% and net income per diluted share of $0.16. The company's sales order backlog grew 75% to $43.3 million by the end of the fiscal year, driven by the commencement of shipments for a previously announced $22 million data center order. Looking ahead to fiscal 2027, Clearfield projects revenue between $195 million and $205 million, reflecting an anticipated 30% growth at the midpoint. Additionally, the company maintains a strong balance sheet with $157 million in cash and investments and no debt, while CEO Cheri Beranek has announced plans to retire in March 2027.Technology
- Nov 10, 11:50 AMThe TIAA Real Estate Account reported a Total Return of 3.96% for the quarter ended September 30, 2026, while its Adjusted Total Return, which excludes the impact of liquid assets and liquidity guarantee expenses, stood at 4.27%. Over the same period, the NCREIF Fund Index - Open End Diversified Core Equity (NFI-ODCE) returned 1.51% on a value-weighted basis and 1.57% on an equal-weighted basis. Since inception, the Account has achieved a Total Return of 5.35% compared to the NFI-ODCE's 6.85% value-weighted return. The Account maintained a loan-to-value ratio of 17.8% as of September 30, 2026, with liquid assets comprising less than 8% of total net assets.
- APTNov 10, 9:41 AMAlpha Pro Tech, Ltd. reported third-quarter 2026 net sales of $16.6 million, representing a 12.3% increase from the $14.8 million recorded in the same period of 2025. Net income for the quarter rose 97.2% to $1.9 million, or $0.19 per diluted share, compared to $976,000, or $0.09 per share, in the prior year. The growth was driven by a 30.2% surge in the Disposable Protective Apparel segment and a 1.7% increase in the Building Supply segment, which saw housewrap sales climb 13.1%. As of September 30, 2026, the company held $25.5 million in cash, $52.1 million in working capital, and maintained a debt-free balance sheet.Industrials
- MANENov 10, 8:54 AMVeradermics reported positive topline results from its Phase 3 Study 304 and 12-month data from Phase 2/3 Study 302 for VDPHL01, an oral non-hormonal treatment for male pattern hair loss, demonstrating robust hair growth and a favorable safety profile. The company also announced positive Phase 2 results from open-label Study 207 in women with pattern hair loss and completed enrollment in the registration-directed Study 306, with topline data expected in the first half of 2027. For the third quarter ended September 30, 2026, Veradermics reported a net loss of $21.0 million and held $798.4 million in cash, cash equivalents, and marketable securities, which is projected to fund operations through 2030.Healthcare
- ACCSNov 10, 8:53 AMACCESS Newswire reported third-quarter 2026 revenue of $5.5 million, a 4% decrease from the same period in 2025, driven by lower press release volumes in a softer market. Despite the revenue decline, the company achieved a gross margin of 75% and an Adjusted EBITDA margin of 15%, while generating $469,000 in positive cash flow from operations. The number of active customers increased by 14% year-over-year to 14,134, and average annual recurring revenue per subscription customer rose to $12,331. Management expects annualized cost savings exceeding $1.5 million from organizational streamlining completed in October 2026 to contribute to a return to top-line growth in 2027.Communication Services
- IMSRNov 10, 8:43 AMTerrestrial Energy reported a net loss of $11.0 million for the third quarter ended September 30, 2026, driven by increased research and development costs and general and administrative expenses. The company selected Ameresco as its advanced nuclear technology supplier for a project at the U.S. Army's Aberdeen Proving Ground, extending its commercial pipeline into the federal defense sector. Additionally, Terrestrial Energy submitted two topical reports to the U.S. Nuclear Regulatory Commission, completing its 2026 guidance of at least three submissions. The company ended the quarter with $276.3 million in cash and cash equivalents and authorized a share repurchase program of up to $25 million.Utilities
- PWCMNov 10, 8:29 AMPowerCompute mined 9.0 Bitcoin in October 2026, representing a 20% year-over-year increase and an 11.1% rise from the previous month. The company's active hashrate reached approximately 800 PH/s by October 31, 2026, an 11.4% increase achieved by installing more efficient miners on existing power capacity without adding new megawatts. During the month, the company generated approximately $46,000 from energy sales and held a balance of 65.7 Bitcoin, valued at roughly $5.1 million based on a price of $77,000 per coin.Financial Services
- MXCTNov 10, 8:21 AMMaxCyte reported third-quarter 2026 total revenue of $10.2 million, representing a 49% increase from the prior year, driven by $8.2 million in core revenue and $2.0 million in strategic platform license program revenue. The company raised its full-year 2026 total revenue guidance to at least $34.5 million, reflecting a projected return to growth with core revenue expected to reach approximately $28 million. MaxCyte announced a proposed acquisition of Akron Bio, a supplier of GMP-grade reagents, which is expected to nearly double the company's revenue base upon closing. Financial results for the quarter showed a net loss of $4.8 million and an EBITDA loss of $5.1 million, while total cash, cash equivalents, and investments stood at $132.7 million as of September 30, 2026.Healthcare
- DOMHNov 10, 8:20 AMDominari Holdings Inc. reported a net loss of $1.9 million for the third quarter of 2026, a 65% sequential reduction from the $5.4 million loss in the second quarter. Total revenue for the quarter declined to $16.4 million from $52.4 million in the prior year period, primarily due to lower underwriting revenue and carried interest. Despite the revenue drop, the company reduced operating expenses by 65% year-over-year and narrowed its year-to-date operating loss to $40.6 million. The company also initiated a stock repurchase program, having bought back over 1.9 million shares for approximately $3.4 million as of the release date.Financial Services
- KULRNov 10, 8:15 AMKULR Technology Group reported third-quarter 2026 revenue of $7.4 million, representing a 197% year-over-year increase driven by product sales that nearly quadrupled to $6.5 million. The company completed its exit from Bitcoin mining by selling all holdings for approximately $80.1 million, repaid its outstanding debt, and ended the quarter with $54.5 million in cash and no digital assets. Gross margin for the quarter was 4%, reflecting lower margins on initial production builds and custom programs, while research and development expenses rose to $5.02 million due to investments in NDAA-compliant battery supply chains. To improve future profitability, KULR implemented a reduction in force in November 2026 expected to generate $4 million in annualized cost savings and plans to ramp up production of autonomous system batteries in 2027.Technology
- ATOSNov 10, 8:15 AMAtossa Therapeutics reported total operating expenses of $5.9 million for the third quarter of 2026, a decrease from $9.3 million in the same period of 2025. The company entered into a Stapled Contingent Value Rights agreement on October 8, 2026, entitling shareholders to 25% of net proceeds up to $50 million from the sale of a future FDA priority review voucher. Anticipated milestones include FDA clearance for Investigational New Drug applications for (Z)-endoxifen in Duchenne Muscular Dystrophy and McCune-Albright Syndrome by early 2027, with Phase 2 trials expected to begin that year. Additionally, the company plans to present Karisma trial results and I-SPY2 study data at the San Antonio Breast Cancer Symposium in December 2026.Healthcare
- CRBPNov 10, 8:08 AMCorbus Pharmaceuticals reported a net loss of $37.8 million for the third quarter of 2026, driven primarily by a $15 million development milestone payment for its sutantatug envedotin program. The company initiated dosing in the registrational TEMPO-1 Phase 3 study for sutantatug envedotin in patients with second-line oropharyngeal cancer and announced positive topline data from the CANYON-1 Phase 1b obesity study of CRB-913. CRB-913 demonstrated a mean weight loss of 5% at a 60 mg daily dose after 12 weeks with a favorable safety profile and no observed plateau. Additionally, Corbus appointed Leonardo Viana Nicacio as Chief Medical Officer and holds $115.3 million in cash and investments, which is projected to fund operations through 2028.Healthcare
- TLSINov 10, 8:06 AMTriSalus Life Sciences reported third-quarter 2026 revenue of $12.9 million, representing an 11.3% increase from the prior year period. The company revised its full-year 2026 revenue guidance to a range of $46 million to $48 million. Regulatory updates include CMS finalizing policies that will increase Medicare reimbursement rates for PEDD procedures to approximately $20,910 in hospitals and $13,800 in office-based labs starting January 1, 2027. Additionally, the company received FDA clearance for its TriNav Advance device and achieved the enrollment cutoff for the PROTECT registry interim analysis.Healthcare
- JRSHNov 10, 8:05 AMJerash Holdings (US), Inc. reported a 19.8 percent increase in revenue to $50.3 million for its fiscal 2027 second quarter ended September 30, 2026, driven by higher shipments to U.S. customers. Gross profit rose 45.4 percent to $9.1 million, expanding the gross margin to 18.2 percent due to automation gains and strategic raw material purchases. Net income for the quarter reached $2.2 million, or $0.16 per diluted share, representing a 4.5-fold increase compared to the prior year period. The company announced a quarterly dividend of $0.05 per share and expects revenue for the third quarter to fall between $49 million and $51 million.Consumer Cyclical
- AVNWNov 10, 8:05 AMAviat Networks reported fiscal 2027 first-quarter total revenues of $102.0 million, a 5.0% decrease from the prior year period. The company recorded a GAAP net loss of $2.8 million, or $0.22 per diluted share, while non-GAAP net income was $1.5 million, or $0.12 per share. Despite lower revenues, the quarter featured record bookings exceeding $150 million, representing a 75% year-over-year increase. Adjusted EBITDA for the quarter was $6.0 million, and the company updated its full-year revenue guidance to a range of $450 million to $475 million.Technology
- TYRANov 10, 8:03 AMTyra Biosciences reported initial Phase 2 results for its oral FGFR3-selective inhibitor dabogratinib in patients with FGFR3-altered low-grade intermediate-risk non-muscle invasive bladder cancer, showing a 79% overall response rate at the 60 mg dose. The company completed a $400 million public offering in September 2026, bringing its total cash, cash equivalents, and marketable securities to $700.5 million as of September 30, 2026, which supports operations through 2030. During the third quarter of 2026, research and development expenses increased to $43.1 million, driven by ongoing clinical trials for dabogratinib across bladder cancer, upper tract urothelial carcinoma, and achondroplasia indications.Healthcare
- COYANov 10, 8:02 AMCoya Therapeutics completed enrollment of 137 participants in its Phase 2/3 ALSTARS trial for the treatment of ALS and announced plans for an open-label extension. The company reported a net loss of $10.6 million for the quarter ended September 30, 2026, driven primarily by a $5.6 million increase in clinical product candidate costs. As of September 30, 2026, Coya held $35.8 million in cash and cash equivalents, which is sufficient to fund operations through the second half of 2027. Topline data from the 24-week double-blind treatment phase of the ALSTARS trial is anticipated in early Q2 2027.Healthcare
- CODXNov 10, 8:02 AMCo-Diagnostics, Inc. reported third-quarter 2026 revenue of $0.3 million and a net loss of $6.3 million, or $1.01 per share. The company advanced two regulatory submissions under review, including a 510(k) for its Flu A/B & RSV test with the U.S. FDA and a tuberculosis test with India's CDSCO. Operating expenses decreased by 12% year-over-year to $6.2 million, driven by reduced personnel and stock-based compensation costs. Additionally, the company expanded its platform capabilities through new collaborations, international deployments, and the launch of cloud infrastructure in India.Healthcare
- PEPGNov 10, 8:00 AMPepGen reported positive top-line results from the 10 mg/kg cohort of its Phase 2 FREEDOM2-DM1 trial, demonstrating a mean splicing correction of 46.5% and improvements in functional measures such as hand grip strength and mobility. The company has fully enrolled the third and highest dose cohort of 12.5 mg/kg, with results expected in the first half of 2027, while interim safety and clinical data for the FREEDOM-OLE study are anticipated in January 2027. Financially, PepGen recorded a net loss of $19.4 million for the quarter ended September 30, 2026, and maintains $104.8 million in cash and marketable securities sufficient to fund operations into 2028. The U.S. FDA has selected PGN-EDODM1 for its CMC Development and Readiness Pilot program to accelerate manufacturing alignment, though the FREEDOM2 study remains subject to a partial clinical hold pending further nonclinical data.Healthcare
- PMVPNov 10, 8:00 AMPMV Pharmaceuticals reported a net loss of $34.4 million for the third quarter of 2026, driven largely by a $12.8 million non-cash loss from changes in the fair value of warrant liabilities associated with a recent public offering. The company announced the completion of enrollment for the primary analysis population in the Phase 2 monotherapy portion of its PYNNACLE clinical trial for rezatapopt in platinum-resistant ovarian cancer. Interim data from this trial showed an overall response rate of 46% among 76 patients, with a median duration of response of 10.0 months and a favorable safety profile. Following a $50 million public offering, PMV Pharma holds $108.5 million in cash and marketable securities, projecting a runway into the first quarter of 2028 to support the planned submission of a New Drug Application in early 2027.Healthcare
- ALHNov 10, 7:51 AMAlliance Laundry Holdings reported third-quarter 2026 net revenues of $461 million, representing a 5% year-over-year increase driven by volume, mix, and pricing actions. Net income for the quarter reached $65 million, while Adjusted EBITDA rose 14% to $127 million with a margin of 27.5%. The company repaid $45 million in debt and repurchased $75 million of common stock, reducing its net leverage ratio to 2.25x. Full-year 2026 guidance was updated to reflect revenue growth of 6% to 7% and Adjusted EBITDA growth of approximately 10%.Consumer Cyclical
- HIVENov 10, 7:44 AMHIVE Digital Technologies Ltd. reported Q2 fiscal 2027 revenue of $84.9 million, driven by a 70.7% year-over-year increase in high-performance computing revenue to $8.8 million. The company achieved a gross operating margin of 35.6% and reported adjusted EBITDA of $24.8 million, while recording a GAAP net loss of $78.7 million due to significant non-cash charges including depreciation and equipment impairment. HIVE maintains a dual-engine business model combining Bitcoin mining with AI infrastructure, holding $139 million in cash and $22.6 million in digital currencies as of September 30, 2026. The firm has secured approximately $185 million in contracted GPU Cloud annualized run rate revenue, including major agreements with Bell AI Fabric and an investment-grade enterprise customer.Financial Services
- KLRSNov 10, 7:42 AMKalaris Therapeutics reported a net loss of $11.0 million for the third quarter ended September 30, 2026, with cash, cash equivalents, and marketable securities totaling $82.9 million. The company expects its current cash reserves to fund operations into 2028, extending beyond the anticipated readout of Phase 1b/2 data for its drug candidate TH103 in neovascular age-related macular degeneration. Preliminary data from the ongoing Phase 1b/2 study is now projected for the second half of 2027 following a supply interruption that delayed the availability of a new drug batch until the second quarter of 2027. Despite the delay, Kalaris successfully completed the technology transfer of TH103 to a commercial-scale manufacturer, with test batches meeting target specifications for future Phase 3 development.Healthcare
- MCFTNov 10, 7:36 AMMasterCraft Boat Holdings, Inc. reported net sales of $154.1 million for the first three months of its transition period ended October 4, 2026, representing a 123.4% increase from the prior-year period. This growth was driven by a $59.3 million contribution from the Marine Products Transaction completed in May 2026, alongside higher unit volumes and favorable pricing in existing segments. The company recorded income from continuing operations of $12.1 million, or $0.50 per diluted share, and reported an Adjusted EBITDA of $20.1 million. Additionally, the company repurchased $4.8 million of its shares during the quarter and expects consolidated net sales for the full six-month transition period to range between $293 million and $297 million.Consumer Cyclical
- XLONov 10, 7:35 AMXilio Therapeutics initiated the first patient dosing in its Phase 1/2 clinical trial for XTX501, a PD-1/masked IL-2 bispecific antibody, in patients with metastatic non-small cell lung cancer. The company plans to submit investigational new drug applications for its masked T cell engager programs, XTX602 and XTX701, in the fourth quarter of 2027. For the third quarter ended September 30, 2026, Xilio reported cash and cash equivalents of $122.2 million and a net loss of $5.9 million. Based on current operating plans, the company anticipates its cash reserves will fund operations into the first quarter of 2028.Healthcare
- XGNNov 10, 7:33 AMExagen Inc. reported third-quarter 2026 revenue of $18.4 million, representing a 7% increase compared to the same period in 2025. The company achieved a trailing twelve-month average selling price of $451 per test for its AVISE CTD offering, marking the 14th consecutive quarter of growth. For the nine months ended September 30, 2026, total revenue reached $55.7 million while the net loss decreased to $13.5 million from $15.3 million in the prior year period. Exagen reiterated its full-year 2026 revenue guidance of $72 million to $75 million and ended the quarter with approximately $28.1 million in cash and cash equivalents.Healthcare
- AMBQNov 10, 7:31 AMAmbiq Micro reported third-quarter 2026 net sales of $38.1 million, representing an 110% year-over-year increase driven by strong demand for edge AI solutions. Gross profit more than doubled to $17.8 million, expanding the GAAP gross margin by 440 basis points to 46.7% compared to the prior year. The company's active customer base grew by approximately 50% year-over-year, with seven customers now generating over $1 million in quarterly net sales. Looking ahead to the fourth quarter, Ambiq forecasts net sales between $43.5 million and $44.5 million, supported by accelerating demand and manufacturing efficiencies.Technology
- ABUSNov 10, 7:31 AMArbutus Biopharma reported a net income of $59.1 million for the third quarter of 2026, driven by a $67.3 million cash dividend from Genevant and a $178.4 million settlement payment from Moderna. The company returned $230 million to shareholders through a tender offer in early October 2026, purchasing 46 million shares at $5.00 per share. Arbutus expanded its patent infringement litigation against Pfizer and BioNTech by filing new lawsuits in Japan and amending a Canadian case, while the FDA lifted a clinical hold on its oral PD-L1 inhibitor, AB-101. Additionally, the company highlighted positive Phase 2a clinical data for its RNAi therapeutic imdusiran, which achieved functional cures in eight hepatitis B patients.Healthcare
- KUSTNov 10, 7:30 AMKustom Entertainment, Inc. reported a 57% increase in third-quarter revenue from continuing operations to $2.7 million, driven by growth in its TicketSmarter marketplace and the 30th anniversary Country Stampede festival. The company achieved net income of $2.3 million for the quarter, a significant turnaround from the net loss recorded in the same period of the previous year. Following the sale of its legacy video solutions business to Cycurion in August 2026, the company's stockholders' equity more than tripled to $7.9 million while total liabilities declined by $9.3 million. Management plans to close the acquisition of TFL, LLC by December 18, 2026, and will expand the 2027 Country Stampede Music Festival to a larger venue in Gilley's Park City.Communication Services
- VREOFNov 10, 7:30 AMVireo Growth Inc. reported third-quarter 2026 GAAP revenue of $253.7 million, representing a 177% year-over-year increase driven by recent mergers and acquisitions. The company achieved an annualized revenue run rate exceeding $1 billion and closed the quarter with $106.8 million in cash while executing a consolidation strategy that includes the acquisition of C21 Investments and PharmaCann Colorado assets. Adjusted EBITDA for the quarter reached $42.7 million, and the company announced a share repurchase program alongside new financing facilities to support its growth. Management provided guidance for the fourth quarter of 2026, expecting revenue between $250 million and $265 million and Adjusted EBITDA between $45 million and $48 million.
- EFOINov 10, 7:28 AMEnergy Focus, Inc. reported third-quarter 2026 net sales of $4.8 million, representing a 481.2% increase from the same period in 2025, driven primarily by the expansion of its Uninterruptible Power Supply business with a new customer in Taiwan. The company achieved a gross profit margin of 20.5% and reported net income of $0.5 million, or $0.08 per share, compared to a net loss in the prior year period. Cash reserves rose to $3.3 million as of September 30, 2026, supported by short-term borrowings and favorable timing in customer collections relative to supplier payments. Additionally, the company received an $184,000 refund from U.S. Customs and Border Protection, which was recorded as a reduction to the cost of goods sold.Consumer Cyclical
- CLRBNov 10, 7:25 AMCellectar Biosciences reported a net loss of $8.0 million for the third quarter of 2026, driven by increased research and development expenses associated with its Phase 3 confirmatory trial for iopofosine I 131. The company presented new efficacy data at the International Workshop for Waldenström Macroglobulinemia showing an 87.5% overall response rate in patients treated immediately after BTK inhibitor therapy. Cellectar remains on track to dose the first patient in its Phase 3 trial in the first quarter of 2027 and plans to file for accelerated approval with the FDA in the first half of 2027. Additionally, the company initiated a Phase 1b dosimetry trial and highlighted a case study of a diffuse large B-cell lymphoma patient who maintained a complete response for over eight years following treatment.Healthcare
- AUTLNov 10, 7:25 AMAutolus Therapeutics reported net product revenue of $41.2 million for the third quarter of 2026, representing a 95% year-over-year increase driven by AUCATZYL sales. The company raised its full-year 2026 revenue guidance to at least $150 million and achieved a gross margin of 57% through manufacturing efficiency and increased volumes. Clinical programs for obe-cel are advancing in pediatric ALL, lupus nephritis, and progressive multiple sclerosis, with the FDA granting RMAT designation for lupus indications in September 2026.Healthcare
- CALCNov 10, 7:15 AMCalciMedica reported a net loss of $1.7 million for the third quarter ended September 30, 2026, with cash, cash equivalents, and short-term investments totaling $13.8 million. The company anticipates its current cash runway will fund operations into the second half of 2027. Clinical updates include plans for an Auxora Phase 1b proof-of-concept trial in pulmonary hypertension and an IND submission for the oral candidate CM5480, both expected in mid-2027. Additionally, the FDA has aligned with CalciMedica's Phase 2b trial design for Auxora in acute pancreatitis, which will utilize lactate dehydrogenase levels for patient enrichment.Healthcare
- SRRKNov 10, 7:10 AMScholar Rock reported a net loss of $107.2 million for the third quarter of 2026, driven by the U.S. launch of ISEMBYLD, which generated $0.6 million in product revenue. The company holds $413.6 million in cash, cash equivalents, and marketable securities as of September 30, 2026, and has entered a definitive agreement to sell a Priority Review Voucher for $205 million. Regulatory progress includes the FDA approval of ISEMBYLD for spinal muscular atrophy, a resubmitted Marketing Authorisation Application in Europe expected to yield a CHMP opinion in the first half of 2027, and a Japanese New Drug Application accepted for priority review.Healthcare
- LNSRNov 10, 7:10 AMLENSAR, Inc. reported third-quarter 2026 total revenue of $14.1 million, a 1% decrease from the prior year, driven by lower system sales that were partially offset by growth in procedure volume and recurring revenue. Recurring revenue increased 17% year-over-year to $12.6 million, representing 89% of total revenue, while procedure volume rose 12% to 52,545. The company placed 10 ALLY Robotic Cataract Laser Systems during the quarter, bringing the total ALLY installed base to approximately 225 systems and the total laser installed base to 450 systems. Despite the revenue decline, the company achieved an Adjusted EBITDA of $1.7 million and reported a net loss of $4.7 million.Healthcare
- COAGNov 10, 7:08 AMHemab Therapeutics initiated the SOLARA Phase 3 trial for sutacimig in Glanzmann thrombasthenia, marking the first pivotal study of a subcutaneous prophylactic treatment for the condition. The company also dosed its first participant in a Phase 1 trial for HMB-003 to treat heavy menstrual bleeding and reported early clinical data showing sutacimig significantly reduced prothrombin time in patients with Factor VII deficiency. Financially, the company reported a net loss of $27.3 million for the third quarter of 2026, with cash and marketable securities totaling $430.2 million to fund operations through 2029. Additionally, Hemab strengthened its Board of Directors by appointing Keli Walbert, who brings over two decades of commercial leadership experience in the biopharmaceutical industry.Healthcare
- PDYNNov 10, 7:06 AMPalladyne AI reported record third-quarter 2026 revenue of $8.6 million, representing an 895% increase year-over-year and a 48% increase sequentially. The company raised its full-year 2026 revenue guidance to a range of $25 million to $27 million, reflecting expected growth of 377% to 415% compared to 2025. Operational highlights included the expiration of 20.5 million warrants and 2.3 million contingent shares, which reduced fully diluted shares by 9%, and the delivery of next-generation BRAIN FC-1 flight computers. Despite a GAAP net loss of $12.0 million for the quarter, the company maintained $47.0 million in cash and marketable securities to support continued growth into 2027.Technology
- CGEMNov 10, 7:06 AMCullinan Therapeutics reported a net loss of $49.4 million for the third quarter of 2026 and holds $313.8 million in cash and investments, providing a runway into 2029. The company initiated a potentially registrational Phase 2 study for CLN-049 in relapsed or refractory acute myeloid leukemia and began a global Phase 1/2 study for velinotamig in autoimmune cytopenias. Additionally, a New Drug Application for zipalertinib in combination with chemotherapy for first-line EGFR ex20ins non-small cell lung cancer was submitted under the FDA's Real-Time Oncology Review program. Clinical data updates for CLN-978 in autoimmune diseases and CLN-049 in leukemia are scheduled for presentation in December 2026.Healthcare
- SIONNov 10, 7:05 AMSionna Therapeutics announced plans to advance its SION-451 and SION-2222 dual combination into the AscenSION CF Phase 2 proof-of-concept trial, expected to begin in the first quarter of 2027. The company reported a net loss of $32.4 million for the third quarter of 2026, driven by increased research and development expenses and restructuring costs associated with a 46% workforce reduction. As of September 30, 2026, Sionna held $249.8 million in cash and cash equivalents, which is projected to fund operations through the second half of 2029. Clinical and nonclinical data presented at the 2026 North American Cystic Fibrosis Conference support the potential of NBD1 stabilizer combinations to benefit a broad population of people with cystic fibrosis.Healthcare
- UPBNov 10, 7:05 AMUpstream Bio, Inc. reported a net loss of $41.2 million for the third quarter ended September 30, 2026, driven by increased research and development expenses related to its verekitug programs. The company holds $207.4 million in cash and short-term investments, which is projected to fund operations through 2027. Upstream Bio plans to initiate Phase 3 clinical trials for verekitug in severe asthma and chronic rhinosinusitis with nasal polyps during the first quarter of 2027. Additionally, ongoing Phase 2 trials for verekitug in COPD and severe asthma are expected to yield data in the second half of 2027.Healthcare
- OLMANov 10, 7:05 AMOlema Oncology reported a net loss of $73.6 million for the third quarter of 2026, driven by increased clinical trial enrollment and preparation for potential commercialization. The company ended the quarter with $413.8 million in cash, cash equivalents, and marketable securities. Key operational milestones include continued strong enrollment in the Phase 3 OPERA-02 trial and the Phase 1b/2 study of OP-3136, with top-line data from the pivotal Phase 3 OPERA-01 trial anticipated in the first quarter of 2027. Additionally, Jason O'Byrne was appointed as Chief Financial Officer to support the company's expansion into a fully integrated oncology business.Healthcare
- MASSNov 10, 7:05 AM908 Devices reported third-quarter 2026 revenue of $19.0 million, representing a 35% year-over-year increase driven by growth in its FTIR portfolio and the addition of NIRLab revenue. The company achieved a record 308 device placements during the quarter, bringing the total installed base to 4,409 units, while recurring revenue accounted for 27% of total sales. Operating expenses decreased by $8.2 million to $15.5 million, primarily due to an $11.0 million non-cash reduction in the fair value of contingent consideration, resulting in a net loss of $4.6 million. The company raised its full-year 2026 revenue guidance to a range of $68.5 million to $70.0 million and ended the quarter with $99.1 million in cash and no outstanding debt.Healthcare
- HUMANov 10, 7:05 AMHumacyte reported third-quarter 2026 commercial sales of $1.0 million for its Symvess product, representing a 151% increase over the second quarter and a 44% expansion in hospital adoption. The company plans to file a Supplemental Biologics License Application with the FDA in November 2026 to add dialysis access as a new indication for its Acellular Tissue Engineered Vessel (ATEV), supported by positive Phase 3 trial results. Additionally, Humacyte initiated a first-in-human Phase 2a clinical study for its Coronary Tissue Engineered Vessel (CTEV) in coronary artery bypass grafting. For the nine months ended September 30, 2026, the company recorded a net loss of $70.0 million while maintaining $64.9 million in cash and cash equivalents.Healthcare
- OVIDNov 10, 7:03 AMOvid Therapeutics reported a net loss of $20.8 million for the third quarter ended September 30, 2026, with cash, cash equivalents, and marketable securities totaling $161.4 million as of that date. The company is advancing its lead candidate OV329, a next-generation GABA-AT inhibitor, through a Phase 2 study for treatment-resistant focal epilepsy expected to conclude in the second half of 2027, alongside a photosensitivity study with results anticipated in early 2027. Additionally, OV4071, the first oral KCC2 direct activator, is progressing in a Phase 1 trial with topline data expected in the first quarter of 2027, while a pediatric formulation of OV329 is on track to initiate a study for TSC-associated seizures before the end of 2026.Healthcare
- IRDNov 10, 7:01 AMOpus Genetics reported a net loss of $46.5 million for the third quarter of 2026, driven by increased research and development expenses and fair value changes in financial instruments. The company's cash position stands at $89.0 million as of September 30, 2026, with projections indicating operations will be funded through 2029. Key pipeline milestones include the completion of dosing for the OPGx-BEST1 Cohort 2 trial, full enrollment of the OPGx-LCA5 Phase 3 trial, and FDA clearance for the OPGx-RDH12 IND application. Additionally, the FDA approved phentolamine ophthalmic solution 0.75% for presbyopia, triggering a regulatory milestone payment from commercial partner Viatris Inc.Healthcare
- QBTSNov 10, 7:01 AMD-Wave Quantum Inc. reported third-quarter 2026 revenue of $4.5 million, representing a 21% increase year over year, driven by growth in professional services and quantum computing as a service. The company achieved bookings of $37.4 million for the first nine months of 2026, a 611% increase compared to the same period in 2025, while remaining performance obligations rose 1,221% to $38.3 million. D-Wave secured a definitive agreement with the U.S. Department of Commerce to access up to $100 million in CHIPS and Science Act funding to support the development of next-generation quantum systems. Despite a net loss of $48.2 million for the quarter, the company expanded its commercial reach through new partnerships with entities such as NTT DOCOMO, CGI, and LG CNS, and delivered its first annealing quantum computer in Italy.Technology
- LQDANov 10, 7:00 AMLiquidia Corporation reported a net loss of $236.3 million for the third quarter of 2026, a figure that includes a $389.7 million charge for a global litigation settlement with United Therapeutics. Despite the settlement charge, the company achieved net product sales of $222.7 million for YUTREPIA, marking a 31% increase from the previous quarter and securing continuity of care for all patients. The company's cash and cash equivalents rose to $396.1 million prior to settlement payments, while non-GAAP adjusted EBITDA reached $140.5 million for the fifth consecutive quarter. Additionally, Liquidia received Fast Track designation from the FDA for YUTREPIA to treat systemic sclerosis-associated Raynaud's phenomenon and initiated the RE-WARM Phase 2 study for this indication.Healthcare
- REFINov 10, 7:00 AMChicago Atlantic Real Estate Finance reported third-quarter 2026 distributable earnings of $0.49 per diluted share, driven by net interest income of $12.5 million despite a challenging macroeconomic environment. The company's total loan principal outstanding increased to $527.7 million, a figure that includes $59.1 million in Koach Notes acquired in exchange for newly issued common stock. A pending merger with Chicago Atlantic BDC, Inc. is expected to close in 2027, subject to stockholder and regulatory approvals. The company maintains a dividend payout ratio target of 90% to 100% of distributable earnings for the full year 2026.Financial Services
- HBIONov 10, 7:00 AMHarvard Bioscience reported third-quarter 2026 revenue of $22.2 million, representing an 8% year-over-year increase, while reaffirming full-year revenue growth guidance of 3% to 5%. The company posted a net loss of $2.6 million for the quarter and $9.0 million for the first nine months, a significant improvement from the $53.9 million loss in the prior year period driven by a goodwill impairment charge. Adjusted EBITDA for the quarter was $1.8 million, and the company expects fourth-quarter revenue to range between $23.7 million and $25.5 million with adjusted EBITDA between $3.8 million and $4.2 million.Healthcare
- JBINov 10, 7:00 AMJanus International Group reported a net loss of $13.3 million, or $0.10 per diluted share, for the third quarter of 2026, with total revenues declining 2.8% year-over-year to $213.1 million. Adjusted EBITDA for the quarter was $34.0 million, representing a 22.0% decrease compared to the prior year period, while the company's Nokē Smart Entry System connected devices grew 19.4% to 524,000 units. The company updated its full-year 2026 revenue guidance to a range of $855 million to $865 million and adjusted EBITDA guidance to $127 million to $133 million. During the quarter, Janus repurchased approximately 5.0 million shares of common stock for $25.3 million and made a voluntary prepayment of $30.0 million toward its First Lien Term Loan.Industrials
- PLXNov 10, 6:54 AMProtalix BioTherapeutics reported total revenues of $75.6 million for the nine months ended September 30, 2026, representing a $32.0 million increase from the same period in 2025. The company achieved a net income of $26.1 million for the nine-month period and $4.0 million for the third quarter, driven primarily by higher sales to partner Chiesi and a $25.0 million milestone payment. Protalix reaffirmed its 2026 revenue guidance of approximately $78.0 million to $83.0 million and maintains a cash position of $48.5 million as of September 30, 2026. Clinical progress includes the ongoing Phase 2 RELEASE study for PRX-115, with top-line results anticipated in the second half of 2027, and the recent marketing authorization of Elfabrio in Brazil.Healthcare
- SBHNov 10, 6:50 AMSally Beauty Holdings reported fourth-quarter 2026 consolidated net sales of $953 million, representing a 0.6% increase year-over-year, while consolidated comparable sales grew by 0.9%. The company achieved GAAP diluted earnings per share of $0.60, a 22% increase, and adjusted diluted earnings per share of $0.62, up 13%. For the full fiscal year 2026, net sales reached $3.73 billion with adjusted diluted earnings per share rising 9% to $2.08. Looking ahead to fiscal 2027, the company provided guidance for consolidated net sales between $3.77 billion and $3.81 billion and adjusted diluted earnings per share between $2.20 and $2.30.Consumer Cyclical
- MNKKQNov 10, 6:36 AMKeenova Therapeutics reported third-quarter 2026 net sales of $550 million, driven by a 25% increase in Acthar Gel sales to $227 million and an 82% surge in XIAFLEX sales to $164 million. The company recorded a loss from continuing operations of $96 million but achieved an adjusted EBITDA of $233 million, reflecting strong operational performance and the realization of merger synergies. Keenova raised its full-year 2026 net sales guidance to a range of $2.00 billion to $2.025 billion and adjusted EBITDA guidance to $750 million to $770 million based on improved growth expectations for its core brands. Additionally, the company advanced its XIAFLEX pipeline with an expected sBLA submission for plantar fibromatosis in the first quarter of 2027 and the initiation of a Phase 3 study for hammer toe.Healthcare
- TDGNov 10, 6:32 AMTransDigm Group reported fiscal 2026 fourth-quarter net sales of $2.988 billion, representing a 23% increase from the prior year, while adjusted earnings per share rose 15% to $12.44. The company completed the acquisition of Prince & Izant for approximately $1.07 billion and returned $943 million to shareholders through stock repurchases during the quarter. For the full fiscal year 2026, net sales reached $10.557 billion with EBITDA As Defined increasing 17% to $5.563 billion. Looking ahead, TransDigm projects fiscal 2027 net sales between $11.95 billion and $12.15 billion, with adjusted earnings per share expected to range from $47.09 to $47.94.Industrials
- VGNov 10, 6:31 AMVenture Global reported record third-quarter 2026 results with revenue of $4.8 billion and net income of $2.5 billion, representing significant year-over-year growth driven by increased LNG sales volumes and higher prices. The company commenced commercial operations at the Plaquemines Phase 1 project in October 2026, achieving this milestone in just over 53 months from the final investment decision. Additionally, Venture Global announced strategic frame agreements with GE Vernova and Baker Hughes to expand its island-mode power network for potential AI data center support. The company raised its full-year 2026 Consolidated Adjusted EBITDA guidance to a range of $10.0 billion to $10.3 billion and declared a quarterly cash dividend of $0.04 per share.Energy
- SSMNov 10, 6:30 AMSono Group N.V. reported a net income of $0.6 million for the third quarter of 2026, marking a shift from a $1.4 million loss in the same period of 2025 following the sale of its legacy solar business. The company, now operating as a Bitcoin treasury firm, generated $0.7 million in digital asset treasury income driven by a $1.5 million fair-value gain on its Bitcoin holdings. General and administrative expenses decreased by 24% to $0.6 million, while the company holds 53.40 Bitcoin valued at $4.4 million as collateral for its covered-call program. Additionally, Sono plans to vote on a proposed redomiciliation to Delaware on December 11, 2026, and has entered into a non-binding letter of intent for a potential business combination with Sports One.Consumer Cyclical
- BDTXNov 10, 6:28 AMBlack Diamond Therapeutics reported updated Phase 2 results for silevertinib showing an 86% central nervous system objective response rate and a median progression-free survival of 12.2 months in patients with untreated brain metastases. Following a collaborative End-of-Phase 2 meeting with the FDA, the company received support for a pivotal Phase 3 trial design targeting accelerated approval based on CNS response and full approval based on progression-free survival. The company plans to initiate this global Phase 3 registrational trial in the second quarter of 2027 with 300 patients harboring EGFR non-classical mutations. Financially, Black Diamond ended the third quarter of 2026 with $102.0 million in cash and cash equivalents, which is projected to fund operations through the second half of 2028.Healthcare
- APNov 10, 6:20 AMAmpco-Pittsburgh Corporation reported third-quarter 2026 net sales of $111.7 million, representing a 3% increase over the prior year period. Net income attributable to the company rose to $0.5 million, or $0.02 per share, compared to a net loss of $2.2 million in the same period last year. Adjusted EBITDA increased by 2% to $9.4 million, while free cash flow improved significantly to $19.7 million from $4.6 million in the prior year. The company reduced its net debt by $19.5 million to $111.0 million and saw its backlog grow by $50.6 million to $379.5 million.Industrials
- STINov 9, 5:30 PMSolidion Technology reported a positive net income of approximately $244,000 for the third quarter of 2026, marking a significant turnaround from the $4.1 million loss in the prior-year period. The company maintained a cash balance of $26.2 million as of September 30, 2026, while reducing total liabilities by roughly 40% to $7.5 million compared to year-end 2025. Revenue for the quarter reached $41,638, and the company strengthened its stockholders' equity to $23.8 million. Strategic initiatives include the development of a PEAK Series UPS for AI data centers and high-power battery cells, alongside a new board of three independent directors and a $1.0 million share repurchase authorization.Industrials
- Nov 9, 5:21 PMAs of September 30, 2026, the business development company reported total assets of $1.17 billion and a portfolio of 64 companies with investments at fair value reaching $1.02 billion. The weighted average yield at amortized cost stood at 10.6%, while the net interest margin was 4.7%, resulting in a distribution rate of 8.1% for the period. Financial performance for the nine months ended September 30, 2026, showed total investment income of $71.2 million against total expenses of $42.5 million, though net assets decreased by $5.3 million due to unrealized losses on investments. The company maintains a strong asset coverage ratio of 207.4% with a diversified portfolio across regions and industries, including significant exposure to professional services and healthcare.
- URGNov 9, 5:20 PMUr-Energy reported a 67.3% year-over-year increase in sales volume for the first three quarters of 2026, selling 460,000 pounds of U3O8 for $30.6 million in revenue. During the third quarter alone, the company sold 190,000 pounds at an average price of $64.95 per pound while maintaining a low cash cost of $40.40 per pound sold. Operational highlights include a 26.4% increase in captured pounds year-to-date and the commencement of full operations at the Shirley Basin mine. The company also advanced exploration at Lost Creek South and progressed a technical report for the potential Lost Soldier satellite mine.Energy
- CWCONov 9, 5:16 PMConsolidated Water Co. Ltd. reported third-quarter 2026 total revenue of $30.9 million, an 11.9% decrease from the prior year, driven by declines in services and manufacturing revenue that were partially offset by growth in retail and bulk segments. Net income attributable to stockholders from continuing operations totaled $2.4 million, or $0.15 per diluted share, compared to $5.6 million in the same period of 2025. The company secured a new 25-year retail water license in the Cayman Islands effective August 2026 and received approximately $10.1 million in purchase orders for municipal water treatment equipment scheduled for delivery in November 2027. Additionally, the firm announced a $39.8 million design-build agreement for a water purification facility in Pismo Beach, California, with construction anticipated to begin in spring 2027.Utilities
- MAPSNov 9, 5:12 PMWM Technology, Inc. reported third-quarter 2026 revenues of $38.5 million, a decrease from $42.2 million in the prior year period, driven by client payment difficulties and churn in established markets. The company recorded a net loss of $5.9 million for the quarter, while Adjusted EBITDA declined to $0.8 million from $7.6 million in the same period last year. Management attributed the financial results to increased marketing spend, one-time expenses including a securities litigation settlement, and workforce reduction costs, while noting that strategic efforts to improve collections and user acquisition are laying the foundation for future growth.Technology
- VGZNov 9, 5:10 PMVista Gold Corp. will release its financial results for the quarter ended September 30, 2026, before the market opens on November 12, 2026. The company plans to host a conference call at 8:00 a.m. MST on the same date to review these results and provide updates on corporate and project activities. Participants can join via toll-free numbers or an international line using conference ID 20627, with an audio replay available through November 30, 2026. Vista Gold holds the Mt Todd gold project in the Northern Territory of Australia, which is described as a development-stage deposit with significant expansion and exploration potential.Basic Materials
- HNRGNov 9, 5:05 PMHallador Energy Company reported a net loss of $4.5 million for the third quarter of 2026, while Adjusted EBITDA improved to $17.3 million compared to a loss in the prior quarter. The company advanced its Turtle Creek natural gas generation project toward a final investment decision before year-end, securing a $600 million senior secured construction bridge loan and taking title to turbine equipment en route from the Philippines. Total contracted forward sales at the segment level increased 26% to approximately $3.0 billion, driven by new agreements that price substantially higher than previous contracts. Management targets generating approximately $1.6 billion of value from the Turtle Creek project within 24 months as it aims for commercial operation in the second half of 2028.Utilities
- DOUGNov 9, 5:03 PMDouglas Elliman Inc. reported third-quarter 2026 operating income of $6.3 million and net income of $7.4 million, marking a significant turnaround from the prior year's losses. The company maintained a strong balance sheet with approximately $123 million in cash and equivalents while eliminating all long-term debt. Revenues for the quarter totaled $252.1 million, and the firm achieved a gross transaction value of $10.0 billion with an average transaction price of $1.83 million. Additionally, the Board approved a $10 million share repurchase program and highlighted a development marketing pipeline valued at $26.0 billion.Real Estate
- MVSTNov 9, 5:01 PMMicrovast Holdings reported a 62.8% decline in third-quarter 2026 revenues to $45.8 million, driven by a significant drop in sales volume and weaker demand in Europe and APAC markets. The company recorded a net loss of $76.8 million, primarily due to $35.7 million in non-cash impairment charges on long-lived assets and a $9.3 million write-down for obsolete inventories. With total debt reaching $177.0 million and a working capital deficit of $3.1 million, management has concluded that substantial doubt exists regarding its ability to continue as a going concern without additional financing or debt restructuring. Consequently, the company is implementing cost-reduction initiatives and deferring discretionary capital expenditures while negotiating with lenders to refinance near-term obligations.Industrials
- RANINov 9, 5:00 PMRani Therapeutics Holdings, Inc. reported a net loss of $8.8 million for the third quarter ended September 30, 2026, driven by increased research and development expenses of $6.0 million. The company holds $45.3 million in cash, cash equivalents, and marketable securities, which is expected to fund operations through the end of 2027. In October 2026, the RaniPill platform technology was accepted into the FDA's Emerging Technology Program to facilitate early regulatory engagement. Additionally, enrollment continues in the Phase 1a expansion cohort for the RT-114 study, with data anticipated by the end of 2026.Healthcare
- BCSFNov 9, 5:00 PMBain Capital Specialty Finance, Inc. reported net investment income of $27.7 million, or $0.43 per share, for the third quarter ended September 30, 2026. The company's net asset value per share decreased to $16.49 from $16.65 at the end of the previous quarter, while total investment portfolio fair value stood at $2,270.3 million. The Board of Directors declared a fourth-quarter dividend of $0.42 per share, payable on December 29, 2026, to shareholders of record as of December 15, 2026. Additionally, the company increased its senior secured revolving credit facility capacity to $955.0 million and maintained a net debt-to-equity ratio of 1.18x.Financial Services
- NINENov 9, 5:00 PMNine Energy Service reported third-quarter 2026 revenues of $142.0 million, a net loss of $5.1 million, and adjusted EBITDA of $8.3 million. Cementing revenue increased by 11% sequentially, while Coiled Tubing operations faced constraints due to a large-diameter unit remaining out of service. The company's total liquidity stood at $46.0 million as of September 30, 2026, comprising $16.1 million in cash and $29.9 million in availability under its revolving credit facility. Management expects fourth-quarter revenue to remain flat with modestly higher profitability driven by a shift toward higher-margin cementing and international tools businesses.Energy
- EXODNov 9, 4:58 PMExodus Movement, Inc. reported third-quarter 2026 revenue of $32.5 million, representing a 7% increase from the same period in 2025. The company recorded a net loss of $8.3 million for the quarter, a significant shift from the $17.0 million net income reported in the prior year period. Operational metrics showed 1.4 million monthly active users and 1.4 million quarterly funded users, while total swap volume decreased by 3.4% to $1.1 billion. Exodus continues to integrate its acquired entities, Monavate and Baanx, with plans to reduce combined annual costs by approximately $30 million by 2027.Technology
- EQPTNov 9, 4:57 PMEquipmentShare reported third-quarter 2026 total revenue of $1,468 million, representing a 55% year-over-year increase driven by a 49% rise in rental segment revenue. Net income for the quarter reached $20 million, while adjusted net income rose to $46 million, supported by a 52% increase in rental segment adjusted EBITDA to $491 million. The company expanded its managed fleet to $10.663 billion in original equipment cost and opened 18 new operational locations during the quarter. Management projects full-year 2026 total revenue between $5.8 billion and $6.0 billion, with adjusted core EBITDA guidance ranging from $2.1 billion to $2.2 billion.Industrials
- SMCNov 9, 4:57 PMSummit Midstream Corporation reported third-quarter 2026 net income of $15.9 million and Adjusted EBITDA of $70.7 million, representing a 16% increase from the second quarter. The company raised its full-year 2026 Adjusted EBITDA guidance to a range of $250 million to $260 million, driven by strong producer activity and a 40% increase in liquids volume throughput within its Rockies Segment. Double E Pipeline achieved record throughput of 1,002 MMcf/d, while the company reached a final investment decision on the Double E Mainline Compression Expansion to meet growing Permian Basin demand. As of September 30, 2026, the company maintained a total net leverage ratio of approximately 3.9x and held $12.5 million in unrestricted cash.Energy
- TDWNov 9, 4:55 PMTidewater Inc. reported revenue of $360.4 million for the third quarter of 2026, representing a 5.3% increase from the previous quarter, alongside a net income of $17.5 million. The company achieved an average day rate of $23,775 and a weighted average leading edge day rate of $27,373, while closing a $500 million all-cash acquisition of Wilson Sons Ultratug Offshore. Tidewater updated its full-year 2026 revenue guidance to a range of $1.43 billion to $1.44 billion and initiated 2027 revenue guidance of $1.70 billion to $1.75 billion. Additionally, the company generated $75.2 million in net cash from operating activities and $90.9 million in free cash flow during the quarter.Energy
- GMRSNov 9, 4:52 PMGMR Solutions Inc. reported net revenue of $1.596 billion for the third quarter of 2026, representing a 5.9% increase from the prior year, while net income rose 81.7% to $135.6 million. Adjusted EBITDA for the quarter reached $356.6 million, up 4.2% year-over-year, driven by growth in core emergent services and improved revenue per transport despite inflationary pressures. The company updated its full-year 2026 guidance to project net revenue between $5.9 billion and $6.05 billion and Adjusted EBITDA between $1.135 billion and $1.195 billion. Additionally, GMR strengthened its balance sheet by reducing leverage through a $200 million repayment on its senior secured term loan and maintaining a liquidity position of approximately $999.3 million.Healthcare
- NOVTNov 9, 4:50 PMNovanta reported third-quarter 2026 GAAP revenue of $305 million, representing a 23% increase from the prior year, driven by strong commercial momentum and the impact of its largest acquisition to date. The company achieved an Adjusted EBITDA of $80.3 million, a 38% year-over-year increase, while Adjusted Diluted EPS rose 21% to $1.05. Customer bookings grew by 29%, expanding the backlog to $543 million and supporting a solid foundation for future growth. Looking ahead, Novanta expects full-year 2026 GAAP revenue to range between $1.135 billion and $1.140 billion, with Adjusted EBITDA projected between $274 million and $277 million.Technology
- ELMTNov 9, 4:50 PMThe Elmet Group Co. reported third-quarter 2026 revenue of $79.6 million, representing a 55.6% increase from the prior year period, driven by strong demand in aerospace, defense, and government markets. The company achieved a record gross profit margin of 31.3% and an adjusted EBITDA of $17.0 million, while its open order backlog surged 298% to $347.4 million. This growth follows a landmark $450 million investment from the Department of War and a framework agreement with the Defense Logistics Agency, which are funding expanded domestic tungsten capabilities and manufacturing modernization.Industrials
- ASTSNov 9, 4:49 PMAST SpaceMobile announced plans to activate nationwide intermittent cellular service in the United States and other key markets by the end of 2026, leveraging partnerships with over 60 mobile network operators. The company secured $1.0 billion in non-dilutive funding from Japan for satellite manufacturing and launch, while also advancing its proprietary Blacklift reusable rocket program for late 2028 deployment. Financial results for the third quarter of 2026 showed revenue growth to $42.3 million, driven by gateway deliveries and U.S. government contracts, alongside a cash position of approximately $3.2 billion. Production is transitioning to full-scale ASIC integration with a target monthly capacity of six satellites by December 2026, aiming to deploy over 100 BlueBird satellites cumulatively in 2027 and 2028.Technology
Research Reports
Technology →Sep 28, 2026 to Nov 12, 2026 · 363 companies
Technology Earnings Report — 2026-09-28 to 2026-11-12
Report generated: 2026-11-12 11:05:19 EST
Overview
Companies reported: 363 (2026-09-28 - 2026-11-12). Technology sector results were overwhelmingly positive, driven primarily by surging demand for AI infrastructure that propelled record revenue growth across hyperscalers, data center operators, and semiconductor firms. Companies such as CoreWeave (CRWV), Super Micro Computer (SMCI), and Sandisk Corp (SNDK) led the sector with triple-digit year-over-year revenue increases, while profitability expanded significantly for firms like Netlist (NLST) and Palantir (PLTR) through operating leverage and product mix shifts. This performance was underpinned by robust backlog visibility and aggressive capital expenditure plans to scale physical infrastructure, though the sector faced divergent outcomes with outliers like GoPro (GPRO) and Ideal Power (IPWR) reporting severe contractions.
Leaderboard
Top 5 by Revenue Growth (YoY)
| # | Company | Ticker | Revenue Growth YoY | Revenue |
|---|---|---|---|---|
| 1 | Boost Run Inc. | BRUN | 496% | $39.9 million |
| 2 | Sandisk Corp. | SNDK | 378% | $11.031 billion |
| 3 | IonQ Inc. | IONQ | 336% | $173.8 million |
| 4 | Super Micro Computer Inc. | SMCI | 298% | $19.9 billion |
| 5 | CoreWeave Inc. | CRWV | 168% | $3.66 billion |
Note: Sandisk Corp. (SNDK) and Super Micro Computer Inc. (SMCI) reported revenue figures that include significant non-recurring items or acquisitions impacting the year-over-year comparison.
Top 5 by Net Income Growth (YoY)
| # | Company | Ticker | Net Income Growth YoY | Net Income |
|---|---|---|---|---|
| 1 | Strategy Inc | MSTR | n/a | $19.53 billion |
| 2 | Sandisk Corp | SNDK | n/a | $8.101 billion |
| 3 | Core Scientific | CORZ | n/a | $1.2 billion |
| 4 | IonQ Inc | IONQ | n/a | $564.0 million |
| 5 | Netlist Inc | NLST | n/a | $85.4 million |
Net income growth rates are not listed for the top entries as the summaries provide absolute net income figures or attribute gains to non-cash items (e.g., warrant liability changes, digital asset gains) without explicitly stating a comparable prior-year net income figure for a direct percentage calculation.
Themes
- AI infrastructure demand is a primary revenue driver across the sector, with hyperscalers and data center operators accelerating spending on GPUs, networking, and power solutions; companies like CoreWeave (CRWV), Super Micro Computer (SMCI), and AMD (AMD) reported record revenue growth directly tied to AI workload deployment, while semiconductor equipment firms such as KLA (KLAC) and Onto Innovation (ONTO) cited robust demand from AI ecosystem buildouts.
- Significant capital expenditure expansion is evident as firms scale physical infrastructure to meet compute needs, with CoreWeave (CRWV) raising its capex outlook to $37–$39 billion and Arista Networks (ANET) expanding its liquid-cooled product portfolios to support high-density AI clusters.
- Revenue growth is increasingly concentrated in recurring software and subscription models, particularly for AI-enabled platforms; ServiceNow (NOW) raised its AI annual contract value target to $1.7 billion, while Palantir (PLTR) saw U.S. commercial revenue surpass government revenue for the first time, driven by agentic AI adoption.
- M&A activity is accelerating as companies seek to integrate AI capabilities and expand market reach, with major transactions including Microsoft's (MSFT) strategic investments, Marvell (MRVL)'s acquisition of Lumentum, and onsemi's (ON) agreement to acquire Synaptics to bolster AI processor power delivery.
- Cost management and margin expansion are critical themes, with many firms achieving profitability through operating leverage and product mix shifts; Netlist (NLST) and D-Wave Quantum (QBTS) reported significant margin improvements, while others like Lattice Semiconductor (LSCC) and Monolithic Power Systems (MPWR) expanded non-GAAP margins through high-margin AI server and data center product lines.
- Supply chain constraints and component availability remain a key operational focus, with companies like Netgear (NTGR) and Ubiquiti (UI) citing memory and semiconductor supply issues, while Intel (INTC) and AMD (AMD) emphasized securing wafer allocation and expanding capacity to meet surging demand.
- Strong balance sheets and liquidity positions are enabling aggressive capital allocation strategies, including share repurchases and dividends; Apple (AAPL) returned $28 billion to shareholders in a single quarter, and Fortinet (FTNT) increased its buyback authorization by $1.2 billion, reflecting confidence in cash generation despite high growth investments.
- Strategic pivots toward specialized AI hardware and software solutions are reshaping product portfolios, with firms like NVIDIA (via partners like CoreWeave) and specialized AI infrastructure providers (e.g., QumulusAI (QMLS), Boost Run (BRUN)) securing multi-year contracts to supply high-performance computing resources.
- Regulatory and geopolitical factors continue to influence operations, with companies like Clearfield (CLFD) and Viasat (VSAT) navigating government contract awards and spectrum authorizations, while others like Intel (INTC) and AMD (AMD) face export control risks and supply chain diversification challenges.
- Transition from traditional hardware sales to service-based and solution-oriented models is driving recurring revenue, with firms like Cisco (via partners), Fortinet (FTNT), and Cloudflare (NET) emphasizing platform ecosystems and managed services to capture long-term value in the AI era.
Market Outlook & Trends
- Revenue growth is being driven primarily by AI infrastructure demand, with hyperscalers and data center operators accelerating capital expenditures; CoreWeave (CRWV) reported a 168% YoY revenue surge to $3.66 billion, while Super Micro Computer (SMCI) saw net sales jump 298% YoY to $19.9 billion, and AMD (AMD) noted a 97% surge in its Data Center segment.
- Backlog and order visibility remain robust across the sector, with companies like M-tron Industries (MPTI) reporting a 44.3% backlog increase to $84.9 million, Clearfield (CLFD) seeing a 75% backlog rise, and CoreWeave (CRWV) securing a $132.5 billion revenue backlog.
- Capacity expansion and supply chain constraints are key themes, as evidenced by Netlist (NLST) and nLIGHT (LASR) citing supply chain constraints affecting product revenue, while Key Tronic (KTCC) and Netgear (NTGR) noted manufacturing constraints and supply chain financing issues delaying shipments.
- Pricing power and margin expansion are evident in semiconductor and equipment segments, with companies like KLA (KLAC) and FormFactor (FORM) reporting significant gross margin improvements driven by advanced packaging and AI demand, while Diodes (DIOD) and Wolfspeed (WOLF) highlighted margin pressures from mix shifts and inventory costs.
- Software and infrastructure firms are transitioning toward recurring revenue models and AI-driven services, with Palantir (PLTR) highlighting the "Sovereign AI movement" as a growth driver and ServiceNow (NOW) raising its AI annual contract value targets to $1.7 billion.
- M&A activity is accelerating as companies seek to integrate AI capabilities and expand market reach, with Digi International (DGII) acquiring Disruptive Technologies (DT), Five9 (FIVN) acquiring Level AI, and Marvell (MRVL) announcing an all-stock acquisition of Lumentum (LITE).
- Capital allocation strategies are shifting toward share repurchases and dividends to return value to shareholders, with Apple (AAPL) returning $28 billion in a single quarter, Microsoft (MSFT) returning $10.2 billion, and numerous firms like Fortinet (FTNT) and Broadcom (AVGO) authorizing or executing significant buyback programs.
- Risks identified by management include geopolitical tensions, regulatory uncertainties, and supply chain volatility, with Intel (INTC) citing PC slowdowns and trade regulations, while others like Uber (UBER) and Lyft (LYFT) face regulatory and legal settlement costs impacting net income.
- Several companies are revising guidance upward due to stronger-than-expected demand, including Arista Networks (ANET), which raised Q4 guidance, and Datadog (DDOG), which increased full-year revenue guidance, reflecting confidence in sustained AI adoption.
- Conversely, some firms are lowering guidance or facing headwinds due to macroeconomic softness, tariff impacts, and customer delays, with First Solar (FSLR) reducing volume guidance and Xerox (XRX) significantly lowering revenue and earnings outlooks due to unfavorable product mix and input costs.
Key Numbers
- CoreWeave (CRWV) reported Q3 2026 revenue of $3.66 billion, a 168% year-over-year increase, while Adjusted EBITDA rose 169% to $2.26 billion.
- Super Micro Computer (SMCI) posted Q1 FY2027 net sales of $19.9 billion, up 298% year-over-year, with net income reaching $1.594 billion.
- Arista Networks (ANET) achieved Q3 2026 revenue of $3.66 billion, a 58.5% year-over-year increase, with non-GAAP diluted EPS rising to $1.20.
- AMD (AMD) recorded Q3 2026 revenue of $13.4 billion, up 45% year-over-year, driven by a 97% surge in Data Center segment revenue to $8.5 billion.
- Palantir Technologies (PLTR) reported Q3 2026 revenue of $2.313 billion, a 96% year-over-year increase, with GAAP net income of $1.128 billion.
- Shopify (SHOP) saw Q3 2026 revenue grow 32% year-over-year to $3.742 billion, with net income rising to $462 million.
- Microsoft (MSFT) reported Q1 FY2027 revenue of $92.3 billion, up 19% year-over-year, with Azure revenue surging 48%.
- Apple (AAPL) posted Q3 2026 revenue of $114.5 billion, a 12% year-over-year increase, with Services revenue reaching a record $31.6 billion.
- Lattice Semiconductor (LSCC) reported Q3 2026 revenue of $291.0 million, a 118.3% year-over-year increase, with Non-GAAP net income jumping 171.7% to $103.7 million.
- Monolithic Power Systems (MPWR) achieved Q3 2026 revenue of $1,202.4 million, up 63.1% year-over-year, with non-GAAP net income rising 77.3% to $402.7 million.
Outliers
- CoreWeave (CRWV) posted the strongest report with Q3 revenue surging 168% YoY to $3.66 billion and a massive backlog of $132.5 billion, driven by aggressive infrastructure build-out and AI demand.
- Netlist (NLST) delivered a standout turnaround with net sales up 149% YoY to $105.1 million, achieving a major profitability shift to $85.4 million net income supported by a 65.5% gross margin.
- GoPro (GPRO) presented the weakest report, citing substantial doubt regarding its ability to continue as a going concern, material weaknesses in internal controls, and a 41% revenue decline to $96 million.
- Ideal Power (IPWR) reported the most severe revenue contraction with Q3 sales falling to just $7,000 from $24,450 the prior year, alongside a widened net loss of $3.6 million.
Earnings Call Transcripts
More →- FLNGFlex LNG Q3-2026 Video Webcast - FLEX LNG LTD 1d ago
- CHYMCHIME FINANCIAL INC (CHYM) - KBW FINTECH ECOSYSTEM CONFERENCE - CHIME FINANCIAL INC 1d ago
- LUNGStifel 2026 Healthcare Conference - PULMONX CORP 1d ago
- CELCSTIFEL 2026 HEALTHCARE CONFERENCE - CELCUITY INC 1d ago
- NOCBAIRD 2026 GLOBAL INDUSTRIAL CONFERENCE - NORTHROP GRUMMAN CORP 1d ago
- SENSCG MEDTECH, DIAGNOSTICS AND DIGITAL HEALTH & SERVICES FORUM - SENSEONICS HOLDINGS INC 1d ago
- STAACG MEDTECH, DIAGNOSTICS AND DIGITAL HEALTH & SERVICES FORUM - STAAR SURGICAL CO 1d ago
- KIDSSTIFEL 2026 HEALTHCARE CONFERENCE - ORTHOPEDIATRICS CORP 1d ago
- DEFTgoeasy - Q3 2026 Earnings Call - DEFI TECHNOLOGIES INC 1d ago
- SWAGStran & Company Third Quarter 2026 Earnings Call - STRAN & COMPANY INC 1d ago
- CBLLCG MEDTECH, DIAGNOSTICS AND DIGITAL HEALTH & SERVICES FORUM - CERIBELL INC 1d ago
- RUMRUM Group Inc. Third Quarter 2026 Earnings Call - RUM GROUP INC 1d ago
- AYISPECIAL MEETING OF SHAREHOLDERS - ACUITY INC (DE) 1d ago
- MGNXSTIFEL 2026 HEALTHCARE CONFERENCE - MACROGENICS INC 1d ago
- TRVISTIFEL 2026 HEALTHCARE CONFERENCE - TREVI THERAPEUTICS INC 1d ago
- CBLLCG MEDTECH, DIAGNOSTICS AND DIGITAL HEALTH & SERVICES FORUM - CERIBELL INC 1d ago
- LUNGCG MEDTECH, DIAGNOSTICS AND DIGITAL HEALTH & SERVICES FORUM - PULMONX CORP 1d ago
- AIIAmerican Integrity Insurance Group Q3 2026 Earnings Call - AMERICAN INTEGRITY INSURANCE GROUP INC 1d ago
- BAIRD 2026 GLOBAL INDUSTRIAL CONFERENCE - Regal Rexnord Corporation 1d ago
- LIVNSTIFEL 2026 HEALTHCARE CONFERENCE - LIVANOVA PLC 1d ago
- BCAXSTIFEL 2026 HEALTHCARE CONFERENCE - BICARA THERAPEUTICS INC 1d ago
- DNLIStifel 2026 Healthcare Conference - DENALI THERAPEUTICS INC 1d ago
- USEGBig Sky Industrial Inc's Third Quarter 2026 Earnings Conference - BIG SKY INDUSTRIAL INC 1d ago
- MDXGCG MEDTECH, DIAGNOSTICS AND DIGITAL HEALTH & SERVICES FORUM - MIMEDX GROUP INC 1d ago
- MDXGCG MEDTECH, DIAGNOSTICS AND DIGITAL HEALTH & SERVICES FORUM - MIMEDX GROUP INC 1d ago
- USEGBig Sky Industrial Inc's Third Quarter 2026 Earnings Conference - BIG SKY INDUSTRIAL INC 1d ago
- TELTE Connectivity plc at BAIRD 2026 Global Industrial Conference - TE CONNECTIVITY PLC 1d ago
- MPBAIRD 2026 GLOBAL INDUSTRIAL CONFERENCE - MP MATERIALS CORP 1d ago
- BBNXSTIFEL 2026 HEALTHCARE CONFERENCE - BETA BIONICS INC 1d ago
- EVGNICL Third Quarter 2026 Earnings Call - International - EVOGENE LTD 1d ago
Press Releases
More →- IIIAI-Enabled Total Compensation Platforms Help Enterprises Manage Increasing Complexity, ISG says Business Wire · 4m ago
- AWKWest Virginia American Water Announces $580,000 Infrastructure Upgrades in Oak Hill PR Newswire · 7m ago
- JJacobs declares quarterly dividend Business Wire · 13m ago
- AWKIndiana American Water President Addresses ASCE 2026 Report Card for Indiana's Infrastructure PR Newswire · 16m ago
- STLAStellantis Global Supplier Conference Honors 61 Suppliers Worldwide for Excellence in Performance, Quality, Innovation and Value Creation GlobeNewswire · 19m ago
- KEYSKeysight Survey Finds Fewer than Half of Grid Operators Believe Network Is Ready as Power Demand Surges Business Wire · 21m ago
- TRIThomson Reuters to Present at TD Securities Technology Conference PR Newswire · 21m ago
- TOPSTop Ships Announces Sale of Two Newbuilding MR Tankers for about $14.5 million GlobeNewswire · 21m ago
- TKRTimken Earns Recognition on Forbes America's Best Companies 2027 List PR Newswire · 21m ago
- TGLTreasure Global Announces 1-for-24 Reverse Stock Split to Support Nasdaq Bid Price Compliance GlobeNewswire · 21m ago
- OMCNew Ad Council and Surgo Health Report Finds Young People Report Mental Health Symptoms at Twice the Rate Parents Recognize PR Newswire · 23m ago
- AWKVoters in Stone County Approve Sale of Water System to Missouri American Water PR Newswire · 25m ago
- LUVSOUTHWEST AIRLINES DECLARES 191st QUARTERLY DIVIDEND PR Newswire · 36m ago
- OBAIBond Reports Approximately 60% Adoption Among Residents Introduced to Its City-Funded Personal Security Program, About 12 Times the Industry Average GlobeNewswire · 36m ago
- RUBIRubico Inc. Reports Net Income of $1.4 Million, Revenues of $5.4 Million and EBITDA of $3.3 Million for the Three Months Ended September 30, 2026 GlobeNewswire · 50m ago
- CCLCunard Unveils First Look at Reimagined Queen Victoria Following Extensive Transformation PR Newswire · 51m ago
- BWENDresner Partners Advised MCM on Its Sale to Broadwind GlobeNewswire · 51m ago
- PHVSPharvaris Presents Clinical and Real-World Data at the ACAAI 2026 Annual Scientific Meeting GlobeNewswire · 53m ago
- ROKRockwell Automation Introduces LogixEdge Controllers for Software-Defined Automation PR Newswire · 1h ago
- VYXNCR Voyix to Present at Upcoming Investor Conferences Business Wire · 1h ago
- NTHINeOnc CEO Buys More Shares Below $5 as NTHI Secures FDA Meeting to Discuss Phase 3 Trial GlobeNewswire · 1h ago
- TDTHTrident Eliminates US$3 Million of Debt Through Founder Equity Conversion GlobeNewswire · 1h ago
- GILSueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of December 14, 2026 in Gildan Activewear Inc. Lawsuit - GIL PR Newswire · 1h ago
- ARDXSueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Ardelyx, Inc. Lawsuit - ARDX PR Newswire · 1h ago
- TMUST-Mobile Powers New Ways to Experience the FORMULA 1 HEINEKEN LAS VEGAS GRAND PRIX On and Off the Track Business Wire · 1h ago
- AMZNFuture Ready 2030: Amazon Is Helping More People Build Skills for New Careers in AI, Robotics, and Beyond Business Wire · 1h ago
- ALKALK to present positive phase II data on its tablet for the treatment of peanut allergy at ACAAI 2026 GlobeNewswire · 1h ago
- BCBrunswick Corporation Wins Best of Show, Three Additional Honors at 2026 In-House Creative Awards GlobeNewswire · 1h ago
- RITMNewrez Launches Personal Loans, Powered by Upgrade, Giving Homeowners More Ways to Achieve Their Financial Goals Business Wire · 1h ago
- NTLAIntellia Therapeutics Presents Additional Positive Clinical and Patient-Reported Data for Lonvoguran Ziclumeran (lonvo-z) at ACAAI 2026 GlobeNewswire · 1h ago
BNN Bloomberg
More →- Democrats’ blue tsunami could be reversing travel turnoff of Canada-U.S. trade war 11m ago
- Canadian Tire courts gift shoppers with price cuts as costs squeeze consumers 27m ago
- NVDAJensen Huang resigns as Nvidia CEO 46m ago
- Small caps starting to gain traction: Brooke Thackray 47m ago
- ANTAdvocacy groups sue AI giants to freeze new models, warning of 'catastrophic' risks 58m ago
- NVDAHow Nvidia’s Jensen Huang got entangled in a China chip and spy scandal 1h ago
- Pelican AI brings 25 years of banking AI to faster, safer global payment screening 1h ago
- CHARBONE reports strongest quarter to date in preliminary third-quarter results 1h ago
- NVDANvidia CEO Jensen Huang resigns after his affair raises national security concerns 1h ago
- NVDANvidia shares plunge 13% at open after CEO Jensen Huang resigns 1h ago
- PM Carney defends Stellantis remarks after CTV News reports government knew of Roshel deal 2h ago
- Nvidia CEO Jensen Huang to step down in big blow to AI boom 2h ago
- U.S. spoke with Canada about trade deal in past few days, USTR says 2h ago
- Turkiye, AtkinsRealis sign deal for study on possible nuclear plant 2h ago
- Canadian Tire reports Q3 profit up from year ago, raises quarterly dividend 2h ago
- BNBrookfield reports third-quarter profit up from year ago 2h ago
- CAECAE raises earnings forecast for the year even as profits fall 3h ago
- PM Carney in Ireland for meetings with European leaders, ahead of Asia summits 3h ago
- Trump threatens to double tariffs on Mexico if it does not halt migrants 3h ago
- Cargojet reports $19.1M third-quarter profit, up from $8.8 million last year 3h ago
- NVDANvidia tumbles early amid questions about Nvidia CEO Jensen Huang’s future 3h ago
- Lutnick stalled Trump crackdown on diversion of Nvidia chips to China, Axios reports 4h ago
- World shares are mixed as Nvidia's troubles weigh on AI stocks 4h ago
- Joly set to hold meeting in Toronto with Stellantis, union and Ontario minister 5h ago
- Stan Wong: Tech and AI are under pressure. Is the market missing the bigger picture? 6h ago
- PM Carney touches down in Dublin, set to address European leaders 13h ago
- Joly didn't meet with Roshel before deal signed with Stellantis: minister's office 14h ago
- A Quebec town was once preparing for a big EV battery boost. Will it still come? 14h ago
- PM Carney arrives in Dublin for the European Political Community meet 14h ago
- Nvidia board meets to decide CEO Huang’s future, source says 15h ago
Earnings Reports
More →- FBDTFirst Breach Inc. Announces Third Quarter 2026 Earnings Conference Call 2h ago
- VSXYVictoria’s Secret & Co. Invites You to Listen to the Third Quarter 2026 Earnings Call 3h ago
- CAECAE raises earnings forecast for the year even as profits fall 3h ago
- WMTWalmart To Host Third Quarter Earnings Conference Call November 19, 2026 3h ago
- CMCTCreative Media & Community Trust Announces Date for Its Third Quarter 2026 Earnings Release and Conference Call 3h ago
- SAILSailPoint Announces Date of Fiscal Third Quarter 2027 Earnings Conference Call and Participation in Upcoming Investor Conference 3h ago
- SPHSuburban Propane Partners, L.P. Announces Full Year and Fourth Quarter Results 3h ago
- TWSTTwist Bioscience Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results 4h ago
- NBISNebius reports third quarter 2026 financial results 4h ago
- BNBrookfield Corporation Reports 16% Increase in Earnings 4h ago
- DPCDPC Holdings Reports Record Third Quarter 2026 Results 4h ago
- EYENational Vision Holdings, Inc. Reports Third Quarter 2026 Financial Results 5h ago
- CMBTCMB.TECH ANNOUNCES Q3 2026 RESULTS ON 26/11/2026 8h ago
- PROPPrairie Operating Co. Announces Third Quarter 2026 Earnings Release Date and Conference Call 16h ago
- DDSCORRECTION - Dillard’s, Inc. to Report Third Quarter and Year-to-Date Results 18h ago
- AGBKAgi Inc. Reports Third Quarter 2026 Results 18h ago
- AZOAutoZone to Release First Quarter Fiscal 2027 Earnings December 8, 2026 18h ago
- KITTNauticus Robotics, Inc. Announces Date for 2026 Third Quarter Earnings Conference Call 18h ago
- CEPLCapstone Energy+ Reschedules Second Quarter Fiscal Year 2027 Earnings Conference Call and Webcast to Monday, November 16, 2026 at 4:45 p.m. ET 19h ago
- KNOPKNOT Offshore Partners LP Announces 3rd Quarter 2026 Earnings Results Conference Call 19h ago
- DDIDoubleDown Interactive Reports Third Quarter 2026 Revenue of $94.3 Million and Earnings per Fully Diluted Common Share of $7.41 19h ago
- TKTeekay Corporation Ltd. Third Quarter 2026 Update 19h ago
- HMRHeidmar Announces Date for the Third Quarter 2026 Financial Results, Conference Call, and Webcast 19h ago
- SNEXStoneX Group Inc. to Announce 2026 Fiscal Fourth Quarter Earnings on November 18, 2026 19h ago
- MSFTCoreWeave turns to customer prepayments, shorter contracts to fund AI growth 20h ago
- GDDefense Contractors Detail Earnings, Army Orders and Rocket Output in New Releases 21h ago
- XTNDXTEND Announces Timing for Third Quarter Earnings Conference Call and Participation in Upcoming Investor Conferences 22h ago
- GGNGAMCO Global Gold, Natural Resources & Income Trust Declares Monthly Distributions of $0.035 Per Share 22h ago
- GNTGAMCO Natural Resources, Gold & Income Trust Declares Monthly Distributions of $0.06 per Share 22h ago
- CAAPCorporación América Airports Announces Third Quarter 2026 Financial Results Call and Webcast 22h ago
FDA Approvals
More →- NTHINeOnc CEO Buys More Shares Below $5 as NTHI Secures FDA Meeting to Discuss Phase 3 Trial GlobeNewswire · 1h ago
- NTHINeOnc Insider Buying Expands Ahead of FDA Discussions and Two Key Brain Cancer Data Presentations GlobeNewswire · 1h ago
- TSHATaysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update GlobeNewswire · 3h ago
- NGENNervGen Receives FDA Breakthrough Therapy Designation for NVG-291 in Chronic Spinal Cord Injury GlobeNewswire · 4h ago
- BBIOA Run of FDA Target Dates Fills the Biotech Calendar From Late November to Year End PR Newswire · 4h ago
- NTHIFDA Meeting Could Put NeOnc's NEO100 Experimental Brain Cancer Drug on Faster Track GlobeNewswire · 1d ago
- NTHINeOnc Technologies Granted FDA Type B End-of-Phase Meeting to Discuss Potential Accelerated Approval Pathway and Phase 3 Confirmatory Trial for Intranasal NEO100 GlobeNewswire · 1d ago
- PYPDPolyPid Provides Corporate Update and Reports Third Quarter 2026 Financial Results GlobeNewswire · 1d ago
- INOINOVIO Reports Third Quarter 2026 Financial Results and Recent Business Highlights PR Newswire · 1d ago
- MGXMetagenomi Therapeutics Announces FDA Clearance of Investigational New Drug Application for MGX-001 and Reports Third Quarter 2026 Financial Results GlobeNewswire · 1d ago
- FRNMFreenome Reports Third Quarter 2026 Financial Results GlobeNewswire · 1d ago
- GRAL1780183 - GRAIL INC Earnings Call Transcripts · 2d ago
- OWLTOwlet Expands Into Everyday Family Health With Launch of Smart Thermometer Business Wire · 2d ago
- WATWaters Achieves FDA 510(k) Clearance for Ready-to-Use Flow Cytometry Clinical Tests for Leukemia and Lymphoma PR Newswire · 2d ago
- SRRKScholar Rock Reports Third Quarter 2026 Financial Results and Recent Business Highlights Business Wire · 2d ago
- BDTXBlack Diamond Therapeutics Announces Positive Updated Silevertinib Phase 2 Results, FDA Feedback Supporting a Clear Path to Potential Registration in 1L EGFR-NCM NSCLC, and Provides Corporate Update GlobeNewswire · 2d ago
- BDTXBlack Diamond Therapeutics Announces Positive Updated Silevertinib Phase 2 Results, FDA Feedback Supporting a Clear Path to Potential Registration in 1L EGFR-NCM NSCLC, and Provides Corporate Update GlobeNewswire · 2d ago
- NVOFDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound CNBC · 2d ago
- RANIRani Therapeutics Reports Third Quarter 2026 Financial Results; Provides Corporate Update GlobeNewswire · 2d ago
- LRMRLarimar Therapeutics Completes Rolling BLA Submission Seeking Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia GlobeNewswire · 2d ago
- RANIRani Therapeutics Reports Third Quarter 2026 Financial Results; Provides Corporate Update GlobeNewswire · 2d ago
- TRVITrevi Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates GlobeNewswire · 2d ago
- HYPRHyperfine, Inc. Reports Third Quarter 2026 Financial Results Business Wire · 2d ago
- BDTXBlack Diamond Therapeutics to Host Webcast Highlighting Updated Silevertinib Phase 2 Data and FDA Feedback Supporting a Clear Phase 3 Path to Potential Accelerated Approval in 1L EGFR-NCM NSCLC GlobeNewswire · 2d ago
- SIGASIGA Announces Retirement of Chief Scientific Officer Dennis Hruby, Ph.D. GlobeNewswire · 2d ago
- BDTXBlack Diamond Therapeutics to Host Webcast Highlighting Updated Silevertinib Phase 2 Data and FDA Feedback Supporting a Clear Phase 3 Path to Potential Accelerated Approval in 1L EGFR-NCM NSCLC GlobeNewswire · 2d ago
- NNOXUSARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows GlobeNewswire · 3d ago
- NNOXUSARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows GlobeNewswire · 3d ago
- CELCCelcuity Announces FDA Acceptance of sNDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer GlobeNewswire · 3d ago
- CELCCelcuity Announces FDA Acceptance of sNDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer GlobeNewswire · 3d ago